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Dear Colleague:  
 
In December 2003, the Division of Tuberculosis Elimination (DTBE), National Center 
for HIV, STD and TB Prevention (NCHSTP), Centers for Disease Control and 
Prevention (CDC) convened The Tuberculosis Behavioral and Social Science Research 
Forum in Atlanta, Georgia.  The theme was Planting the Seeds for Future Research. The 
goals of the Forum were to identify and prioritize TB behavioral and social science 
research gaps; to use that information to develop a feasible, goal-oriented research 
agenda that will guide TB behavioral and social science activities over a 5-year period; 
and to foster productive partnerships and ongoing communications between national, 
state, and local governmental and nongovernmental behavioral and social science 
researchers focusing on tuberculosis (TB). 
 
The Forum brought together over 60 academicians, researchers, TB controllers and 
program staff, and CDC representatives.  The expectation was that their varied 
perspectives would contribute to the development of a research agenda addressing high 
priority behavioral and social aspects of TB prevention and control.  
 
The Forum was convened to address the need for further TB behavioral and social 
science research, as called for in the Institute of Medicine’s 2000 report Ending Neglect: 
The Elimination of Tuberculosis in the United States.  The Forum builds on the precedent 
of a 1994 workshop sponsored by CDC, the National Institutes of Health, and the Health 
Resources and Services Administration, Tuberculosis and Behavior: National Workshop 
on Research for the 21st Century.  
 
Behavioral and social science research has the potential to make a tremendous impact on 
efforts to prevent and control the spread of TB.  This research is needed to understand the 
behaviors of both patients and providers, and the impact of their actions on TB-related 
care seeking, diagnosis, treatment success, and prevention.  In addition, health care 
service delivery and systems research are needed to address the structure and 
organization of health systems as well as the environmental, economic, and sociopolitical 
issues and laws that impact the delivery of TB services.  
 
Progress has been made at CDC in incorporating behavioral and social science 
perspectives into TB prevention and control; however, there is still much work to be done 
in this area.  At CDC and elsewhere, behavioral and social scientists are currently 
engaged in research addressing a broad range of relevant sociocultural, behavioral, and 
structural issues.  Further research should be conducted in a systematic manner, based on 
sound theories and using rigorous methodologies. 
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DTBE is pleased to share with you the proceedings from the Forum.  We hope that you 
will find the information of interest as you plan future behavioral and social science 
research and programmatic activities in your work addressing TB prevention and control. 
 
If you have any specific questions or comments regarding the Forum or the Forum 
Proceedings, please join the TB Behavioral Science listserv at the following address:  
http://cdcnpin.org/scripts/tb_behavioral_science.asp.  
 
 
Sincerely,  
 
 
 
Kenneth G. Castro, M.D. 
Assistant Surgeon General, USPHS 
Director 
Division of Tuberculosis Elimination 
National Center for HIV, STD, and TB Prevention  
Centers for Disease Control and Prevention 
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Executive Summary 
In December 2003, the U.S. Centers for Disease Control and Prevention (CDC), Division of 
Tuberculosis Elimination (DTBE) convened the TB Behavioral and Social Science Research 
Forum: Planting the Seeds for Future Research.  The Forum’s overarching goal was to identify 
and prioritize TB behavioral and social science research needs, which will be used to develop a 
research agenda for TB prevention, control, and treatment.  These Forum Proceedings include 
summaries of presentations and discussions, as well as a synthesis of research needs and 
priorities identified by attendees.  
Forum presentations addressed behavioral and social science research in TB, including CDC’s 
current research activities in these disciplines.  Dr. Jessica Ogden and Dr. Masae Kawamura 
delivered keynote addresses on the role of behavioral and social sciences in TB control, and how 
research can improve TB treatment and control programs. Other speakers presented specific 
research findings addressing cultural, social, and environmental influences on TB education and 
patient adherence to treatment.  A panel of patients and providers described their firsthand 
experiences with local TB programs.  In addition, a panel of scientists described strategies to 
disseminate and translate research findings into practice.  
The Forum included breakout sessions for participants to identify needs and priorities for TB 
behavioral and social science research.  Section III of the Forum Proceedings is a compilation of 
the results of the breakout sessions.  The identified topics, subtopics, methodologies, and 
research questions have been organized using five broad levels of influence based on a socio-
ecological framework.  The five broad levels, along with a few examples, are listed below: 
• Intrapersonal:  patients’ knowledge, attitudes, and perceptions (KAP); health-seeking 
behaviors; acceptance of and adherence to treatment; patient satisfaction; social stigma; and 
providers’ KAP, training, and practices 
• Interpersonal: communication between patients and providers; family and peer influences 
• Health systems and organizations:  organizational structure (including collaboration 
between provider communities and systems; impact of sharing patient information); service 
delivery; contact investigations; health communications; and special challenges of high risk 
settings and populations 
• Community: impact of TB services on communities and patients  
• Public policy: government commitment and funding; health insurance and immigration 
policies 
Forum participants’ presentations and discussions reaffirmed the ongoing need for behavioral 
and social science research to improve TB prevention and control.  It is CDC’s hope that the 
Forum Proceedings will be widely used to plan future behavioral and social science research and 
programmatic activities to enhance TB prevention and control. 
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The Forum Proceedings document is divided into four main sections: 
Section I:  Introduction and Background 
• Introduction  
• Background information on TB behavioral and social science research   
Section II:  Presentations and Panel Discussions 
• Summaries of Forum presentations and panel discussions 
Section III:  Results of Breakout Group Sessions 
• Identification of TB behavioral and social science research gaps and needs 
• Outline and descriptions of major TB behavioral and social science research topics and 
subtopics identified at the Forum 
Section IV:  Appendices  
• Forum agenda 
• Presentation slides 
• List of major TB behavioral and social science research topics, subtopics, and questions  
• Participant list  
• References 
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Section I.  Introduction and Background 
Introduction 
These proceedings summarize the presentations and discussions that took place during The 
Tuberculosis Behavioral and Social Sciences Research Forum: Planting the Seeds for Future 
Research, which was held in Atlanta, Georgia, on December 10-11, 2003.  This meeting was 
built on the foundation of a previous workshop, Tuberculosis and Behavior: National Workshop 
on Research for the 21st Century, held in Bethesda, Maryland in 1994.  Plans for holding a 
second workshop emerged largely in response to renewed calls for further TB behavioral science 
research. Specifically, the Institute of Medicine’s (IOM) 2000 report Ending Neglect: The 
Elimination of Tuberculosis in the United States identified the need for further behavioral and 
social science research in TB control and treatment.  The IOM report included the following: 
“Recommendation 5.3. To promote better understanding of patient and provider nonadherence 
with tuberculosis recommendations and guidelines, a plan for a behavioral and social science 
research agenda should be developed and implemented”  (IOM 2000 report, page 123). The 
Forum provided an excellent and timely opportunity to revisit the behavioral science issues 
raised during the 1994 workshop.  
The goals of the Forum were to provide participants an opportunity to  
• Identify and prioritize TB behavioral and social science research gaps; 
• Develop a feasible, goal-oriented research agenda that will guide TB behavioral and social 
science activities; 
• Establish an ongoing partnership among national, state, and local governmental and non-
governmental behavioral and social science researchers focusing on TB; and 
• Create a mechanism for ongoing communication among TB behavioral and social science 
researchers. 
The Forum was designed to be an interactive “working meeting” and included presentations, 
panel discussions, and breakout sessions.  The Forum brought together an interdisciplinary group 
of over 60 individuals involved or interested in TB behavioral and social science research, 
including academicians, researchers, contractors, TB program staff and patients, and staff from 
the National Center for HIV, STD, and TB Prevention, including many from the Division of 
Tuberculosis Elimination.  
We hope that this document will be useful in several ways. It may be cited as a statement of the 
need for interdisciplinary research that includes the perspectives of the behavioral and social 
sciences.  It may also inspire researchers to conduct studies to address the identified research 
gaps and needs, leading to improvements in TB treatment and control.  It is also hoped that it 
will serve as a foundation for the development of a TB research agenda for the behavioral and 
social sciences.  Finally, it will also serve as an important document confirming the important 
role that behavioral and social sciences play in TB prevention and control and reminding 
researchers and program staff alike that, although we are making progress toward the elimination 
of tuberculosis, we still have much to learn and improve upon before we arrive at that goal.  
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Background 
 
Behavioral and Social Sciences in Disease Prevention  
Behavioral, psychosocial, and socio-cultural factors related to lifestyle contribute to many of the 
major causes of morbidity and mortality in the United States (Schneiderman, et. al, 2001).  The 
past 50 years have shown that to adequately address many health problems, social science 
theories and methodologies must be incorporated into the design of effective interventions and 
prevention activities.  In fact, many of today’s public health challenges require the utilization of 
behavioral and social science to address a wide range of health problems ranging from 
cardiovascular health, smoking, obesity, and unintentional injuries, to infectious diseases such as 
HIV/AIDS and TB.   
The U.S. National Institutes of Health (NIH) defines behavioral and social sciences research as a 
large, multifaceted field, encompassing a wide array of disciplines.  The field employs a variety 
of methodological approaches including surveys and questionnaires, interviews, randomized 
clinical trials, direct observation, descriptive methods, laboratory and field experiments, 
standardized tests, ethnography, and evaluation.  Yet, behavioral and social sciences research is 
not restricted to a set of disciplines or methodological approaches.  Instead, the field is defined 
by substantive areas of research that transcend disciplinary and methodological boundaries.  In 
addition, several key cross-cutting themes characterize social and behavioral sciences research.  
These include an emphasis on theory-driven research; the search for general principles of 
behavioral and social functioning; the importance ascribed to a developmental, lifespan 
perspective; an emphasis on individual variation, and variation across socio-demographic 
categories such as gender, age, and socio-cultural status; and a focus on both the social and 
biological context of behavior (http://obssr.od.nih.gov/funding/definition.html).   
Our understanding of public health problems, as well as our identification of ways to address 
them, is informed by the application of behavioral and social sciences.  Behavioral and social 
science research plays a critical role in developing, implementing, and evaluating disease control 
and prevention programs.  In particular, it is clear that health programs are more likely to be 
effective if they are based on a clear understanding of the targeted health behaviors and the 
environmental context in which they take place (Glanz et. al, 1990, Snider and Satcher, 1997).  
Further, social science research can contribute to a better understanding of how operational and 
infrastructural factors may impact the control or prevention of a health problem. 
 
Behavioral and Social Science Research at CDC 
As a result of lessons learned over the past two decades, the CDC has expanded its focus from a 
traditional epidemiological and biomedical approach to one that increasingly incorporates the 
behavioral and social sciences.  This shift is a recognition that the solutions to many of today’s 
public health problems require the application of multi-disciplinary research focusing on 
behavioral, societal, and cultural factors of individuals, groups, organizations, as well as health 
systems.  The application of behavioral and social sciences in the development, implementation, 
and assessment of prevention programs helps the public gain a better understanding of risk group 
characteristics in addition to the frequency, context, and determinants of risk behaviors (Snider 
and Satcher, 1997). 
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CDC has taken steps to integrate behavioral and social sciences into prevention activities 
throughout the agency resulting in programs that vary by organizational setting and substantive 
focus.  The incorporation of a behavioral and social science perspective into CDC’s work can be 
seen in areas such as the development of surveillance systems, risk factor identification and 
determinants research, and intervention testing (Galavotti et. al, 1997).  CDC has also realized 
the importance of establishing partnerships with other organizations, such as with professional 
societies including the American Psychological Association, the American Anthropological 
Association, and the American Sociological Association, to expand the role of behavioral and 
social sciences in co-sponsored educational activities (Snider and Satcher, 1997). 
In addition, the expansion of CDC behavioral and social science activities can be further 
evidenced by the establishment in 1995 of a CDC Behavioral and Social Science Working Group 
(BSSWG), whose mission is to further the understanding and use of behavioral and social 
science at CDC, as well as to promote and ensure excellence in behavioral and social science 
research throughout the agency (Snider and Satcher, 1997). 
 
Behavioral and Social Science Research in the National Center for HIV, STD, and TB 
Prevention (NCHSTP) 
Within CDC’s National Center for HIV, STD and TB Prevention (NCHSTP), behavioral and 
social science research has become increasingly recognized as critical to the improvement of 
efforts to prevent and control these three public health areas.  This is particularly true for HIV 
prevention, where behavioral interventions that seek to reduce risky behaviors offer the most 
commonly recommended methods to stem the epidemic.  Transmission of HIV and other 
sexually transmitted diseases (STDs) have been reduced by applying effective behavioral 
interventions that address sexual and drug-using behaviors.  Although tuberculosis’ airborne 
mode of transmission places it in a different category from HIV and STD control in terms of 
behaviors that put people at risk and can thus be targeted for interventions, behavioral and social 
science research plays a crucial role in TB prevention and control.  Due to the lengthy treatment 
regimen, the control of TB continues to be plagued by the persistent challenges associated with 
adherence to LTBI and TB medications.  Acceptance of and adherence to lengthy treatment for 
the asymptomatic condition of LTBI further increase these challenges. 
The 2000 Institute of Medicine report Ending Neglect: The Elimination of Tuberculosis in the 
United States called for additional research to understand the determinants of the behaviors of 
providers, patients, and systems and to improve methods for predicting and monitoring 
adherence to therapy (IOM, 2000).  In addition, other issues relevant to effective TB control can 
be further addressed from a behavioral and social science perspective.  These issues include, but 
are not limited to, identifying and treating LTBI and TB disease among persons in the United 
States, especially among African Americans in the Southeast and foreign-born persons; persons 
with TB/HIV co-infection; and persons with multidrug resistant TB (MDR-TB).  Other issues 
include addressing stigma experienced by persons affected by TB; preventing the development 
of TB among persons at high risk; and addressing providers’ non-adherence to guidelines and 
recommendations. 
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Furthermore, TB control efforts are challenged by the disparities in communities affected by TB.  
Social and economic factors such as poverty, homelessness, substance use, availability of and 
accessibility to appropriate care and services, and TB knowledge, attitudes and beliefs, have a 
significant impact on the personal TB experience.  Behavioral and social science research in TB 
has helped us better understand the behavior of TB patients and contacts, as well as that of 
providers.  It can further help us address questions such as: What point in the course of illness do 
people seek health care?  What issues influence the decision to seek care?  What issues influence 
acceptance of recommended medications?  What factors affect the decision and ability to 
continue and complete treatment?  Changes in the epidemic, such as the emergence of multidrug-
resistant strains and the increasing impact on foreign-born persons, highlight the need for a 
broader, multi-disciplinary approach to create innovative strategies to enhance future TB 
prevention and control efforts.  
The persistent challenges of preventing and controlling TB present a clear example of a public 
health problem that requires a multidisciplinary approach – one that looks beyond the biomedical 
model of TB control.  Incorporating multiple perspectives that include not only the traditional 
social sciences but also includes such disciplines as economics, epidemiology, and health policy 
analysis that strengthen the research design and outcomes.  These disciplines use a wide range of 
research methods and theoretical models to understand, predict, and influence attitudinal, 
behavioral, and social processes that impact health outcomes.  Multi-disciplinary research is 
critical for the development and implementation of effective TB prevention and control 
programs.  
 
Behavioral and Social Science Activities for TB Prevention and Control in CDC’s Division 
of Tuberculosis Elimination (DTBE) 
 
DTBE’s behavioral and social science research focuses largely on the major behavioral 
components influencing effective TB prevention and control -- issues including but not limited to 
treatment adherence, care-seeking behavior, patient-provider communication, perceptions of and 
ways to enhance the effectiveness of contact investigations, factors influencing acceptance of 
and adherence to LTBI treatment, and provider behaviors.  Much of the research includes or 
targets pertinent high-risk populations, such as minorities, foreign-born, and disenfranchised 
populations.   
 
In August 1994, CDC and the National Institutes of Health (NIH) co-sponsored a national 
workshop on tuberculosis behavioral research.  The workshop was a response to the 
recommendation for behavioral and social science research on tuberculosis as stated in the 
“National Action Plan to Combat Multidrug-Resistant Tuberculosis” (MMWR 1992; 41 (No. 
RR-11): 1-48.  This workshop brought together TB researchers, TB program staff, and interested 
stakeholders to establish an agenda for research on the primary behavioral, social, and health 
services aspects of tuberculosis treatment, prevention, and control.  A total of 66 participants, 
including experts in tuberculosis, health education, and the social and behavioral sciences, as 
well as representatives of local and national governmental and international organizations, met in 
Bethesda, Maryland.  The workshop was organized around five general and overlapping aspects 
of tuberculosis, including public knowledge of TB prevention and treatment; provider knowledge 
and practice; populations at high risk for TB; quality of TB control services; and patient 
adherence to treatment regimens. 
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Several years later, in 2000, the Institute of Medicine published Ending Neglect: The Elimination 
of Tuberculosis in the United States, a report that called for a behavioral science research agenda 
to help bring about the elimination of TB.  Beginning in 2001, DTBE initiated a process to 
revitalize the tuberculosis research agenda, focusing on the behavioral and social sciences.  The 
momentum generated by these events led to the December 2003 Tuberculosis Behavioral and 
Social Science Research Forum:  Planting the Seeds for Future Research.   
Extensive planning by an external steering committee, TB program staff, contractors, a CDC 
Planning Committee and other CDC colleagues culminated in the 2003 Behavioral and Social 
Science Research Forum, held in Atlanta, Georgia.  The purpose of the Forum was to provide 
participants an opportunity to 
• Identify and prioritize TB behavioral and social science research gaps; 
• Develop a feasible, goal-oriented research agenda that will guide TB behavioral and social 
science activities; 
• Establish an ongoing partnership among national, state, and local governmental and non-
governmental behavioral and social science researchers focusing on TB;  
• Create a mechanism for ongoing communication among TB behavioral and social science 
researchers. 
Toward these goals, the Forum was designed to be a working and interactive meeting and was 
organized into various activities, including:  
• Presentations on CDC’s behavioral and social science research in TB control and 
elimination;  
• Considerations and perspectives on TB control and behavioral and social science applications 
from panels of research, programmatic, and community representatives; and 
• Facilitated breakout groups to identify behavioral and social science research gaps and needs 
and research questions 
Recognizing that there is much work that still needs to be done before TB is eliminated, we hope 
this summary document of the Forum Proceedings will serve as a useful resource and provide the 
impetus for advancing efforts to control and eventually eliminate TB.   
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Section II.  Presentations and Panel Discussions  
The following section, which summarizes the Forum presentations and panel discussions, is 
organized according to the order of events at the Forum.  For the reader’s reference, a copy of the 
Forum agenda and presentation slides are included in Appendices A and B, respectively.  The 
Forum began with opening remarks and presentations highlighting the role of behavioral and 
social science research in TB control and elimination.  Following these presentations, a diverse 
group of researchers, scientists, community providers, staff of TB control programs, and patients 
shared their unique perspectives on TB control and behavioral and social science research in TB.  
DAY ONE 
WELCOME ADDRESS:  OPENING REMARKS  
Harold Jaffe, M.D. 
Director, National Center for HIV, STD, and Tuberculosis Prevention, Centers for Disease 
Control and Prevention  
Day 1, Morning Session  
Dr. Jaffe’s opening remarks highlighted behavioral and social science research contributions to 
understanding the behavior of patients and providers in several health fields and their relevance 
to TB control and prevention.  Early social science research has contributed to our understanding 
that cultural differences, race, gender, and ethnicity are as important as individual-level 
differences in predicting the success of health and disease prevention efforts.  Behavioral 
sciences have been critical to U.S. and international activities addressing HIV/AIDS, STDs, and 
TB.  For HIV/AIDS, behavioral sciences have enhanced our understanding of attitudes, health-
seeking behaviors, treatment adherence, and prevention strategies.  This research makes clear 
that “one size does not fit all” when developing prevention programs, a point that is also 
applicable to TB treatment and control strategies.  
More recently, the Institute of Medicine report Ending Neglect: Eliminating Tuberculosis in the 
United States called for studies to understand how interventions can be tailored to particular 
high-risk populations. Clearly, there is an expanding role for behavioral and social science 
research in informing the fight against tuberculosis.  This Forum marks the continuation and 
refinement of efforts to set an agenda for TB control and prevention research in these disciplines.  
************************************************************************  
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WELCOME ADDRESS:  BEHAVIORAL AND SOCIAL SCIENCE RESEARCH IN TUBERCULOSIS 
CONTROL  
Kenneth Castro, M.D. 
Director, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention  
Day 1, Morning Session  
Dr. Castro’s presentation on the role of behavioral and social scientists in TB control set the 
framework for the discussions that would guide the Forum.  Drawing from research efforts in TB 
control that preceded the Forum, he specifically cited recommendations from the 1994 CDC/NIH 
national workshop to set a research agenda on Improving Tuberculosis Treatment and Control, 
and also cited the call for behavioral science research from the 2000 Institute of Medicine (IOM) 
report Ending Neglect: Eliminating Tuberculosis in the United States.  
These efforts have helped shape the role of, and need for, behavioral and social science research 
in TB control.  Dr. Castro outlined the TB research needed in these disciplines:  
• Individual and interpersonal health behavior research is needed to address patient behaviors 
related to care seeking and adherence, provider behavior, and health care service delivery.  
• Systems research is needed to address the structure and organization of health systems; 
environmental, economic, and sociopolitical dynamics; and policies and laws.  
Behavioral and social scientists are conducting research to identify, understand, and address a 
broad range of relevant sociocultural, behavioral, and structural issues.  They are also conducting 
systematic, theory-based multidisciplinary research based on scientifically rigorous experimental 
and quasi-experimental designs.  
Although the ultimate purpose of the forthcoming TB behavioral and social science research 
agenda is to guide CDC research in these areas, Dr. Castro said he hoped that the research 
agenda would also be used to inform ongoing development and refinement of TB control 
strategies and policies for sister agencies, task forces, and academic institutions.   
************************************************************************  
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WELCOME ADDRESS:  BEHAVIORAL AND SOCIAL SCIENCES IN TUBERCULOSIS ELIMINATION  
Wanda Walton, Ph.D.  
Chief, Communications, Education, and Behavioral Studies Branch, Division of 
Tuberculosis Elimination, Centers for Disease Control and Prevention  
Day 1, Morning Session  
Dr. Walton described the expanding role for behavioral scientists within the CDC’s Division of 
Tuberculosis Elimination (DTBE) and highlighted current behavioral and social science projects 
involving providers and patients.  Current provider-focused studies include research to identify 
barriers to the acceptance and implementation of the 2000 guidelines for targeted testing and 
treatment for latent TB infection (LTBI) among private providers, and development of strategies 
to overcome such barriers.  A second study aims to identify factors that facilitate or hinder health 
care workers’ adherence to local protocols for administration of annual worksite tuberculosis 
skin tests (TST) and treatment of LTBI.  
Current patient-focused studies include:  
• An ethnographic study seeking to understand the culturally-mediated perceptions, attitudes, 
and experiences regarding TB among five foreign-born populations in the United States;  
• Research to develop culturally and linguistically appropriate patient education materials on 
TB;  
• An assessment of the usefulness of social network techniques to increase the identification of 
female contacts during contact investigations; and  
• Research to assess the knowledge, attitudes, and culture-specific beliefs about LTBI among 
several high-risk groups.  
Three studies recently initiated through the TB Epidemiological Studies Consortium include:  
• Task Order 11: Addressing TB Disease among African Americans in the Southeast; 
• Task Order 12: Assessing TB Knowledge, Attitudes, Beliefs, and Practices Among Private 
Providers Serving Foreign-born Populations; and  
• Task Order 14: Developing Culturally Appropriate Educational Materials for Hispanic 
Service Organizations.  
Dr. Walton added that the research Forum is part of this expanding behavioral and social science 
capacity within the Division, and marks the beginning of the next 5-year cycle of DTBE’s 
activities in these disciplines.  
***********************************************************************  
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KEYNOTE SESSION:  WHEN SACRED COWS BECOME THE TIGER’S BREAKFAST: DEFINING A 
ROLE FOR THE SOCIAL SCIENCES IN TUBERCULOSIS CONTROL  
Jessica Ogden, Ph.D.  
Technical Specialist, International Center for Research on Women  
Day 1, Morning Session  
Dr. Ogden presented a critical perspective on public health and TB control paradigms. Her 
presentation described a multidisciplinary approach to TB control that combines the strengths of 
the medical sciences with those of the behavioral and social sciences.  Her proposed approach 
was informed by lessons learned from directly observed therapy short-course (DOTS) programs 
for TB treatment in India.  
Dr. Ogden proposed a shift away from some of the “sacred cows” of classical public health 
thinking that emphasize disease control and elimination toward a social science paradigm 
focusing on the interactions among disease control personnel, individual patients, and the 
cultural and social contexts in which they live.  At the level of the patient, such a paradigm 
emphasizes care, with particular attention to developing trust and fostering patient-provider 
partnerships.  Outcomes in TB treatment and control are also strongly influenced by social and 
cultural contexts, including social structures within households, communities, and the policy-
making environment.  For example, social and cultural influences may determine who can adopt 
the sick role (and when), the range of treatment options available, and the extent to which a 
person can access and adhere to treatment.  
A multidisciplinary, multilevel approach that takes into account the respective influences and 
roles of patients, communities, and households, as well as programs, providers, and policies can 
help to answer the following questions related to TB:  
• Why don’t patients come for treatment?  
• Why do they only come when it’s too late?  
• Why don’t they complete their therapy?  
• How can we make our programs accessible and acceptable?  
• How can we meet the health needs of the community?  
• How can we involve communities as participants in their own health?  
Answering such questions in ways that address the multiple levels of influence is a critical step 
in improving TB control programs and the outcomes that they are able to achieve.  
***********************************************************************  
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KEYNOTE SESSION:  BEHAVIOR, SOCIETY AND TUBERCULOSIS CONTROL  
Masae Kawamura, M.D. 
Chairperson, Advisory Council for the Elimination of Tuberculosis; Director, Tuberculosis 
Control Section San Francisco Department of Public Health Tuberculosis Clinic, Ward 94 
San Francisco General Hospital  
Day 1, Morning Session  
Dr. Kawamura noted the accomplishments of TB control efforts and offered pathways to further 
improving TB control programs.  In particular, she identified several ways in which behavioral 
and social sciences can be applied to TB control, including: 
• Validating what we are doing right and wrong; 
• Introducing new behavioral strategies that have been proven in other fields; 
• Refining currently successful behavioral strategies, such as DOT, to improve implementation 
and outcomes; 
• Determining when strategies are appropriate or harmful; and 
• Framing TB data in their full context with demographics, social determinants, health 
disparities, and incidence of other diseases so the data are useful for advocacy and policy 
making.  
She also offered the following considerations to guide TB research and programs.  
• Research interventions must be practical and well planned.  
• If new resources will be needed to implement interventions, then the costs, savings, and 
benefits of such interventions should be documented.  
• When choosing staff, remember that civil service front-line staff may prove to be different 
from dedicated research staff.  
Dr. Kawamura identified specific populations and LTBI issues that still need to be addressed. 
Strategies are needed to engage minority and foreign-born communities, especially 
undocumented persons and new immigrants living on both sides of the U.S.-Mexico border.  
More work is needed to engage these patients and improve contact investigation methods and 
LTBI adherence strategies among them.  Additionally, health promotion and prevention for 
LTBI could be improved by integrating targeted testing and LTBI treatment into primary care. 
Nontraditional approaches that go beyond education and incentives and enablers are needed to 
increase LTBI treatment adherence.  Finally, the root causes of TB must be addressed. 
Communities and countries must mobilize to take action, and TB-related information must be 
provided in useful formats.  
Dr. Kawamura recommended a “macro” approach to enhance TB control efforts while 
acknowledging the individual-level strategies that have contributed to previous TB control 
successes.  During the discussion with Forum participants, she emphasized that the time has 
come to insist on ways to improve TB interventions.  She concluded by reminding participants 
that patients’ perspectives are greatly needed to inform programs.  
************************************************************************  
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PRELIMINARY RESULTS FROM THE TUBERCULOSIS BEHAVIORAL AND SOCIAL SCIENCE 
LITERATURE REVIEW  
Cathy Rawls, M.P.H., C.H.E.S.  
Association of Schools of Public Health Fellow, Communications, Education, and 
Behavioral Studies Branch, Division of TB Elimination, Centers for Disease Control and 
Prevention  
Cristina Booker, M.P.H.  
Analyst, Public Health Applications and Research Area, Abt Associates, Inc.  
Day 1, Morning Session  
One element of DTBE’s development of a research agenda includes a comprehensive review of 
TB behavioral and social science literature.  Ms. Rawls and Ms. Booker presented preliminary 
results from the literature review, which was still in progress at the time of the Forum.  
DTBE staff conducted a search in OVID across five databases (CINAHL, Embase, Medline, 
PsycInfo and Sociofile). This search identified literature that addresses behavioral, sociological, 
and cultural factors affecting TB prevention and treatment among affected populations and 
health care providers. General inclusion criteria used in this process were as follows:  
• TB research that used social science methods or applied social science theory or concepts;  
• Published works (including scientific, peer-reviewed literature, review articles, book 
chapters, and meta-analyses);  
• Literature published after 1980; and  
• Literature published in the English language that presents data or information for the United 
States or other countries.  
A team of DTBE staff and contractors from Abt Associates reviewed and abstracted 175 articles 
that were identified for inclusion. To ensure consistency, the team created data abstraction tools 
for obtaining relevant information from the literature.  Multiple reviewers conducted joint article 
reviews to ensure inter-rater reliability.  Key items abstracted from the literature included study 
descriptions such as study design, objectives, theoretical basis, sampling design, data collection 
methods, target population, geographic location, structural setting, and quantitative and 
qualitative analysis; key findings; limitations; conclusions; and recommendations.  
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Ms. Rawls and Ms. Booker presented preliminary analysis on article types (e.g., research, 
evaluation, or non-research); broad issues addressed in the literature (e.g., patient adherence; 
provider adherence; cultural and social domains, including knowledge, attitudes, and beliefs; 
health-seeking behaviors; structural influences; and other domains); and geographic areas and 
populations covered.  They also identified overarching themes that emerged from authors’ 
conclusions and recommendations, including the following areas to be addressed by future TB 
research or practice:  
• Underlying social or cultural factors associated with TB, such as poverty and patients’ health 
beliefs;  
• Health care-seeking behavior, such as health care-seeking delays related to stigma and length 
of treatment;  
• Patient-related adherence issues, such as patient-identified barriers and facilitators to 
adherence;  
• Provider-related adherence issues, such as diagnosis and treatment delays;  
• Health education strategies, such as culturally appropriate interventions to increase accurate 
TB knowledge and reduce TB-related prejudices;  
• TB control and eradication strategies, including novel and coordinated approaches that 
involve other health services and diverse types of providers; and  
• Resource and funding allocations, including increased resources for interdisciplinary research 
and continued support for public health TB programs.  
Continued activities for the TB behavioral and social science literature review will include a 
review of 100 additional articles and a database consisting of all the article reviews.  
************************************************************************  
NEIGHBORHOOD HEALTH MESSENGERS: USING LOCAL KNOWLEDGE, TRUST, AND 
RELATIONSHIPS TO CREATE CULTURALLY EFFECTIVE TUBERCULOSIS EDUCATION AND CARE 
FOR IMMIGRANT AND REFUGEE FAMILIES  
Stefan Goldberg, M.D.  
(on behalf of Patrick Chaulk, M.D., M.P.H.), Medical Officer, Clinical and Health Systems 
Research Branch, Division of Tuberculosis Elimination, Centers for Disease Control and 
Prevention  
Day 1, Morning Session  
Dr. Goldberg described a research project that utilized neighborhood health messengers, or 
“cultural case managers,” within a bilingual, bicultural TB control and prevention program, 
using local knowledge to create trust and relationships among immigrants and refugees.  He 
provided details on two different cultural case management LTBI treatment programs: one in 
Seattle, WA, for new refugees and immigrants, and one in Boston, MA, for the Haitian 
community.  
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Based on experience in the Seattle project, the following factors emerged as attributes of 
effective cultural case managers:  
• Having sufficient knowledge of the languages of target populations to formulate 
understandable and credible messages;  
• Having experience with establishing effective and mutually trusting relationships with the 
target community;  
• Being highly regarded in the target community, and therefore able to be trusted messengers 
in the community; and  
• Being able to educate target communities about public health strategies and the complex 
health care system.  
The Seattle program achieved a therapy acceptance rate of 88% and a therapy completion rate of 
82%. Interviews suggested that the success of this program was largely due to the outreach 
workers’ ability to build trusting relationships with their clients.  
The Haitian Collaborative Project in Boston conducted community mapping activities as part of 
its cultural case management project. Dr. Goldberg offered the following selected cultural 
findings for this project:  
• TB can be more stigmatizing than AIDS.  
• There is no framework for understanding “latent TB infection.” Offering treatment in the 
absence of patient symptoms may be seen as experimentation.  
• Pharmaceuticals are often considered dangerous.  
• There is widespread mistrust of American physicians.  
• Health beliefs are often complex and may involve secular or spiritual components.  
• Some words and phrases such as “negative” and “positive” test results may be difficult to 
translate or have unintended or unclear meanings.  
• Perception that a positive reaction to the tuberculin skin test is common.  In some 
populations, this is perceived as “normal” or a result of childhood vaccination with BCG.  
************************************************************************  
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PSYCHOSOCIAL, SOCIAL STRUCTURAL, AND ENVIRONMENTAL DETERMINANTS OF 
TUBERCULOSIS CONTROL  
Donald E. Morisky, Sc.D., M.S.P.H., Sc.M.  
Professor, School of Public Health Department of Community Health Sciences, University 
of California, Los Angeles  
Day 1, Morning Session  
Dr. Morisky presented research results from two randomized studies of adherence to anti-TB 
regimens.  The first study used cognitive and behavioral outcome markers, such as knowledge, 
beliefs, values, and attitudes, to assess the effectiveness of an educational intervention.  
Participants were randomized to one of three intervention groups: 1) educational counseling, 
2) incentives/rewards, 3) a combination of educational counseling and incentives/rewards, or to 
the control group.  Those who participated in the educational counseling intervention showed a 
significantly higher level of medication compliance from baseline to exit interview.  Dr. Morisky 
identified factors that may affect drop-out rates, such as ethnic background, gender, 
unemployment, homelessness, drug use, HIV status, primary language, and marital status.  
The second study focused on foreign-born adolescents’ adherence to LTBI treatment. 
Determinants of these adolescents’ compliance with and completion of treatment were 
categorized as individual, environment, or other.  
Individual determinants of compliance included:  
• An understanding of the medical regimen;  
• Belief in the benefits of treatment;  
• Positive attitudes regarding treatment; and  
• High levels of self-esteem and self-efficacy.  
Environmental determinants of compliance included: 
• Family member reinforcement in the home;  
• Good patient/provider communication;  
• Systematic approaches for patient monitoring, follow-up, and reinforcement;  
• Convenience of picking up medication from the clinic; and  
• Use of medication containers and cueing behaviors.  
Other determinants of completion of care included:  
• Regular appointment-keeping behavior;  
• High levels of adherence;  
• Use of community health workers;  
• Reinforcement of positive behaviors by health care staff; and  
• Use of peer counselors to clarify health concerns.  
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During the discussion with Forum participants, Dr. Morisky commented further on 
communication about non-adherence between patients and providers. Patients are often afraid of 
talking about non-adherence, and social desirability pressures further influence communication 
between patients and providers.  To address this issue, families should be encouraged to provide 
positive reinforcement for patients who are adherent to their treatment regimens.  
***********************************************************************  
COMMUNITY PERSPECTIVES IN TUBERCULOSIS CONTROL AND ELIMINATION: THE PERSONAL 
EXPERIENCES OF PATIENTS AND PROVIDERS PANEL DISCUSSION  
Robin Shrestha-Kuwahara, M.P.H. 
Behavioral Scientist, Clinical and Health Systems Research Branch, Division of 
Tuberculosis Elimination, Centers for Disease Control and Prevention 
Representatives from DeKalb County and Fulton County Public Health Departments  
Day 1, Morning Session  
In this session, a panel of three TB patients and two TB outreach workers from local health 
departments in Georgia shared their personal experiences with and perspectives on TB treatment.  
The discussion was loosely structured to elicit the personal experiences that patients and 
outreach workers wished to highlight.  Owing to this format, no slides or handouts were 
prepared.  The following excerpts have been organized around the categories that emerged 
during the discussion.  
Patient experiences and perspectives  
Reactions to tuberculosis diagnosis  
The patient panelists described their reactions and those of their family members to their being 
diagnosed with TB. Some patients talked of being initially shunned by their families and being 
asked to leave their homes.  These patients understood that their families’ responses were 
inappropriate and based on misinformation about TB transmission, but the rejection was 
nonetheless very painful to them.  One patient brought up the denial that she initially felt upon 
being diagnosed with TB, but she emphasized how important her family’s support was and how 
they urged her to seek care.  
Views of treatment and directly observed therapy  
All of the patients reported believing that directly observed therapy (DOT) worked for them, 
although all three had some problems with it.  Two of the patients experienced stigma owing to 
their TB illness, but didn’t use that specific term.  At first, they felt that the outreach workers’ 
visits were intrusive and embarrassing.  The patients also mentioned that the medications 
themselves tasted unpleasant and had some bad side effects. Overall, however, the patients felt 
that DOT helped them get through the treatment.  
 17 
Supports and enablers for tuberculosis treatment  
The patients mentioned several other factors besides DOT that assisted them during their course 
of treatment:  
• Assistance with basic needs such as housing, food vouchers, and other financial help;  
• Positive, trusting relationships with providers;  
• Faith in oneself;  
• Spiritual grounding; and  
• Support of family and friends.  
Provider experiences and perspectives  
Two outreach workers who provide DOT to TB patients also participated in the panel. Overall, 
they emphasized that patients have complex lives and problems; they need support and 
understanding to maintain adherence to TB medications and otherwise lead healthy lives. Key 
qualities for successful TB workers include patience, love of people, and a devotion to public 
health.  
Challenges to tuberculosis care  
The outreach workers listed the following challenges in working with TB patients:  
• Lengthy regimens that patients may desert once they are feeling better;  
• Failure of some patients to make appointments or otherwise comply with treatment;  
• Some patients’ suspicion that their whereabouts will be divulged by TB workers to 
immigration or law enforcement authorities; and  
• Common co-morbid conditions such as mental illness and substance use.  
Key elements of effective tuberculosis care  
The outreach workers discussed the following key elements for addressing the above challenges 
and generally meeting the needs of TB patients:  
• Nonjudgmental support and empathy for patients;  
• Incentives for adherence, such as food vouchers and transportation;  
• Clearly stated expectations regarding the treatment;  
• Motivation for adherence, such as the threat of multi drug-resistant TB; and  
• DOT, without which many patients would fail to complete their TB treatment.  
 
************************************************************************  
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GROUP DISCUSSION OF THEMES AND ISSUES FROM DAY ONE  
Mark Nichter, Ph.D., M.P.H. 
Professor, Department of Anthropology, University of Arizona  
Day 1, Afternoon Session  
Dr. Nichter led Forum participants in a group discussion of themes that emerged during the first 
day of the Forum.  The following is a summary of the main themes and issues discussed.  
Patients’ needs  
The group recognized the importance both of addressing the needs of TB patients, as well as 
overcoming the barriers to meeting those needs.  More research is needed to gather patients’ 
perspectives on the following topics:  
• The value patients place on their health;  
• The continuum of patient needs, including social needs and access to medications;  
• Patients’ negative opinions about TB treatment;  
• Patients’ mistrust of government agencies as a barrier to TB treatment; and 
• The tradeoff between long-term benefits of taking TB medications and possible short-term 
drawbacks, such as unpleasant side effects.  
Some underlying patient needs such as family support, housing, and financial assistance are well 
documented, but policy makers and funders must be convinced that addressing these needs may 
be critical to patient adherence to TB regimens. Families of TB patients can play either positive 
or negative roles in TB treatment.  Supportive families may be especially important for 
adolescents and some ethnic groups.   
Standardized and tailored approaches to working with TB patients must be balanced.  Adherence 
to standardized TB treatment protocols is extremely important, but tailored interventions that 
meet patients’ individual needs may be required to facilitate such adherence.  
Providers’ needs  
More research should focus on identifying and understanding the needs of TB providers in areas 
such as adherence to guidelines and reimbursement for insured services. Providers also need 
more education and training on dealing with patients’ emotional issues.  
Patient-provider relationship  
Building trust between patients and providers requires early and ongoing attention.  If treated 
with respect and sensitivity, clients who may initially be considered challenging often develop 
good relationships with clinicians.  If a provider has undue suspicions of a patient or has 
assumptions about patient non-adherence, these may present additional barriers to working with 
TB patients.  
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Directly observed therapy programs  
Participants discussed the strengths and limitations of DOT programs.  Suggestions for 
improving these models included the following:  
• Comparison of home-based and clinic-based DOT models based on patients’ needs;  
• DOT programs designed to address issues of TB-related stigma in work and home 
environments;  
• Cost-effectiveness research comparing home- and clinic-based DOT models;  
• Research to identify the characteristics of subpopulations and patients for whom DOT is 
particularly effective; and 
• Research on the sustainability and educational and cultural appropriateness of different DOT 
approaches with diverse populations.  
Health care systems  
Standard TB treatment protocols are needed in health care settings.  Additionally, TB control 
programs need capacity building to prepare for new developments and trends, such as the 
increasing diversity of populations affected by TB and the programs needed to reach varying 
patient groups.  
Additional challenges for health systems involve the image and reputation of health departments 
and many patients’ mistrust of systems and the medications they provide.  In particular, there is a 
need for better understanding of gender differences in seeking health services.  Other health care 
systems issues that were discussed include the interactions between public health and private 
providers, and also those between different health care programs and services, e.g., the 
interaction between TB programs and HIV programs. 
Policy makers  
Policy makers have extremely important roles to play in the development and support of TB 
programs.  As they make decisions about programs, policy makers should be encouraged to 
address the following issues:  
• TB education needs among patients, providers, and communities at large;  
• Underlying socioeconomic and cultural factors contributing to TB and influencing responses 
to TB programs; 
• Health insurance needs and problems associated with various insurance plans; 
• Funding and other resources needed to support and sustain effective TB programs;  and 
• Disparities in TB rates among different populations. 
 
************************************************************************  
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BREAKOUT GROUP SESSIONS I: IDENTIFYING RESEARCH GAPS AND NEEDS 
Day 1, Afternoon Session  
Breakout sessions were held to identify TB research gaps and needs.  A summary of the results 
can be found in Section III: Results of Breakout Group Sessions: Identification of Tuberculosis 
Behavioral and Social Science Research Gaps and Needs  
*********************************************************************** 
DAY TWO 
BREAKOUT GROUP SESSIONS II: DETERMINING AND PRIORITIZING RESEARCH 
QUESTIONS AND METHODS  
Day 2, Morning Session  
Breakout sessions were continued to prioritize research questions and methods identified on Day 
One.  A summary of the results can be found in Section III: Results of Breakout Group Sessions: 
Identification of Tuberculosis Behavioral and Social Science Research Gaps and Needs.  
*********************************************************************** 
TURNING RESEARCH INTO PRACTICE PANEL DISCUSSION 
Jane Mezoff, DrPH  
Behavioral Scientist, Communications, Education, and Behavioral Studies Branch, 
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention 
Day 2, Afternoon Session  
CDC researchers from across the agency participated in a panel on the translation of research 
findings into practice.  Recognizing the importance of disseminating and making practical use of 
research results “on the ground” as key components of an expanded research agenda, these 
presenters addressed the theoretical concerns and practical challenges associated with such an 
expansion.  They offered several models from the HIV and asthma fields for using research 
findings to improve interventions and better serve communities.  They also offered suggestions 
for tackling the “nuts and bolts” of disseminating and translating research findings to the field.  
 
SHARPENING THE FOCUS ON TURNING RESEARCH INTO PRACTICE: THE PROMISE OF 
PARTICIPATORY RESEARCH APPROACHES  
Shawna Mercer, M.Sc., Ph.D. 
Health Scientist, Public Health Practice Program Office, Office of the Director, Centers for 
Disease Control and Prevention  
Day 2, Afternoon Session  
Dr. Mercer outlined challenges in translating research into practice and offered participatory 
research as an approach to addressing these challenges. The challenges include the following:  
• There may be insufficient recognition of the complexities inherent in putting public health 
research into practice in diverse settings;  
• Research findings may not be internally or externally valid; and  
• Best practices may not be locally appropriate or affordable.  
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Participatory research is a flexible approach, rather than a set of specific methods, that may 
address these challenges by actively involving all stakeholders—practitioners, policy makers, 
and members of affected communities—in the research process from the beginning.  
Accordingly, it is more likely to keep communities involved and to produce locally relevant 
findings and implementation guidance.  
The Office of Science and Extramural Research’s Extramural Prevention Research Grant 
Program (EPRP) solicited proposals for participatory research to develop community-based 
prevention strategies.  EPRP funding currently supports 26 three-year grants for a total of about 
$11.4 million.  The funded projects address a wide range of health issues including preventing 
obesity, tobacco use, and injuries; supporting school health; reducing health disparities; and 
increasing access to health care.  Among these, a project on diabetes among Appalachian 
Hispanics seeks to develop a model approach to addressing rural health problems.  
************************************************************************  
TWO CDC MODELS FROM HIV PREVENTION: REPLICATING EFFECTIVE PROGRAMS AND 
DIFFUSION OF EFFECTIVE BEHAVIORAL INTERVENTIONS  
Agatha Eke, Ph.D. 
Behavioral Scientist, Behavioral Intervention Research Branch, Division of HIV/AIDS 
Prevention, Centers for Disease Control and Prevention  
Day 2, Afternoon Session  
Dr. Eke described two sequential CDC initiatives to translate research into practice:  Replicating 
Effective Programs (REP) and Diffusion of Effective Behavioral Interventions (DEBI).  REP is 
involved with translation and packaging of science-based HIV interventions, while DEBI 
supports the diffusion of the translated interventions into practice.  Both models are generally 
applicable to interventions on other public health topics such as TB.  
The REP project is in line with the recommendations made in the Institute of Medicine HIV 
prevention report of September 2000 and CDC’s HIV Prevention Strategic Plan; both spoke to 
the need for development and use of effective, evidence-based HIV prevention interventions at 
all levels.  REP sought to move HIV prevention beyond the endpoint of researchers publishing 
their results to a new paradigm in which researchers, practitioners, and communities are in active 
collaboration to translate research into improved prevention practice.  Initiated in 1996, REP has 
thus far produced packages for seven HIV prevention interventions whose effectiveness has been 
documented through rigorous research methods. Four more intervention packages are currently 
in development.  These intervention packages are then selected and implemented by local 
agencies.  
Some important lessons emerged from the implementation phase of the initial REP packages:  
• Importance of keeping the interventions as simple as possible, focusing on “core elements”;  
• Flexibility to allow adaptation to local contexts;  
• Need for maintaining detailed records and documentation of implementation;  
• Value of clear “how to” materials;  
• Importance of collaboration among researchers, practitioners, and communities; and  
• Value of technical assistance during implementation.  
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DEBI represents the next step along the continuum of CDC’s technology transfer and 
dissemination efforts in HIV prevention.  It develops and coordinates a national strategy for 
diffusing science-based HIV interventions to state- and community-level programs.  DEBI 
objectives for each intervention are accomplished in three phases that involve planning and 
development of curricula and related materials; implementation of an institute for master 
trainers; and larger scale roll-out in which up to 700 facilitators at state and local levels are 
trained and provided technical assistance and individualized coaching.  Additional mechanisms 
for diffusing science-based interventions include satellite broadcasts, newsletters, Web-based 
discussion forums, and conference calls.  
The DEBI model represents a further important effort to bridge the gap that commonly exists 
between public health researchers and practitioners.  In the funding process for this initiative, 
there were specific requirements and incentives for the collaborations among researchers who 
have developed and evaluated the interventions, the front-line practitioners who will be trained to 
replicate or adapt these interventions, and the communities in which they will be implemented. 
Lessons learned from DEBI include:  
• Active partnership and clear communication among all stakeholders are very important to a 
successful translation of research into practice;  
• Multiple disciplines and skills are needed for the process to succeed;  
• Implementing interventions with fidelity is important, but local adaptation may also be 
necessary to maximize effectiveness;  
• Differences between researchers’ and communities’ definitions of “effective” interventions 
must be harmonized; and  
• Successful diffusion may help to overcome myths about lack of capacity and inability to 
collaborate across sectors.  
A member of the audience noted that the TB field is far behind the HIV field in such translation 
of research into practice, and that this represents very important work in which there is much to 
learn from the HIV experience.  
***********************************************************************  
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EFFECTIVE INTERVENTION FOR ASTHMA 
Leslie Boss, M.P.H., Ph.D. 
Epidemiologist, Environmental Health Division, National Center for Environmental 
Health, Centers for Disease Control and Prevention 
Day 2, Afternoon Session  
Dr. Boss presented a model for continuously generating and refining interventions through 
ongoing translation of research findings.  She gave some examples of translated interventions in 
the field of asthma control and treatment.  For effective interventions to be widely adopted, they 
need to be widely known, evidence-based, appropriate to the target population and setting, well 
documented in accessible materials, and suitable for implementation by available staff, assuming 
access to proper training.  Through implementation experience, gaps in interventions may be 
discovered that can then be addressed by further intervention research and translation of these 
research findings into additional interventions that fill these gaps.  
Dr. Boss then provided some examples of asthma interventions based on translation of research 
findings.  These interventions target various age groups (e.g., pre-school age, elementary school 
age, teens, and adults) in different settings (e.g., health care, school, and home).  Information 
about this ongoing research and translation of research findings into implementation practice 
may be disseminated by means of the Internet, searchable literature databases, conferences, and 
various types of publications.  More information can be found at the following website:  
http://www.cdc.gov/nceh/airpollution/asthm a/interventions/interventions.htm  
************************************************************************  
POTENTIAL FUNDING OPPORTUNITIES  
Kathryn O’Toole, M.B.A.  
Associate Director of Management and Operations, Division of Tuberculosis Elimination, 
Centers for Disease Control and Prevention  
Day 2, Afternoon Session  
Ms. O’Toole summarized CDC’s TB-related funding.  In fiscal year (FY) 2003, DTBE allocated 
almost $140 million for domestic and international activities.  The majority of this funding goes 
to support TB programs in state and big city health departments.  About $2 million goes to 
support international activities.  A certain portion of DTBE’s budget is set aside to fund research 
projects submitted by staff of CDC, TB Epidemiologic Studies Consortium (TBESC) 
researchers, and investigators from the TB Trials Consortium.  Applicants first submit research 
concepts that are initially screened by the TBESC Research Chair and DTBE Associate Director 
for Science, then reviewed and scored by a special committee and DTBE senior staff.  
Investigators whose concepts receive high scores are asked to develop and submit full proposals 
for review by DTBE.  
Because of anticipated budgetary shortages in FY2004, no new projects will be funded through 
this process this year.  Depending on the budget situation in FY2005, some new projects may be 
funded in that fiscal year.  
************************************************************************  
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CLOSING REMARKS:  MAINTAINING THE MOMENTUM ON DEVELOPMENT OF A TUBERCULOSIS 
RESEARCH AGENDA 
Nick DeLuca, M.A. 
Team Leader, Education, Training, and Behavioral Studies Team, Communications, 
Education, and Behavioral Studies Branch, Division of Tuberculosis Elimination, Centers 
for Disease Control and Prevention  
Day 2, Afternoon Session  
Nick DeLuca, CDC DTBE’s Forum Team Co-Leader, delivered closing remarks.  He 
acknowledged the Forum Steering Committee, local TB program staff, and CDC staff and 
contractors who helped plan and implement the Forum.  Mr. DeLuca described the following 
next steps that CDC may take to maintain the momentum for developing the TB behavioral and 
social science research agenda:  
• Behavioral science listserv and e-mail communications to generate more input on TB 
research needs from Forum participants and interested persons who could not attend;  
• Database to store the literature reviews; and  
• Report of the TB behavioral and social science literature review, guided by the themes 
identified in breakout group discussions.  
Information gathered from Forum presentations, panel discussions, and breakout sessions 
reaffirmed the ongoing need for behavioral and social science research to inform improvements 
in the practice of TB prevention, control, and treatment.  Solid research is needed to address 
important TB outcomes, such as patient adherence and provider practices, and social and cultural 
issues that influence all facets of the ongoing TB epidemic and responses to it.  Several key 
points came out of this Forum:  
• TB patients, providers, and researchers offer diverse and important perspectives on the 
challenges and potential solutions to be addressed by future TB behavioral and social science 
research and TB treatment and control programs;  
• Multidisciplinary and multilevel approaches to improving TB control and treatment efforts 
should involve key stakeholders such as patients, providers, families, communities, health 
systems, and policy makers; and  
• Innovative research and tailored interventions are needed to improve existing TB treatment 
and control efforts and to overcome the social, cultural, environmental and structural 
challenges faced by patients, providers, communities, and TB programs.  
The perspectives compiled from Forum attendees and ongoing Forum-related activities will be 
essential components of the CDC DTBE’s forthcoming TB research agenda.  The Forum 
Proceedings will be shared with stakeholders and interested parties.  It is CDC’s hope that this 
document will be widely used by those working in TB prevention, control, and treatment.  
************************************************************************  
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Section III.  Results of Breakout Groups Sessions 
Identification of Tuberculosis Behavioral and Social Science Research 
Gaps and Needs  
Summary of Breakout Sessions at the Forum 
There were four small breakout groups consisting of approximately 12 participants that met once 
each day during the Forum.  The objectives for the breakout sessions of the Forum were to 
1) identify areas that have been sufficiently researched, 2) to identify and prioritize research 
needs and gaps, 3) to articulate research questions for each gap area, and 4) to delineate research 
methods/approaches to fill the identified research needs.  The breakout sessions included 
brainstorming and small group discussions.  At the end of the small breakout sessions, all four 
groups reconvened to the larger group to report out and share the highlights from their 
discussions. 
Forum participants used the National Institutes of Health (NIH) definition of behavioral and 
social science research as the basis for group discussion.  (Refer to the Background Section on 
p. 2 for a complete definition). 
To guide the discussions, the four groups were formed around two major themes or domains:  
“external” vs. “internal” influences.  Though the framework is artificial, the purpose of these 
groupings was to initiate thinking from the perspective of factors influencing behaviors, such as 
health-seeking, initiating and adhering to treatment, and providing diagnostic, care, and 
treatment services with respect to provider behaviors, rather than focus on the behaviors 
themselves.  This framework was intended to facilitate discussion about and development of 
research concepts that focus on interventions that directly address the influential factors, and 
narrow the already broad focus to either “external” or “internal” influences to the extent possible.  
Overlap was expected and inevitable, due to the multiple dimensions of influences on behaviors 
and the complex way that these influences interact with one another.  Examples of these types of 
influences were provided during the breakout sessions and are noted below. 
1) “External” influences on health and health behaviors may include factors in the physical or 
‘external’ environment, organizational structures, policies, regulations, guidelines, poverty, 
racism, economic inequality, disparities in care, availability and access issues, legislation 
(e.g., immigration, public health laws).   
2) “Internal” influences on health behaviors may include individual and cultural beliefs, 
etiologies or explanations of causality, knowledge, attitudes, and perceptions. 
Influences such as stigma, social norms and customs could and did fall under both domains, 
depending on whether the discussion was on how these influences are internalized OR how they 
are expressed in society.   
The breakout sessions, each headed by a trained facilitator, were very interactive, consisting of 
independent brainstorming activities in which participants wrote down their ideas on notecards 
and flip charts and subsequently shared information with the breakout group for discussion.  
Each breakout session was followed by a sharing of that group’s ideas with the larger group of 
Forum participants for questions and discussion.   
 26 
For the purpose of organizing the Forum Proceedings, the notes and flip charts were reviewed 
and synthesized using the five broad levels based on the Socio-Ecological Framework.  The five 
broad levels identified are listed below: 
• Intrapersonal 
• Interpersonal 
• Health Systems and Organizations 
• Community 
• Public Policy 
Organization of the Breakout Sessions Findings 
The Socio-Ecological Framework was used to organize the information generated by the 
participants during the Forum breakout sessions because of its multi-layered structural 
components.  According to Sallis and Owen (1997), the Socio-Ecological Framework focuses on 
multiple levels of influence and proposes that health and behavior are caused by multiple factors.  
It assumes that organisms cannot exist or act in isolation; instead they work as an interdependent 
network of relationships influenced by internal and external forces.  More specifically, behaviors 
are influenced by intrapersonal (i.e., individual), social and cultural, and physical environment 
factors.  These multiple factors and interaction among them are relevant for understanding and 
changing health behaviors of individuals, communities, and organizations as a whole.  
Using this framework, the most relevant levels of the model were identified and modified for the 
purposes of the Forum breakout sessions (Refer to Figure 1: The Socio-Ecological 
Framework).  The levels that were used to systematically organize the information derived from 
the Forum breakout sessions are listed below.   
Intrapersonal:  This level focuses on influences (e.g., knowledge, attitudes, and perceptions; 
patient satisfaction; and social stigma) that affect the individual behavior of patients, such as 
health seeking behaviors and adherence to treatment.  This level also addresses individual-level 
issues that may affect providers’ behaviors, such as adherence to guidelines and 
recommendations. 
Interpersonal:  This dyadic level focuses on the relationship between two individuals or units 
regarded as a pair.  Examples of this level include the patient-provider relationship and its impact 
on both the patient and provider as well as influences of a family member, significant other, or 
peer on a patient. 
Health Systems and Organizations:  This larger social system focuses on how individuals, 
small groups, and communities can be affected by structural, economic, and other organizational 
forces.  Examples include the provision, accessibility, and use of health care services, and 
collaboration between provider communities and other systems. 
Community:  This level focuses on influences that affect behavior on a small-group level (e.g., 
family and social networks) in addition to larger groups, such as those in community settings.  
Examples include the influences of family and social networks on individuals; the relationship 
between local health services and individuals and communities; social norms; and social stigma. 
Pubic Policy:  This level focuses on the implications of public policy on the behaviors of 
individuals, groups, communities, and organizations, with special emphasis on issues relating to 
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government commitment, funding, health insurance, and immigration policies. 
Major research topics and subtopics were grouped to the extent possible under the five broad 
levels delineated in the Socio-Ecological Framework.  More detailed information on specific 
topics identified by Forum participants are presented in the sections titled Outline of Major TB 
Behavioral and Social Science Research Topics and Subtopics Identified at the Forum on 
pgs. 28-30, and Descriptions of TB Behavioral and Social Science Research Topics and 
Subtopics Identified at the Forum on pgs. 31-43.  
Specific research questions generated by Forum participants can be found in Appendix C: 
Tuberculosis Behavioral and Social Science Research Gaps and Needs:  Major Topics, 
Subtopics, and Research Questions.   
 
Figure 1: The Socio-Ecological Framework
Public Policy
Community
Intrapersonal
Interpersonal
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Outline of Major TB Behavioral and Social Science Research Topics and 
Subtopics Identified at the Forum 
 
I.  Background  
A.  Health disparities 
 
II. Intrapersonal 
A.  Patients’ knowledge, attitudes, and perceptions 
 
B.  Patients’ behaviors 
1.  Health care-seeking behaviors 
             2.  Adherence to treatment 
 
 C.  Patient satisfaction  
 
 D.  Social stigma  
 
E.  Providers’ knowledge, attitudes, and perceptions  
 
F.  Provider training and practices  
  1.  Diverse training 
2.  Cultural competency 
  3.  Clinical practices 
 
III. Interpersonal 
 A.  Communication between patients and providers 
 
 B.  Family and peer influences 
 
IV. Health Systems and Organizations 
A.  Organizational structure 
1.  Collaborations between provider communities and systems  
  2.  Impact of sharing patient information 
 
 B.  Service delivery 
  1.  Patient-centered approaches 
2.  Case management  
  3.  Advantages and disadvantages of directly observed therapy 
  4.  Role of incentives and enablers 
  5.  Contact investigations 
  6.  Health communications 
7.  Special challenges of high risk settings and populations 
    a.  HIV/TB 
    b.  Homelessness, unstable housing, and mental health issues 
c.  High mobility jobs and migrant labor 
    d.  Incarceration 
    e.  Substance use 
    f.  Foreign born 
    g.  Pediatrics 
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V. Community  
 A.  Impact of TB services on communities and patients 
  1.  Influences of family and social networks 
  2.  Social stigma 
 
VI. Public Policy 
 A.  Government commitment and funding  
 
 B.  Health insurance  
 
C.  Immigration policies 
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Figure 2: Outline of Major TB Behavioral and Social Science Research Topics and Subtopics
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Descriptions of Major TB Behavioral and Social Science Research 
Topics and Subtopics Identified at the Forum 
The following section provides a range and scope of topics that were generated at the Forum.  
For each topic, a brief description is given, followed by an italicized paragraph(s) summarizing 
the general research concepts that were elicited by Forum participants.  For the entire list of 
topics, associated research concepts, as well as specific research questions, refer to Appendix C. 
I. Background 
A. Health disparities 
Vast disparities exist in TB case rates, treatment outcomes, and TB mortality among many 
different population strata.  Historically, these disparities have often been based on 
socioeconomic status and within racial and ethnic minorities, the incarcerated, substance 
abusers, and homeless populations--populations especially vulnerable to poorer TB 
outcomes.  In 2002, TB case rates among non-Hispanic blacks continued to be eight times 
greater than non-Hispanic whites.1  In addition, the past decade has seen disparities emerge 
between U.S-born and foreign-born populations in the United States.  Identifying and 
eliminating disparities in TB case rates, as well as determining effective measures to reduce 
existing disparities, are important steps toward controlling and eventually eliminating TB. 
During the breakout sessions, Forum participants identified the need to better understand 
and address disparities in TB case rates and treatment outcomes.  
II. Intrapersonal 
Intrapersonal influences on behavior such as knowledge, attitudes, and perceptions, 
patient satisfaction, and social stigma affect the individual behavior of patients 
including health seeking behaviors and adherence to treatment.  This level also 
addresses individual-level issues that may affect providers’ behaviors, such as 
adherence to guidelines and recommendations. 
A. Patients’ knowledge, attitudes, and perceptions (KAP) 
An individual’s knowledge, attitudes, and perceptions with respect to health in general and 
with a specific illness, such as TB, influence his/her behavior.  Specifically, these factors 
can influence health seeking, understanding of the diagnosis, understanding of treatment, 
treatment initiation, treatment adherence, and general interactions with health care 
providers. 
Forum participants identified the importance of further understanding patients’ knowledge, 
attitudes, and perceptions with respect to TB, with a particular focus on latent tuberculosis 
infection (LTBI).  The need to identify any differences in these factors among different ethnic 
and cultural groups, specifically Latinos and other foreign-born populations, was 
emphasized.  Finally, participants called for the further use of health behavior models and 
theories to be used as frameworks to better understand the factors that influence knowledge, 
attitudes, beliefs and practices of TB patients.  
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B. Patients’ behaviors 
1. Health care-seeking behaviors 
Health care-seeking behavior for TB includes the recognition of TB-related symptoms, 
presentation to health facilities and/or alternative medical resources (e.g., family and 
community healers), and adherence to effective treatment regimens and treatment 
monitoring. Individual factors, such as knowledge, attitudes, gender, sex, ethnicity, income, 
and education, in addition to health service barriers, including accessibility and acceptability 
of care, cost of services, and quality of care, can often delay or prevent a person from 
seeking TB care and treatment.  
Forum participants identified the need to further understand and influence the barriers and 
facilitating factors to seeking health care for LTBI and TB diagnosis, treatment monitoring, 
and completion of treatment for different populations.  Specific questions were raised 
regarding the availability, accessibility, acceptability, and affordability of care. In addition, 
the group discussed the role of further understanding how an individual’s perceptions of the 
health care system and health care providers influence their health seeking behavior.  
2. Adherence to treatment 
Treatment regimens for LTBI and TB include providing the safest, most effective therapy in 
the shortest amount of time and ensuring adherence to prescribed regimens.  The major 
determinant of a successful treatment outcome is patient adherence to the prescribed drug 
regimen.  Nonadherence can lead to inadequate treatment which can result in relapse, 
continued transmission, and the development of drug resistance.   
Directly observed therapy (DOT) and self-administered therapy are two strategies 
commonly used in TB control.  DOT, a major component of case management, is currently 
recommended for all patients with TB disease.  In addition to DOT, research has shown the 
use of incentives and enablers can also enhance patient adherence.   
Directly observed treatment for LTBI is less common due to limited resources.  Ensuring 
treatment completion of LTBI poses unique challenges as it is often self-administered.   
Forum participants identified the importance of further understanding the barriers and 
facilitators that affect the initiation, duration, and completion of treatment of LTBI and TB 
disease, specifically for different populations, such as foreign-born persons and 
incarcerated/newly-released prisoners.  Discussion focused on ways to better understand 
and enhance DOT.  In addition, a focus of the discussion centered on how to improve 
patient acceptance of LTBI treatment.  The discussion also posed questions on how behavior 
change theories and models could be utilized to better understand and overcome barriers to 
treatment for LTBI and TB disease.   
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C. Patient satisfaction  
Patient satisfaction is how individuals regard the health care services or the manner in which 
they are delivered by health care providers as useful, effective, or beneficial.  It is often 
based on patient expectations of care and the self-assessment of their experiences.  Patient 
satisfaction may play a major role in a patient’s behaviors.  If a patient is dissatisfied with 
the relationship with their provider or with the clinical setting, he or she is much less likely 
to be adherent to medications, keeping appointments, identifying contacts, and so forth.  
Research has shown that patient satisfaction can be increased with effective patient-provider 
communication and development of a trusting relationship. 
Forum participants identified the importance of the relationship between a patient and the 
provider or health care system that serves them and the need to better understand this 
relationship and the role it plays, especially from the perspective of different ethnic and 
cultural groups.  Forum participants also expressed the importance of determining how 
patient satisfaction may be influenced by TB care and services. They also highlighted the 
need to explore the influence of patient satisfaction on behavior such as adherence. 
D. Social stigma 
Evidenced both in research and in practice, stigma associated with TB appears to be 
universal.  The consequences of stigma can be seen affecting care-seeking behaviors, as 
persons have been known to hesitate or choose not to disclose their TB status to family, 
friends, and co-workers out of fear of being socially ostracized, in addition to losing their 
employment and/or temporary housing.  Research has demonstrated that in some cases, 
personal rejection occurs as a result of the stigma surrounding TB.  Stigma has also been 
shown to hinder adherence to treatment.  By identifying the consequences of stigma, social 
science research has illustrated the need for effective intervention strategies to mitigate it.  
During breakout discussions, the research questions surrounding stigma highlighted the 
continuing need to identify the effects or consequences of stigma on care seeking, adherence 
to treatment, and cooperation with health care providers, especially during contact 
investigations, to determine whether certain populations or sub-populations (e.g., foreign-
born communities) are adversely affected by stigma and in which settings (e.g., residential 
or workplace).  Forum participants also raised the issue of better understanding different 
perspectives and sources of stigma.  Additionally, discussions revolved around the need for 
identifying and testing effective ways to mitigate the influences that stigma has on 
individuals and communities.   
E. Providers’ knowledge, attitudes, and perceptions  
A health care provider’s knowledge, attitudes, and perceptions (KAP) about LTBI/TB play 
an important role in their ability to diagnose and treat individuals with TB.  A variety of 
factors, such as medical and health-related training (e.g., U.S.-training vs. foreign training, 
generalist, or specialist), cultural and ethnic background, practice settings, preferred sources 
of information and learning styles can influence providers’ knowledge, attitudes and beliefs 
about LTBI and TB.   
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Forum participants identified the need to better understand the TB-related knowledge, 
attitudes, and perceptions of different providers in a variety of practice settings, including: 
private physicians, primary care physicians, civil surgeons, international medical graduates 
(IMG), and providers who serve foreign-born populations.  Forum participants called for 
the further use of health behavior models and theories to be used as frameworks to better 
understand the factors that influence knowledge, attitudes, beliefs and practices of TB 
providers and how these factors influence their ability to diagnose and treat TB patients.  
F. Provider training and practices  
Providers serving individuals at risk for TB in the United States come from a wide range of 
backgrounds and perspectives.  They may have differing knowledge, attitudes, and practices 
related to TB prevention and control based on factors such as, where they completed their 
medical training, residency, board certification requirements, and continuing education 
experiences.  Personal and cultural factors may also affect their practices.  All of these 
factors may influence the providers’ level of professional competence, cultural competency, 
and clinical behaviors, including their adherence to professional practice guidelines.  
1. Diverse training 
Providers have different levels of knowledge, attitudes and practices related to TB 
prevention and control, based on factors such as where they completed their medical 
training, residency, board certification requirements, and continuing education experiences.  
Moreover, many foreign-trained providers and international medical graduates (IMG) have 
an increasingly important role in TB prevention and control efforts, as they may be the first 
point of contact for foreign-born individuals with TB.   
Forum participants identified the need to assess the impact of working with providers of 
different cultural and professional backgrounds, who have undergone different types of 
training in the area of TB control. Participants also identified the need to improve 
collaborations between health department and non-health department providers.   
2. Cultural competency 
The role of cultural competency in U.S. TB programs has become increasingly important, 
especially over the past two decades as the proportion of persons with TB who are foreign 
born has rapidly increased and now surpasses U.S.-born cases.  In addition, widening 
disparities have emerged among other U.S.-born groups, such as African Americans in the 
Southeast.  Efforts to promote health and prevent and treat disease within culturally diverse 
groups will involve building the capacity of programs to become culturally competent.  This 
is extremely important in health care, as it has generally been shown that minority groups 
use fewer services and are less satisfied in general with their care.  Furthermore, patients 
may avoid care out of fear of being misunderstood or discriminated against.  Providers need 
to be aware of and understand the impact that culture can have on a patient’s TB knowledge, 
attitudes, beliefs, and practices.  By increasing the cultural competency of providers, they 
will be better equipped to provide the most appropriate TB care and treatment.  
Forum participants identified the need to further understand the role of cultural competency 
on the delivery of services to TB patients and ways to increase cultural competency among 
health care providers, including public health nurses and outreach workers.  In particular, 
participants focused on how culturally competent health care workers can influence 
patient’s adherence to treatment for LTBI and TB.  
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3. Clinical Practices 
Clinical practices of providers can include TB screening and treatment, patient management, 
collaborating with the health department for contact investigations, and adherence to 
guidelines and recommendations.  Just as patients are faced with individual or structural 
barriers to adhering to LTBI and TB treatment, health care providers also face numerous 
challenges and barriers to adherence to TB screening and treatment guidelines and 
recommendations.  Providers must be aware of CDC and American Thoracic Society (ATS) 
guidelines in order to implement them.  In addition, other barriers such as provider 
background and practice setting may influence their adherence to guidelines.  Identification 
of barriers to the awareness of and adherence to guidelines and ways to address these 
barriers can improve provider practice and lead to the provision of more effective health 
care.   
Forum participants identified the need to determine ways to increase providers’ awareness 
and adherence to TB treatment guidelines for providers in different health care settings.  In 
these discussions, “providers” include private providers, community health workers, case 
workers, non-health department physicians, and foreign-trained providers.  
III. Interpersonal 
Interpersonal influences on behavior focus on the relationship between two individuals 
or units regarded as a pair.  Examples include the patient-provider relationship and its 
impact on both the patient and provider as well as influences of a family member, 
significant other, or peer on a patient. 
A. Communication between patients and providers 
Communication between patients and providers is critical for effective health care.  It is a 
fundamental element that helps to shape the patient-provider relationship and foster trust.  
Communication includes appropriate linguistic concordance, optimal use of interpreters 
when necessary, verbal and nonverbal expressions and cues, and good listening skills by 
providers.  Communication also ultimately reflects the dynamics of the relationship between 
a provider and the patient.  Provider-patient communication can impact trust, patient 
satisfaction, and treatment adherence.  
Forum participants identified the need for additional research to understand the role of 
provider-patient communication in effective TB case management. Participants discussed 
the need to foster positive interactions and to build trusting and caring relationships 
between patients and providers.  
B. Family and peer influences 
A TB patient’s family, peers, and social networks can be very influential on the patient’s 
behavior.  Family and peer influences can affect an individual’s decision to seek treatment 
and to adhere to provider treatment recommendations.  In addition, peer and social 
influences can impact a TB patient’s willingness to identify contacts during a contact 
investigation.  
Forum participants identified the need for research to further understand the family and 
peer in terms of whether and when a patient enters (and remains in) care.  
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IV. Health Systems and Organizations 
Influences of health systems and organizations on behavior focuses on how structural, 
economic, and other organizational forces can affect the views of individuals, small 
groups, and communities.  Examples include the availability, accessibility, and use of 
health care services by individuals, and collaboration between and among provider 
communities and other systems. 
A. Organizational structure  
The way in which the health care system is organized may play a role in affecting both 
patient and provider behaviors.  Whether the system has a vertical or horizontal structure, 
whether services are integrated with other health and social services or are part of a 
collaborative network, and how the health care system is impacted by other systems within a 
society may impact the availability, delivery, and acceptability of services. 
1. Collaborations between provider communities and systems  
There are many different social and behavioral determinants involved in TB transmission, 
identification, and treatment success.  Certain factors that place individuals at high risk for 
TB, such as poverty, substance abuse, and homelessness, can be greatly impacted by the 
availability and quality of social services.  Both private and public collaborations between 
and among existing social service agencies and TB control efforts, as well as timely and 
appropriate social service referrals for individuals with TB, may play an important role in 
the efforts to successfully eliminate TB. 
There are also a number of relevant collaborations between TB services and other health-
related entities that may need to be better understood and cultivated.  Given the high rate of 
TB/HIV co-infection among certain populations, collaboration between or integration of TB 
and HIV services may lead to better treatment outcomes and improved satisfaction among 
persons receiving these services.  Collaborations with mental health and substance abuse 
services, homeless shelters, and correctional facilities hold equal promise.   
Forum participants identified the need to determine ways to increase collaboration between 
TB programs and other health and social service agencies for related conditions (such as 
HIV/AIDS, mental health, and substance abuse) to improve TB diagnosis, case management, 
and integration of services.  Specific areas for increased research include focusing on 
patients with multiple and varied needs, U.S.-Mexico border issues, and collaboration with 
correctional systems, Immigration and Customs Enforcement, and other agencies. 
2. Impact of sharing patient information 
Patients who have other health and/or social issues such as TB/HIV co-infection, diabetes, 
substance abuse, and mental health issues, in addition to TB or LTBI, may have multiple 
providers.  The sharing of patient information becomes a crucial component in the provision 
of proper and effective health care, especially as it relates to a patient’s TB treatment 
regimen and follow-up care.  Providers who take a holistic approach to their patient’s health 
and who thus have a complete picture of their patient’s health and well-being are better 
equipped to make well-informed decisions that ensure the most appropriate TB care and 
treatment. 
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Forum participants identified the need to focus upon the impact of sharing (or not sharing) 
patient information on case management, service coordination, and health outcomes among 
managing providers in varying settings, such as health departments and correctional, 
mental health, and substance abuse facilities. 
B. Service delivery 
The delivery of health services plays a major role in how patients receive TB care and 
treatment.  From an organizational perspective, accessibility and acceptability of services, 
cost of services, and quality of care can often delay or prevent a person from seeking TB 
care and treatment.  Through the use of patient-centered approaches and effective case 
management, these systematic barriers can be reduced or alleviated, resulting in improved 
provision of care and better treatment outcomes. 
1. Patient-centered approaches 
Patient-centered approaches focus on bringing together compassion, empathy, 
responsiveness, and resources to the needs, values, and expressed preferences of individual 
patients.  Effective patient centered care is essentially a partnership between the provider 
and the patient.  It involves determining individual patient needs and expectations while 
ensuring that efforts are made to address those needs and expectations by the health care 
provider(s). 
Forum participants recognized the potential benefits of delivering TB control services which 
embody a patient centered-approach, and suggested that additional research is needed to 
identify, compare, and standardize different methods and models for patient-centered care. 
2. Case management  
Quality case management is an important component of effective TB care.  It holds the 
potential to increase treatment adherence and treatment outcomes by tailoring case 
management to the patient, by making appropriate referrals to needed health and social 
services, and helping to remove barriers to treatment success.  However, little empirical 
evidence exists that systematically confirms the effect of the various types of case 
management practices.  Part of the reason for this may be that many case management 
practices are not standardized and vary based on case management models and institutions.   
Forum participants identified the need to determine the influences of case management on 
multiple outcomes (e.g., treatment outcomes, reduced homelessness, care for substance 
abuse, receipt of other appropriate social and other health resources) as well as approaches 
to strengthen case management practices. 
3. Advantages and disadvantages of directly observed therapy  
Directly observed therapy (DOT), in which a health care worker or other qualified 
individual watches the patient swallow every dose of the prescribed drugs, is an extremely 
effective strategy for making sure patients take their medicines.  DOT is strongly 
recommended as part of a patient-centered case management plan because it is difficult to 
reliably predict which patients will be adherent.  Successful treatment programs are 
dependent upon public health programs and providers accepting responsibility for a patient’s 
care by ensuring that DOT is appropriately administered.  
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As TB incidence declines and programs are turning their attention to the treatment of LTBI, 
more TB programs are trying to use DOT for LTBI patients.  Data indicating low 
completion rates among patients on treatment suggests the importance of determining the 
appropriate use for DOT with LTBI patients. 
Forum participants identified the need to conduct further research on the effectiveness of 
varying DOT modalities for LTBI and TB, such as clinic, home, or field-based DOT.  Forum 
participants also raised the need to identify patient-centered DOT strategies that are most 
appropriate to the particular needs of patients, questioning the one-size fits all mentality.  
Participants also focused on the need to further delineate the usefulness of DOT in treating 
TB and other co-morbid conditions, such as HIV. 
4. Role of incentives and enablers 
Research has shown that the use of incentives and enablers can enhance patient acceptance 
as well as adherence to treatment for both TB disease and LTBI.  
Incentives and enablers help patients continue and complete treatment and are widely used 
in facilities providing TB services.  Incentives and enablers are most beneficial when they 
are tailored to the patient’s special needs and interests.  Learning as much as possible about 
individual patients through the use of patient-centered approaches will help to identify their 
needs and better assist them in completing treatment. 
Forum participants identified the importance of further understanding the barriers and 
facilitators that affect the initiation, duration, and completion of treatment of LTBI and TB 
disease, and the role that incentives and enablers can have in achieving TB treatment goals, 
specifically for diverse populations, such as foreign-born persons and incarcerated or newly 
released prisoners.   
5. Contact investigations 
The contact investigation (CI) is an important component of TB prevention and control 
efforts, as it is a process for identifying persons exposed to someone with infectious TB, 
evaluating them for LTBI and TB disease, and providing appropriate treatment for LTBI or 
TB disease.  In TB programs in the U.S., there is wide variability in the way in which 
contact investigations are conducted.  Furthermore, the contact investigation can be sensitive 
for TB patients as they are required to elicit personal information, such as who they interact 
with, how often, and where.  Little is known about the social and emotional impact of these 
investigations on the individuals involved and on the identification and follow-up of 
contacts.   
Forum participants identified the need to determine ways to improve contact investigations 
by, for example, gaining a better understanding of patient and contact perceptions and 
being more sensitive to involved parties to enhance contact investigation outcomes.  Finally, 
more research is needed with providers to examine their perspectives on contact 
investigations. 
6. Health communications 
Health communications can be used to share information on TB with the general public, 
local communities, patients and contacts, as well as providers.  Research has demonstrated 
that misconceptions about TB and the stigma associated with the disease still abound, 
suggesting the continuing need to increase knowledge and awareness of TB through 
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effective channels of communication.  Further research to better understand informational 
needs, identify appropriate and effective media for channeling information, and testing 
health messages related to many aspects of TB for a variety of audiences will enhance the 
effectiveness of TB control efforts and hopefully mitigate the stigma associated with TB. 
Forum participants identified the need to identify specific and tailored messages and 
messengers for improving communication about LTBI and TB diagnosis and treatment 
among patients and providers, as well as among family members and within the community. 
7. Special challenges of high risk settings/populations 
a. HIV/TB 
Co-infection of TB and HIV presents challenges for both patients and the providers 
serving them.  One challenge is related to the potential lack of collaboration among TB 
and HIV programs.  It is important that TB providers offer HIV voluntary testing and 
counseling to both TB patients and high risk contacts, and that HIV providers offer TB 
screening and follow-up.  Patients who have both TB and HIV may also face challenges 
associated with the burden of taking medicine for both diseases, as well as with the 
stigma associated with both illnesses. 
Forum participants identified the need to conduct research on patient, provider, and 
agency barriers to the integration of voluntary HIV testing and counseling in TB 
programs as well as the incorporation of TB services in HIV/AIDS programs. 
b. Homelessness, unstable housing, and mental health issues 
TB control also faces significant challenges when dealing with homeless populations or 
with individuals who may also be experiencing mental health or substance abuse issues.  
These issues, combined with a lack of stable housing, make TB screening and follow-up, 
diagnosis, contact investigations, treatment initiation, adherence, and completion of 
treatment extremely challenging. 
Forum participants identified as important the need to assess the TB knowledge, 
attitudes, and perceptions (KAP) as well as other influences on behavior of homeless 
populations.  Participants also identified the need to consider using patient-centered case 
management strategies to identify and address competing health and social issues for this 
population. 
c. High mobility jobs and migrant labor 
Given their mobility, migrant farm workers and other migrant populations present unique 
challenges to TB prevention and control programs with respect to diagnosis, treatment, 
continuity of care, and contact investigations.  U.S.-Mexico border issues, such as 
immigration and frequency of border crossings, create additional challenges. 
Forum participants suggested conducting descriptive and ethnographic research using 
case studies as a possible method, among this special population. This type of research 
might help to determine ways to access migrant networks, mechanisms for tracking 
patients in a non-stigmatizing way, and ways to increase completion of care. 
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d. Incarceration 
Jails and prisons pose a unique challenge for TB prevention and control.  Efforts have 
been made to improve the relationships between health department TB programs with 
jails and prisons to enhance TB screening and follow-up among inmates and correctional 
personnel.  In addition, continuity of care can be a particular challenge for TB patients 
who are incarcerated during treatment and who are later released from prison or jail while 
on treatment.   
Forum participants discussed the need to conduct further research to identify ways to 
improve TB screening activities, as well as adherence to and completion of treatment for 
incarcerated persons and newly released prisoners.  In addition, participants called for 
further research to examine how screening and treatment for TB can be incorporated 
into the diagnosis and treatment for other diseases such as HIV.   
e. Substance use 
Substance abusers are at increased risk for TB. Substance abusers may have competing 
priorities that may prevent them from being diagnosed with TB, accepting and adhering 
to treatment regimens, and identifying contacts. 
Forum participants identified the need to better understand the TB knowledge, attitudes, 
and perceptions (KAP) of substance abusers as well as determine the best ways to 
address these issues, so that this population will receive the most effective TB care and 
services. 
f. Foreign born 
Although TB case rates have steadily declined since 1992, TB in foreign-born persons 
represents a significant challenge for TB control efforts in the United States.  In 2002, TB 
case rates among the foreign born comprised 51% of reported TB cases in the U.S.2  
Foreign-born populations may have unique cultural characteristics, practices, and 
circumstances related to their re-settlement and adjustment to the U.S., that may 
influence their TB treatment and care.    
Forum participants identified the need to acknowledge, understand, and incorporate 
different health-related cultural beliefs and practices of foreign-born patients.  Other 
issues that warrant exploration included foreign-born persons’ perceptions of the U.S. 
health care system and/or the providers who deliver care, determining the role of gender 
and ethnic differences between patients and providers, and identifying and addressing the 
wide range of barriers foreign-born persons encounter when accessing services related 
to LTBI/TB diagnosis, treatment initiation, adherence, completion, and follow-up. 
g. Pediatrics 
Children with LTBI and TB represent another population with unique characteristics and 
needs, as the prevention, diagnosis, and treatment of children is often dependent upon the 
role of the parent, primary care giver, and other adults.   
Forum participants felt it was important to conduct research to test alternative models to 
increase LTBI and TB screening and treatment among children. 
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V. Community 
Influences that are community-related affect behavior on both small and large-group 
levels, such as those in community settings.  Examples include influences of family and 
social networks on individuals, the relationship between local health services and 
individuals/communities, and the impact of social stigma of TB on groups. 
A. Impact of TB services on communities and patients 
Whether defined by a geographic region, a common interest, or shared ethnic or cultural 
background, communities play an important role in people’s lives.  Because a community 
typically shares a set of common interests and values and gains strength from this collective 
entity, it is important for health care providers to understand the communities they serve to 
effectively meet the community’s needs.  Developing a respectful, collaborative relationship 
with communities may strengthen the delivery of health services and improve the general 
health and well-being of communities as a whole.   
Forum participants identified the need to determine the perceptions of TB within 
communities and to understand the origins of those perceptions and the influence of forces 
that affect people’s perceptions, such as the media.  Participants also expressed the need to 
develop tailored, culturally-specific interventions to increase understanding of TB and 
reduce the stigma associated with TB. 
Participants across all groups discussed the need to determine the optimal relationship 
between health departments and the local communities they serve, as well as the role of 
community groups like community-based physicians in increasing TB awareness and 
delivering TB services.  Suggestions were made to conduct more participatory action 
research and to define and determine how local communities can become involved in locally 
driven research. 
1. Influences of family and social networks 
Family groups and social networks have been shown to be extremely influential on many 
different health outcomes.  In terms of TB outcomes, this influence can manifest itself 
positively by facilitating or supporting, for example, care-seeking, treatment adherence, and 
other patient behaviors.  Conversely in other cases, misconceptions held by those close to 
individuals with TB can have negative effects such as increasing the level of stigma attached 
to the disease resulting in social ostracism or isolation.  Furthermore, family units and social 
networks are often adversely affected by the introduction of TB and the consequent stressors 
into their networks.  Successful TB control efforts based on a strong understanding of these 
issues may maximize the positive influences of social networks and minimize disruptions to 
family and social networks.  
Forum participants identified the need to better understand the role of social networks on 
health behaviors and determine strategies for strengthening the positive influences of social 
networks.  Specific focus was given to identifying ways in which TB programs can work with 
families to better understand and mitigate the impact of TB services on social networks. 
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2. Social stigma 
Evidenced both in research and in practice, stigma associated with TB appears to be 
universal.  The consequences of stigma can be seen affecting care-seeking behaviors, as 
persons have been known to hesitate or choose not to disclose their TB status to family or 
friends out of fear of being socially ostracized.  Research has demonstrated that in some 
cases, personal rejection occurs as a result of the strong stigma surrounding TB.  Stigma has 
also been shown to hinder adherence to treatment.  By identifying both the sources and 
consequences of stigma, social science research has illustrated the need for effective 
intervention strategies. 
Social stigma was an issue raised in all of the breakout groups, highlighting the shared 
perception of the need to better understand its sources and identify effective ways to address 
it.  During breakout discussions, forum participants specifically noted the need to define 
stigma from various perspectives, identify existing research to understand the impact of 
stigma, and propose specific measures to address and reduce stigma.  Among these 
measures, it was suggested to identify ways in which the public health community can alter 
its presentation of epidemiologic data to avoid the perpetuation of existing stigmatizations 
and to reinforce that TB is a curable disease. 
Proposed research questions focused on identifying the effects or consequences of stigma on 
care seeking and adherence to treatment, and determining whether certain populations or 
sub-populations are adversely affected by stigma.   
VI. Public Policy 
Public policy influences focus on the implications that public policies have on the 
behaviors of individuals, groups, communities, and organizations with special 
emphasis on issues relating to government commitment, funding, health insurance, and 
immigration policies. 
A. Government commitment and funding  
Governmental entities, from federal to local, play a critical role in TB-related services.  
From federal-level research funding to service delivery at local health departments, TB 
control is influenced greatly by policy decisions.  Given these arrangements, the 
development of a better understanding of the policy process and greater engagement of 
decision-makers by those working in TB control may lead to improvement in TB services. 
Forum participants identified as important the need to focus on identifying appropriate 
decision makers, potential advocates, and strategies to influence TB-related policies. They 
also specifically addressed funding issues such as the identification of effective ways to 
advocate for TB funding as well as possible models for allocation of funds within the TB 
framework. 
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B. Health insurance  
As of 2002, data from the U.S. Census Bureau indicated that 43.6 million people were 
uninsured in the United States.3  The lack of health insurance among people in the U.S. 
creates a serious impediment for those who seek or wish to seek health care for LTBI or TB 
disease, especially as it relates to TB testing and treatment.  It is unknown to what extent a 
lack of appropriate insurance coverage or fear of treatment costs hinder care-seeking, but it 
is suspected that this economic deterrent has clear negative implications. 
Forum participants identified the need to determine the effect of health insurance or lack of 
appropriate coverage for TB services on health behaviors and health outcomes, including 
access to TB diagnosis and treatment.  Further research is needed to determine the impact 
this has on TB patients and their families, in addition to finding alternative funding 
solutions to increasing health care costs and expenses. 
C. Immigration policies 
With over half of TB cases in the United States occurring among individuals born outside of 
the country, the link between immigration and TB services has become increasingly 
important in recent years.  Efforts to coordinate public health efforts with immigration 
activities pose an evolving challenge as changes occur to immigration policy and 
enforcement agencies.  Understanding the impact of these specific changes, as well as 
developing a broader body of knowledge of immigrant issues in general, will likely lead to 
improved TB services and better health outcomes. 
Forum participants identified as important the need to focus on the effect of immigration 
policies, specifically regarding recent changes to policies, on TB services.  Additional 
discussion focused on the need to develop strategies for collaboration with immigration 
authorities to increase access to immigrant communities. 
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Section IV. Appendices 
Appendix A: Forum Agenda 
 
Tuberculosis Behavioral and Social Science Research Forum Agenda  
Planting the Seeds for Future Research  
December 10–11, 2003  ●  Sheraton Colony Square  ●  Atlanta, Georgia  
DAY 1:  Wednesday, December 10, 2003  
 
Time  Session  Presenter(s)  
7:00 am - 8:30 am  Registration and Breakfast   
8:30 am – 8:40 am  Welcome  Nick DeLuca, M.A. Lead Health 
Education Specialist, DTBE, 
NCHSTP 
8:40 am – 9:00 am  Opening Remarks  Harold Jaffe, M.D. Director, NCHSTP 
 
Ken Castro, M.D. Director, DTBE, 
NCHSTP  
 
Wanda Walton, Ph.D. Chief, 
Communications, Education, and 
Behavioral Studies Branch, DTBE, 
NCHSTP  
9:00 am – 9:30 am When Sacred Cows Become 
the Tiger’s Breakfast: Defining 
a Role for the Social Sciences 
in TB Control  
 
Perspectives from TB Programs 
Jessica Ogden, Ph.D. Technical 
Specialist, International Center for 
Research on Women  
 
 
Masae Kawamura, M.D. Director, San 
Francisco TB Control 
9:30 am - 9:45 am  Preliminary Results from the 
Behavioral and Social Science 
Literature Review  
Cathy Rawls, M.P.H., C.H.E.S. ASPH 
Research Fellow, DTBE, NCHSTP  
 
Cristina Booker, M.P.H. Research 
Analyst, Abt Associates, Inc.  
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DAY 1:  Wednesday, December 10, 2003 (cont.)  
9:45 am – 10:45 am  Neighborhood Health 
Messages: Using local 
knowledge, trust, and 
relationships to create 
culturally effective TB 
education and care for 
immigrant and refugee families 
 
Psychosocial, Social, 
Structural, and Environmental 
Determinants of TB Control 
Stefan Goldberg, M.D. Medical 
Officer, DTBE , NCHSTP 
 
 
 
 
 
 
Donald E. Morisky, Sc.D., M.S.P.H., 
Sc.M. Professor, UCLA School of 
Public Health  
10:45 am – 11:00 am  Break   
11:00 am – 12:15 pm  Community Perspectives in TB 
Control and Elimination  
Facilitator:  
Robin Shrestha-Kuwahara, M.P.H., 
Behavioral Scientist, DTBE, NCHSTP 
 
Panelists:  
Representatives from DeKalb County 
and Fulton County Public Health 
Departments  
12:15 pm – 1:15 pm  Lunch   
1:15 pm – 1:45 pm  Interactive Group Discussion 
of Morning Sessions  
Mark Nichter, M.A., Ph.D., M.P.H 
Professor, University of Arizona  
1:45 pm – 2:00 pm  Charge to Breakout Session 
Groups  
Robin Shrestha-Kuwahara, M.P.H. 
Behavioral Scientist, DTBE, NCHSTP 
2:00 pm – 3:45 pm  Breakout Group Sessions I: 
Identifying Research 
Gaps/Needs Groups A & B: 
Internal Influences Groups C 
& D: External Influences  
Facilitators:  
Kelly McCarrier, M.P.H. Rachel 
Albalak, Ph.D. Gaby Benenson, 
M.P.H. Betsy Carter, M.P.H., 
C.H.E.S.  
DTBE, NCHSTP  
3:45 pm – 4:00 pm  Break (Reconvene in large 
group)  
 
4:00 pm – 5:00 pm  Report and Discussion of 
Breakout Group Sessions I (10 
minutes for each group)  
Paul Colson, Ph.D. Program Director, 
Charles P. Felton National TB Center  
5:00 pm  Adjourn   
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DAY 2: Thursday, December 11, 2003  
7:30 am – 8:30 am  Breakfast   
8:30 am – 8:40 am  Overview of the Day’s 
Activities  
Nick DeLuca, M.A. Lead Health 
Education Specialist, DTBE, 
NCHSTP 
8:40 am – 10:40 am Breakout Group Sessions II: 
Determining and Prioritizing 
Research Questions/Methods 
Groups A & B: Internal 
Influences Groups C & D: 
External Influences  
Facilitators:  
Kelly McCarrier, M.P.H. Rachel 
Albalak, Ph.D. Gaby Benenson, 
M.P.H. Betsy Carter, M.P.H., 
C.H.E.S.  
DTBE, NCHSTP 
10:40 am – 11:00 am  Break   
11:00 am – 12:30 pm  Report and Discussion of 
Breakout Group Sessions II 
(10 minutes for each group)  
Paul Colson, Ph.D. Program Director, 
Charles P. Felton National TB Center  
12:30 pm – 1:30 pm  Lunch   
1:30 pm – 2:30 pm  Turning Research into Practice 
Panel Discussion  
Facilitator:  
Jane Mezoff, Dr.PH., Behavioral 
Scientist, DTBE, NCHSTP 
 
Presenters: 
Shawna Mercer, M.Sc., Ph.D. Health 
Scientist, Public Health Program 
Practice Office, CDC  
 
Agatha Eke, Behavioral Scientist, 
Division of HIV/AIDS Prevention, 
NCHSTP  
 
Leslie Boss, M.P.H., Ph.D. Air 
Pollution and Respiratory Health 
Branch, CDC  
2:30 pm – 2:45 pm  Break   
2:45 pm – 4:00 pm  Potential Funding 
Opportunities Maintaining the 
Momentum: Recap and  
 
Next Steps Closing Remarks  
Kate O’Toole, M.B.A. Associate 
Director of Management and 
Operations, DTBE, NCHSTP  
 
Nick DeLuca, M.A. Lead Health 
Education Specialist, DTBE, 
NCHSTP 
4:00 pm  Adjourn   
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Appendix B: Presentation Slides 
 
BEHAVIORAL AND SOCIAL SCIENCE RESEARCH IN TUBERCULOSIS CONTROL 
Kenneth G. Castro, MD 
Director, Division of Tuberculosis Elimination 
Centers for Disease Control and Prevention 
 
   
Behavioral and Social Science
Research in TB Control
Kenneth G. Castro, M.D.
Assistant Surgeon General, USPHS
Director, Division of Tuberculosis Elimination
National Center for HIV, STD, and TB Prevention
Centers for Disease Control and Prevention
Tuberculosis Behavioral and Social Sciences
Research Forum, December 10-11, 2003
 
• 1950s: “Health Belief Model” examined 
motivators of free TB screening programs
• Recently behavioral research studies 
emphasized treatment adherence
Behavioral and Social Science
Research in TB Control
 
   
Behavioral and Social Science
Research Efforts in TB Control
• 1994: TB and Behavior: National Workshop on 
Research for the 21st Century (CDC co-sponsor)
• 2000: IOM Report, Ending Neglect: The 
Elimination of Tuberculosis in the United States
• 2003: TB Behavioral and Social Science 
Research Forum
 
 
 
 
 
 Kenneth G. Castro, MD 
 Behavioral and Social Science 
  Research in TB Control 
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Themes from 1994 Conference  
• How to inform the public about TB and 
overcome stigma?
• How to identify and reach persons at highest 
risk for TB?
• How to increase patient adherence?
• How to improve provider practices?
• How to identify and implement the best mix of 
TB control services? 
 
“Studies are needed to 
determine how basic 
behavioral theories can 
enhance understanding for 
the creation of tailored 
interventions for high risk 
populations”
–Institute of Medicine Report, Ending Neglect: The 
Elimination of Tuberculosis in the United States, 2000 
 
   
IOM Call for Behavioral Science Research
• Explore impact of behavior change models on 
health seeking and adherence
• Identify cultural barriers to Rx, P&C, and role of 
incentives and enablers
• Tailor adherence interventions to needs, 
lifestyles, social support system, and beliefs
• Ensure translation of research into TB programs
 
 
Role of Behavioral and Social Science
Research in TB Control (1)
• Individual and interpersonal health behavior 
research 
–Patient care seeking behavior
–Patient adherence behavior
–Provider behavior
–Health care service delivery
 
   
Role of Behavioral and Social Science
Research in TB Control  (2)
•Systems research
– Health systems structure and 
organization
– Environmental, economic, and 
sociopolitical dynamics
– Policies and laws
 
 
Role of Behavioral and Social Science
Research in TB Control (3)
• Identify, understand, and address broad 
range of relevant socio-cultural, 
behavioral, and structural issues
• Engage systematic, theory-based, 
mutidisciplinary research with 
scientifically rigorous experimental and 
quasi-experimental designs
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BEHAVIORAL AND SOCIAL SCIENCES IN TUBERCULOSIS ELIMINATION 
Wanda Walton, Ph.D. 
Chief, Communications, Education, and Behavioral Studies Branch 
Division of Tuberculosis Elimination, 
Centers for Disease Control and Prevention 
 
 
 
Behavioral and Social Science in 
Tuberculosis Elimination
Wanda Walton, PhD
Communications, Education, and Behavioral 
Studies Branch
Division of Tuberculosis Elimination
 
 
Building TB Behavioral and Social 
Science Capacity within DTBE
Communications, Education, and Behavioral 
Studies Branch
• Conduct research on individual and social 
factors affecting health seeking and treatment 
outcomes related to TB
• Provide consultation
• Provide technical assistance
• Coordinate behavioral science activities of 
DTBE, CDC, and others
Building TB Behavioral and Social Science 
Capacity within DTBE (cont.)
• Division staff with behavioral and social 
science backgrounds
– Communications, Education, and 
Behavioral Studies Branch 
– Clinical and Health Systems Research 
Branch, Health Systems Research Team
• Association of Schools of Public Health 
fellows
 
 
Selected Current Behavioral and 
Social Science Projects in DTBE
   
Wanda Walton, Ph.D. 
Behavioral and Social Sciences 
in TB Elimination 
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Patient Studies
Perceptions of TB Among Foreign-born 
Persons:  An Ethnographic Study
• To understand the culturally-mediated perceptions, 
attitudes, and experiences regarding TB among five 
foreign-born populations in the U.S.
Culturally Appropriate Patient TB Education 
Materials
• To develop culturally and linguistically appropriate 
patient TB education materials
 
 Patient Studies (Continued)
Social Network Techniques in Expanding 
Women’s Access to LTBI Treatment
• To assess the usefulness of social network 
techniques as tools to increase the identification of 
women during contact investigations
Study of Factors Associated with Acceptance of 
and Adherence to Treatment for LTBI 
• To assess the knowledge, attitudes, and culture-
specific beliefs about LTBI among several high risk 
groups
 
 
 
 
 
  
Provider Studies
Identifying Barriers to the Implementation of the 
2000 Targeted Testing and Treatment for LTBI 
Recommendations among Private Providers
• To Identify barriers to the acceptance, 
implementation, and adherence to the guidelines and 
development of strategies to overcome barriers
Factors Influencing Health Care Worker 
Adherence to Worksite TB Screening and 
Treatment Policies
• To identify factors that facilitate or hinder health care 
workers’ abilities or decisions to adhere to local 
protocols for annual TST and LTBI treatment
 
 Research Activities in the TB 
Epidemiologic Research Consortium
• Task Order 11: Addressing TB Disease Among 
African Americans in the Southeast
• Task Order 12:  Assessing TB Knowledge, 
Attitudes, Beliefs, and Practices Among Private 
Providers Serving Foreign-born Populations 
• Task Order 14: Developing Culturally Appropriate 
Educational Materials for Hispanic Service 
Organizations
 
 
 
  
 
Planting the Seeds for Future Research
                             
 
 TB Behavioral and Social Science 
Research Forum - 2003 
Goals
• Identify and prioritize TB behavioral and 
social science research gaps
• Develop a feasible, goal-oriented research 
agenda that will guide TB behavioral and 
social science activities over a  5-year period
 
Wanda Walton, Ph.D. 
Behavioral and Social Sciences 
in TB Elimination 
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Planned TB Activities Related to the Forum
• Systematic inventory and review of published 
TB behavioral and social science literature
• A behavioral science list-serv for ongoing 
discussion and information exchange
• Ongoing workgroups on derived themes
 
Tuberculosis is a social disease, 
and presents problems that 
transcend the conventional 
medical approach.
Rene and Jean Dubos
1952
   
We’ve only just begun…
Karen Carpenter
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KEYNOTE SESSION 
WHEN SACRED COWS BECOME THE TIGER’S BREAKFAST:  DEFINING A ROLE FOR THE SOCIAL 
SCIENCES IN TUBERCULOSIS CONTROL 
Jessica Ogden, Ph.D. 
Technical Specialist 
International Center for Research on Women 
 
 
When sacred cows becomes the 
tiger’s breakfast:
towards defining a role for the social and 
behavioral sciences in TB control
Jessica Ogden
  
• John Porter, London School of Hygiene & Tropical Medicine
• Mukund Uplekar, Communicable Diseases Cluster (Stop TB), WHO
• Sheela Rangan, MaharashtraAssociation of Anthropological Sciences
• Varinder Singh, LalaRam Swarup Institute of TB and Allied Diseases
• Christian Lienhardt, Institute Research du Developpment, Senegal
Acknowledgements
 
 
 
 
 
 
• Situating a social science perspective
• Defining our roles:
•Who are we not?  orientations and contributions of the medical 
sciences in public health/TB control
•Sacred cows whose time has come 
•Who are we instead?  Strengths (and limitations) of social/behavioral 
science approaches (and another ‘sacred cow’)
• Proposed (draft) framework
• Key questions a multi-disciplinary approach can answer
• Some principles to guide our way forward
Overview of presentation
  
Addressing the microbe in relation to an individual or population
Establishing foundations for diagnosis & treatment
Epidemiology: interactions between infectious agent, the host and 
the environment: 
? identify source of infection;  interrupt transmission
 Microbiology & genetics
? understanding the bacteria and developing  new drugs
 Immunology & molecular  biology
? refining response to infection and developing new vaccines
Classical Public Health Paradigms: 
‘elimination of disease’ orientation
 
 
 
 
 
 
 Jessica Ogden, Ph.D. 
  When Sacred Cows Become 
  the Tiger’s Breakfast 
 
53 
• Cholera epidemic in London,1854
• John Snow identifies source of infection (water supply)
• John Snow removes pump handle (interrupts transmission)
• Cholera epidemic ends
• Theory of disease transmission proved
• Deaths prevented
• Community empowered?
Sacred Cow #1: the Broad Street pump handle
  
Control in the community 
? May lead to neglect of wider social realities: ordinary life, poverty, 
health care system constraints
 Power and Agency: who has them and who does not?
? Who has the power to determine success?  Who ‘should’ have it?
? Are people able to take the actions we suggest?
? Are people willing to take these actions?
 Questions of trust: does the control paradigm foster or challenge 
efforts to build trust?
Sacred Cow #2: TB and the limits of ‘control’
 
 
 
 
 
 
Those of us involved in TB would do well to 
consider a shift in paradigm - a shift from a 
focus on control to a focus that privileges care.
• Attentive to Trust
• Fostering Partnership 
  
Understanding how the person and the disease interact in 
context of everyday life
 Health outcomes understood in terms of context 
 People’s responses to ill health made intelligible
 Individual ‘nested’ within layers of social context 
? influencing whether individuals are able and willing to 
obtain, maintain and complete treatment
Relating the individual to the local, national and the global
Social Science Paradigm: wellbeing orientation
“the production of health”
 
 
 
 
 
 
PATIENT
Household
Community
Health & Social Services
Policy
  
Study of ‘beliefs’ and ‘behaviors’ alone will not answer our 
questions
• what people think and what people do mediated by elements 
of culture but also by elements of social structure (e.g. poverty)
affects availability, accessibility and acceptability of 
health care options
impacts on agency - freedom/ability to make choices 
within a range of options, or the ability to take action 
according to belief
Does not account for global and local power relations that 
produce and shape sickness and health
Sacred Cow #3: ‘beliefs’ and ‘behaviors’
 
 
 
 
 Jessica Ogden, Ph.D. 
  When Sacred Cows Become 
  the Tiger’s Breakfast 
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Who can adopt the sick role, and when
Range of treatment optionsavailable
Extent to which a given person has access to Rx
Extent to which a given person will obtain 
diagnosis & Rx
Extent to which a given person can adhere to Rx
These are all aspects to which research and policy can 
respond
Social structures  within household, community, 
polity determine
  
PROGRAMMES
DONORS & POLICY
MAKERS
HEALTH SERVICES
(PROVIDERS)
COMMUNITY &
HOUSEHOLDS
PATIENTS
Interviews 
Case studies
Mapping
focus groups discussions
key informant interview
participant observation
field diaries
Semi-structured questionnaires
ethnographic survey
informal interviews
Semi-structured, open ended Interviews
pre-coded questionnaires
non-participant observation
facility assessment
workshops with practitioners
involvement of NGOs
Stakeholder analysis
Semi-structured 
interviews
Focus group discussion
Key informant interviews
 
 
 
 
 
 
Combines strengths of medical sciences and social/behavioral
sciences
Answering the ‘why’ questions
? Why don’t patients come for treatment?
? Why do they only come when it’s too late?
? Why don’t they complete their therapy?
Answering the ‘how’ questions
? How can we make our programs accessible and acceptable?
? How can we meet health needs of community?
? How can communities be involved as participants in their own health?
Multi-disciplinary Approach
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KEYNOTE SESSION 
BEHAVIOR, SOCIETY AND TUBERCULOSIS CONTROL 
Masae Kawamura, M.D. 
ACET Chairperson 
Director, Tuberculosis Control Section 
San Francisco Department of Public Health  
Tuberculosis Clinic, Ward 94 
San Francisco General Hospital 
 
 
Behavior, Society and 
Tuberculosis Control
L. Masae Kawamura, M.D.
Director, TB Control Section
San Francisco Dept. of Public Health
 
 Program Perspective
• If TB control was exclusively related to 
its biologic cause and biologic cure, we 
would be close to eradication
• But TB persists…..why?
- Root causes are imbedded in society
-Successful TB Control depends on
the behavior of individuals at all levels:
patient, provider, program and society
 
   
Where we are…
Good news: TB incidence is at an all time low 
Take a closer look: 
• FB cases essentially unchanged (24% 
Mexican-born)
• US born cases are dominated by African 
Americans and minorities
• Case rates in inner cities and in poor 
communities in the SE US are as high as 
rates in developing countries
• Outbreaks continue all over the US despite 
contact investigation 
 
 Where we are…
TB has retreated in populations that are most 
difficult to reach
• Disenfranchised homeless
• Addicts and substance users
• Impoverished communities
• Incarcerated
• New and old immigrants
• Individuals who move freely across the 
border
 
   
Masae Kawamura, M.D. 
Behavior, Society and  
Tuberculosis Control 
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TB Control success…
We are premier experts on effective behavioral 
strategies to improve adherence and 
patient/provider relations
• Patient centered DOT 
• Hiring culturally appropriate staff and providing 
cultural competence training and mentoring
• Use of housing, food, transportation vouchers, 
cash, methadone, education, etc as enablers 
and incentives
 
 What we accomplished and continue 
to strive for..
TB Control is about building and maintaining 
supportive/trusting relationships with 
patients and their communities
• Repairing societal connections with the 
disenfranchised
• Creating societal connections with those 
who are not yet integrated in society 
 
   
We have done so much but it is 
not enough…
Long way to go in engaging patients, 
providers, communities and society : 
• undocumented persons and those living 
on both sides of the US-Mexico border
• Minority communities
• New immigrants
Contact investigation: methods and 
treatment adherence
 
 Yet to be addressed…
Health promotion and prevention
• Integration of targeted testing and LTBI 
treatment as a primary care issue 
• Adherence to LTBI treatment beyond 
traditional approaches of education, 
incentives and enablers
Addressing the root causes
• Mobilizing communities and countries to take 
action
• Translating TB information into a meaningful 
format 
 
What behavioral and social 
science research can do for TB 
control..
• Validate what we are doing right and wrong
• Introduce new behavioral strategies that have 
been proven in other fields
• Refine current successful behavioral 
strategies to improve implementation
• Determine when integration strategies are 
appropriate and or harmful
• Frame TB data in its full context with 
demographics, social determinants, other 
health disparities and incidence of other 
diseases so it is meaningful to society   
 
 Word of caution about research 
and research application
• Research interventions must be 
practical and well thought through
• If new resources will be needed for 
implementation, cost savings and health 
benefits should be well characterized
Remember: civil service front-line staff 
may prove to be very different than 
dedicated research staff
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Although we may need to take a more 
“macro” approach to furthering our 
success in TB control, let us never 
forget the individual approaches and 
strategies that have made us incredibly 
successful.
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PRELIMINARY RESULTS FROM THE TUBERCULOSIS BEHAVIORAL AND SOCIAL SCIENCE 
LITERATURE REVIEW 
Cathy Rawls, M.P.H., C.H.E.S. 
ASPH Fellow 
Division of Tuberculosis Elimination,  
Centers for Disease Control and Prevention 
Cristina Booker, M.P.H. 
Analyst 
Public Health Applications and 
Research Area 
Abt Associates Inc. 
 
 
0
TB Behavioral and Social Science Research 
Literature Review
Presented by:
Cathy Rawls, M.P.H., CHES, 
ASPH Behavioral Research Fellow, DTBE, CDC
Cristina Booker, M.P.H., 
Abt Associates, Inc.
Tuberculosis Behavioral and Social Science Research Forum
December 10-11, 2003
  1
Literature review and 
database development
Activities:
Created abstraction form and guide 
Reviewed and analyzed articles
Developed access database
Synthesized preliminary results
 
 
 
 
 
 
3
Literature review methods
Search strategy:
Conducted in OVID across 5 databases 
CINAHL, Embase, Medline, PsycInfo, and Sociofile
Focused on behavioral, sociological, and 
cultural factors for TB prevention and 
treatment
Used refined subject headings and keywords
  4
Inclusion criteria
TB research that used social science methods 
or applied social science theory or concepts  
Published after 1980
US-based and/or international literature in 
English
Published works (including scientific, peer-
reviewed literature, review articles, books 
(including book chapters), and meta-analyses)
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4
Key items abstracted
Study descriptions and methods
Topic areas, study design, theory, sampling design, data 
collection methods, target populations, geographical and 
structural settings
Key results/findings
Limitations
Conclusions
Recommendations 
  5
Article types
175 documents reviewed/abstracted  
(mostly peer-reviewed journal articles)
~33 involved interventions
59%
12%
29% Research
Evaluation
Non-research
 
 
 
 
 
6
Explicit domains addressed (n=175)
0%
10%
20%
30%
40%
50%
Patient Adherence (n=82)
Cultural/Social, incl. K-A-B (n=78)
Structural Influences (n=57)
Health Seeking Behavior (n=33)
Provider Adherence (n=25)
Other (n=21)
  7
Geographic locations (n=175)
30
63
82
n
17
36
47
%
U.S.-based
International-based
Non-location specific (e.g., 
concept/position papers)
Literature
 
 
 
 
 
8
U.S. target populations (n=175)
0%
5%
10%
15%
20%
25%
Ppl with TB (n=33)
US-born rac/eth groups (n=32)
Foreign-born in US( n=28)
Patients (n=26)
Hlth Care Providers (n=14)
Homeless (n=12)
Substance Users (n=12)
Low-income Persons (n=12)
General Popn (n=11)
Ppl with HIV/AIDS (n=8)
Ppl with LTBI (n=8)
Ppl with MDRTB (n=5)
Migrant Farm workers (n=5)
Students (univ/coll) (n=4)
Ppl in corrections (n=2)
Other (n=9)
  9
International target populations (n=175)
0%
5%
10%
15%
20%
25%
30%
35%
40%
Ppl with TB (n=65)
Patients (n=33)
Low-income Persons (n=22)
General Popn (n=14)
Hlth Care Providers (n=11)
Substance Users (n=4)
Homeless (n=3)
Ppl with HIV/AIDS (n=3)
Students: univ/college (n=1)
Ppl with LTBI (n==1)
Ppl with MDRTB (n=1)
Other (n=6)
 
 
 Cathy Rawls, M.P.H., CH.E.S./Cristina Booker, M.P.H. 
 Preliminary Results from the TB Behavioral  
and Social Science Literature Review 
 
60 
10
Themes from the literature review
Underlying social/cultural factors:
• Poverty, gender differentials
• Health beliefs
Health seeking behavior: 
• Barriers and facilitators to care
Patient-related adherence:
• Social support, economic aid, & education
Provider-related adherence:
• Medical education about TB diagnosis & 
treatment
  11
Themes from the literature review (cont.)
Health education strategies: 
• Essential for TB control/eradication
TB control/eradication strategies:
• Integration with other health services
Resource/funding allocations:
• Interdisciplinary research and interventions that 
integrate biological, psychological, behavioral, 
and social variables
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Next steps: literature review report
Based on the data abstraction forms & Access 
database
Features:
Descriptive data
Key outcomes/results
Needs, gaps, and recommendations for future 
research or practice
Expected to be finalized for CDC in early 2004
  13
Next steps: database
Created in Access to store the data abstraction 
forms
Database features:
Keyword searches
Preset queries and reports
Expected to be finalized for CDC in early 2004
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NEIGHBORHOOD HEALTH MESSENGERS:  USING LOCAL KNOWLEDGE, TRUST AND 
RELATIONSHIPS TO CREATE CULTURALLY EFFECTIVE TUBERCULOSIS EDUCATION  
AND CARE FOR IMMIGRANT AND REFUGEE FAMILIES 
Stefan Goldberg, M.D.  
Medical Officer 
Division of TB Elimination, 
Centers for Disease Control and Prevention 
 
Neighborhood Health Messengers
Using local knowledge, trust, and 
relationships  to create culturally effective TB 
education and care for immigrant and 
refugee families
.
Patrick Chaulk, MD, MPH
Annie E. Casey Foundation
Baltimore City Chest Clinic
Johns Hopkins Schools of Medicine and Public Health
Baltimore, MD
Stefan Goldberg, MD
CDC
  
Impact of Immigrants and refugees
on U.S. Culture
• Large influx of immigrants and refugees during the 
1990s:
– Increasingly a multi-cultural nation
• Over 300 languages spoken in the U.S.
– Nearly 20% of the U.S. population speaks a language other than 
English:
– Spanish speakers increased by 43% between 1990 and 2000
– Over 21 million individuals self-report that they speak English less 
than “very well”.
• Virtually all these refugees and immigrants come from 
countries endemic with TB
– FB account >50% of all active US cases
– TB is the leading marker for racial health disparities
Source: US Census, CDC, National Center for Health Statistics  
 
 
 
 
 
Seattle’s Cultural Case Management Program: 
2,194 immigrants tested 1999 - 2000
442 offered treatment
389 (88%) started on treatment 
319 (82%) completed 6-9 month regimen
(vs. 60% nationally, 37% Seattle)
93% of client encounters also involved 
discussions about housing, ESL, mental
and physical health, employment and 
employment training, child care, 
transportation .
Program Performance Measures
Therapy acceptance rates
Treatment completion rates
Referrals for other social services
  
1998 Seattle-King County IPT 
assessment & epidemiology 
• Epidemiology
– 67% of cases foreign-born
– Greatest immigration from Former Soviet Union, Former 
Yugoslavia, and Somalia
• Findings
– Continued growth in demand for TB clinic services
– TB clinic move to Harborview Medical Center, site of 
Community Housecalls and Ethnomed programs
• Recommendations
– Stop “routine” TB clinic preventive therapy except for highest 
risk (ie. “regardless of age” categories and children)
– Develop Cultural Case Management program in 
partnership with Community Housecalls
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Cultural Case Management for 
Treatment of Latent TB Infection
• Federal and grant-funded partnership with 
Harborview Medical Center for “bilingual, 
bicultural case management.”
• Three major groups of new refugees and 
immigrants: Somali, Bosnian, and Russian-
Ukrainian.  
• All refugees evaluated by the TB Clinic were 
evaluated in a custom-designed database 
January 1999 through June 2001.
  
Cultural Case Management 
Principles
• Based on experience of Harborview 
Medical Center’s Community Housecalls 
Program
– 2-way communication and support between 
providers and affected individuals and 
communities
– Case Managers - Cultural Mediators (CCM)
 
 
 
 
 
 
• Bilingual, bicultural program using local knowledge to 
create trust and relationships among immigrants and 
refugees.
• Extensive community mapping/participatory 
research approach
– Identify local assets,  understand local culture and practice.
• Recruit and train community residents to:
– Help create effective messages and education strategies
– Serve as TB field  workers and case managers
– Conduct extensive neighborhood outreach to:
» Recruit residents for TB testing and therapy 
» Assist with clinic visits, home delivery of medications
» Conduct at least monthly house calls; twice-a-week 
phone calls;
» Establish social networks; assist with other needs.
Neighborhood Health Messengers:
“Cultural Case Managers (CCM)”
  
Characteristics of Effective CCMs
• Knowledge:
– Of refugee language beyond mere translation: 
refugee cultures, customs, beliefs, gender roles, 
family structure. Creates credible messages.
• Experience:
– With history of effectively serving the target refugee 
community. Creates  relationships.
• Social standing:
– Highly regarded in the target refugee community: 
just “being from the community” is necessary but not 
sufficient.  Creates trusted messengers.
• Capacity:
– Belief in and ability to explain U.S. medical 
strategies and its complex health care system.  
Creates effective education.  
 
 
 
 
 
Therapy acceptance rates (’96-’98 vs. ’99-’00)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Bosnian Somali Russian
'96-'98
'99-'00
98%
92%
76%
N= 389  (88%)
54% 57% 55%
  
Therapy completion rates (’96-’98 vs. ’99-’01)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Bosnian Somali Russian
1996
2000
79%
89%
95%
N = 319 (82%)
49%
33%
45%
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Elements of Success
• Interviews suggest the success of this 
program is largely due to the outreach 
workers building trusting relationships 
with their clients. 
– Bilingual, bicultural
– Patient-centered, community-centered 
approach
– Supporting needs identified by the patient and 
the community
  
 
Tasks Activities Objectives Goal
Neighborhood Health Messenger Logic Model:  
Action steps for improving family and community health. 
Phase I:  Initial Start -Up
-Develop planning group of 
critical partners
-Choose anchor agency
-Community mapping
-Identify/recruit residents
-Peer training for residents
-Consensus on vital issues
-Secure funding
Phase II: Implementation
Launch door -to-door 
outreach and education  
Evaluate track 
Connect families 
Advocacy
Phase III: Sustainability
--Institutionalization
- Resident leadership 
- Social networks 
- Communities 
organized to obtain  
better services  
- Community/public  
partnerships 
- Increased insurance 
coverage and more 
educated families   
and community 
- Families   
connected to  
providers 
Improved 
Health Status
Getting Started:
-Identify/include critical team members
-Establish regular meetings for 
planning, ongoing program monitoring
Implementation
-Develop service menu, educational
resources and other benefits to share 
as part of door -to-door outreach
specific to your community needs. 
-Develop data collection, analysis and
reporting systems to evaluate and 
monitor program progress
-Obtain data system TA 
-Provide periodic reports to partners,
funders, and community members
Make Long Term Connections Between:
-Families and  Medical providers 
-Families and Resources/Services
-Communities and Health Policymakers
-Communities and Health Systems  
 
 
 
 
 
Haitian Health Care Alternatives
ModernTraditional
Private 
Physicians
Mayetizè
Public 
PhysiciansSupernatural
Mayetizè
Bokò
Christian
Catholic
Priest
Mambo
Priestess
Houngan
Natural
Docktè Fèy
Pikirist
Chalatan
Doktè Zo
Fanm Saj
Herbalist
Bone
setter
Midwife
Dx Illness
Joel Piton, M.D., CCHER
  
Radio outreach Community focus group
Haitian Collaborative Project
 
 
 
 
 
 
  
Client Client Client
TB 
Clinic
TB
Clinic
TB
Clinic
Client Client Client
Traditional TB Clinic Model
At 3 Months At 6 Months At 9 Months
Cultural Case Management Model
TB 
Clinic
TB
Clinic TB
Clinic
3 home 
visits
6 home
visits 9 home
visits
Phone
24
Phone
48
Phone
72
Primary
care
Primary
care
Primary
care
Housing
Housing
Housing
School
School
School
Social
Social
Social
Housing
Trans.
Work
Social Networks
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Selected Cultural Findings
From Community Mapping
• TB more stigmatizing than AIDS
– Often viewed as a curse or test from God.
• No framework for “latent infection”
– Treatment without symptoms = experimentation.
• Pharmaceuticals are dangerous
– Not natural products
– Pollutants
– Liquid “safer” than pills
– US medicines appropriate for Americans not them.
• Mistrust of American physicians
– Mistrust/insecurity of American systems especially since 9/11
• Health belief system often complex
– Secular, religious, and mystical or supernatural components
  
Selected Cultural Findings
From Community Mapping
• Translated words carry different semantics
– “Negative” versus “Positive” test results.
• PPD reactions are common
– So, in some populations, they are perceived as 
“normal”.
– Or,  are a result of childhood immunization with 
BCG.
• Bosnian Story
– Interpreter: “don’t trust what they tell you about TB”
• Russian Story
– Initial interpreter telling the wrong things.
– Repeat BCG and PPD till Positive showing 
protection from TB
 
 
 
 
 
 
Selected Cultural Findings
From System Mapping
• “Treating your TB is very important”…but client can’t get a 
TB clinic appointment for at least another 2 -3 months.
• Clinic visit sometimes disrespectful.
• Recommendations on the treatment of LTBI inconsistent:
– 12  v. 6. v. 9 months; eligibility age raised from 29 to 50.
• Fear of becoming a focus of research and publicity
– E.g. reporting unfamiliar symptoms (has become a reason for concealing personal 
health information.)
• Doctors seem more concerned with saving time than serving 
clients; Too busy to spend the time to understand their 
health concerns; Lack patience, compassion and care 
patients expect of them.
• Immigration process misleading: (-) CXR = no TB so:
– “Why am I being screened again when I was screened in Somalia?”
– How could I have TB if I was told I didn’t have it when I left Somali?
– (+) PPD = prior BCG
• US health care system too confusing
  
Other Lessons Learned
• Cultures are not monolithic:
– E.g., nearly 40 tribes in the Sudan w/ war-like histories
– Class and SES distinctions
• Immigrants have many other more important 
concerns
– Many do not speak English and “interpreters” may speak on 
behalf of the health care system not client.
– Illiteracy high: graphics needed for communication/education
– Employment: limited marketable skills.
– Misunderstanding/misinterpretation of some our health care 
practices.
• Western male clinicians and immigrant female clients 
unacceptable.
– Erosion of traditional male power and roles.
 
 
 
 
 
 
Replication
• Matapan:
– Community Center for Haitian Education & Research
• San Diego
– Nile Sisters, Horn of Africa, Africa Call 
• District of Columbia
– Mary Center For Women & Children
• Denver
– Sisters of Color For Education
  
• Complete replication, refine documentation & evaluation
• Influence the field through:
Local CCM “experts”; replication tool kit
Dissemination
Presentations at professional meetings 
National Jewish Medical Center TB Course
CDC, national, state, local TB control programs
Publications:
Clinical results (IJTLD 8(1):1-7)
Cost effectiveness analysis
Cultural lessons document
Peer site exchange in May 2003
RESULTS.org
Casey Public Health Fellowship @ CDC
Next Steps
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Final Thoughts
• Costs:
– Goal is to cross train CCMs and thereby cross fund
– Leverage Medicaid and other funding streams
• Replication
– Focusing on the process not the knowledge
• Focus groups are an effective engagement strategy to 
develop not just knowledge but trust and relationships
– Go beyond a TB program to broader community building 
agenda
• Promote the benefits of this strategy
– Refine asset mapping and replication tool kit
– Develop customized technical assistance pool
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Professor, Department of Community Health Sciences 
UCLA School of Public Health 
 
 
Donald E. Morisky, Sc.D., M.S.P.H., Sc.M.
Professor and Program Director for Social 
and Behavioral Determinants of AIDS and 
Tuberculosis Training 
Department of Community Health Sciences
UCLA School of Public Health
Psychosocial, Social Structural, 
and Environmental Determinants 
of TB Control
  
Typically associated with homelessness, 
drug or alcohol abuse and/or minimal 
educational achievement
Multiple drug resistant TB (MDR-TB)
Cited as the major cause of the increase in 
incidence rates of TB
Directly Observed Treatment -- Short 
Course (DOTS)
ËReason for Dots.    
 
 
 
 
 
E1 - Educational counseling;
E2 - Incentives/rewards; 
E3 - Combination of E1 and E2;
C - Usual care
Study
Group
R
(Site 1)
(Site 2)
  
A total of 241 patients were randomly  
assigned to one of three intervention groups 
or the control. 
The patients were followed throughout 
their treatment program.  Cognitive and 
behavioral outcome markers were used to 
assess the effectiveness of the educational 
intervention.   
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THREE CATEGORIES OF FACTORS CONTRIBUTING TO
COMPLIANCE TO AN ANTI-TUBERCULOSIS REGIMEN
COGNITIVE FACTORS
ENVIRONMENTAL FACTORS
REINFORCING FACTORS
Knowledge
Beliefs
Values
Attitudes
Availability/Accessibility to Care
Travel to Health Facility
Waiting Time
Health Related Skills
Complexity of Medical Regimen
Family
Peers
Employer
Health Care Provider
Health Educator
Compliance to an
anti-tuberculosis
regimen
  
DEMOGRAPHIC
For all eligible participants interviewed (N=241)
Survey Item Distribution
Male 63%
Ethnicity
- Hispanic
- Black
62%
25%
Spanish-speaking 60%
Unemployed 63%
Education <  High School graduate 55%
Annual Family Income < $10,000 42%
 
 
 
 
 
 
LENGTH OF CARE FOR PARTICIPANTS
IN PROGRAM
39.66
32.27
37.13
31.96
0.00
5.00
10.00
15.00
20.00
25.00
30.00
35.00
40.00
Control Education Incentives Combined
Average
Weeks
Weeks
Intervention Group
ANOVA : p =0.03
(n=61) (n=60) (n=60) (n=60)
  
INTERVENTION EFFECTS  BETWEEN 
BASELINE  INTERVIEW  AND  EXIT  INTERVIEW 
Intervention Group Percentage Difference p - value
C  - Control
E1 - Education
E2 - Incentives
E3 - Combined
.860
.009**
.059
.046*
Knowledge Scale
+   1.5%
+ 31.7%
+ 20.5%
+ 26.7%
Medication Compliance
C  - Control
E1 - Education
E2 - Incentives
E3 - Combined
(Post-test vs Pre-test)
+   9.7%
+ 26.5%
+ 14.1%
+ 16.7%
(Paired t-test)
.47
.006**
.067
.061
* : p < 0.05; ** p < 0.01
 
 
 
 
 
 
$2,680.1
$1,647.5 $1,770.7
$2,070.8
$0.0
$500.0
$1,000.0
$1,500.0
$2,000.0
$2,500.0
$3,000.0
Control Education Incentives Combined
Total Cost
(Dollars)
Dollars
Intervention Group
(n=60) (n=61) (n=60) (n=60)
COST PER COMPLETED CASE
ANOVA : p =0.04
  
84.30%
89.70%
81.00%
82.00%
83.00%
84.00%
85.00%
86.00%
87.00%
88.00%
89.00%
90.00%
Control All Interventions
APPOINTMENT-KEEPING  BEHAVIOR  FOR  
PARTICIPANTS
 p =.04
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38.4
32.9
30.0
31.0
32.0
33.0
34.0
35.0
36.0
37.0
38.0
39.0
Control All Interventions
AVERAGE  WEEKS  OF  TREATMENT UNTIL 
COMPLETION  OF  CARE
 p 
=.044   
Factors to consider for drop out rates
Ethnic Background
Sex
Unemployment
Homeless
Drug Use
HIV
Primary Language
Marital Status  
 
 
 
 
 
  
Why Focus on Adolescents ?
• Incidence of TB increases at adolescence1
• Adolescents more susceptible to active TB2
• Time interval between infection and 
development of active disease is shorter3
• Adherence among adolescents
1. Starke, JR. Infectious diseases of health significance among children and adolescents 
in Texas. Texas Med 90:35-45, 1994.
2.Wilcox WD, Laufer S. Tuberculosis in Adolescents. A Case Commentary.  Clinical 
Pediatrics,1994; 33:258-262. 
Smith MHD. Tuberculosis in adolescents. Clinical Pediatrics, 1967; 6:9-15.
3 McCue M, Afifi LA.  Using peer helpers for tuberculosis prevention. J Am College Health 
1996 Jan, 44(4):173-6.  
 
 
 
 
 
Background of TB Study
• Rationale: Preventive TB treatment study
• Sites:Long Beach and Inglewood Public Health 
Clinics
• Participants: Ethnically diverse adolescents aged 
11-19 years old (n=794)
• Randomized in 4 treatment groups (peer 
counseling only, incentive only, combination of 
peer counseling and incentive, usual care)
• Procedure-Face to face interviews, baseline and 
6 month follow-up
• The present report only includes foreign-born 
adolescents (80% of study population)
  
Independent Variables
• Socio-demographic variables
• Clinic related variables (e.g. waiting time)
• High-risk behaviors (alcohol, drug use,  
gang membership, incarceration)
• Psycho-social variables (self-esteem,  
mastery, self-efficacy)
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Recruitment
Baseline Interview
and
Randomization
(n=880)
Peer Counseling
(n=220)
Final
Interview
Contingency 
Contracting
(n=220)
Combined Peer and
Parent Intervention
(n=220)
Usual Care
(n=220)
Model of Study Group Design - Intervention Experimental Design
Follow to
Treatment 
Completion
or Drop-out
  
 Quasi-Experimental/Control Design Study for 
Adolescent Participants at Baseline Surveys
Recruitment
Baseline Interview
and
Randomization
(Baseline N=390)
(Los Angeles : n=191;
Long Beach : n=199)
E1
E2
E3
C
Peer Counseling
(Baseline  n=94) 
Contingency Contracting
(Baseline  n=100) 
Peer Counseling and 
Contingency Contracting
(Baseline  n=96) 
Standard Care (Control)
(Baseline  n=100) Recruitment : July 1996 -
October 1997  
 
 
 
 
 
 
Theoretical Conceptual Framework
Knowledge 
Attitudes 
Beliefs 
Self Efficacy 
Behavioral Intention 
Subjective norms 
Increased 
Compliance 
Tuberculosis
Prevention
  
Characteristics of 
Foreign-born Adolescents
• 20% failed to complete treatment
• 45% live with both parents
• 78% rate their health as good
• 2% are gang members
• 23% are sexually active
• 8% report a history of incarceration
 
 
 
 
 
 
Factors Associated with 
Completion of Care
• Age (OR=0.85; 95% CI: .76-.85)
• Asian ethnicity (OR=3.37; 95% CI .99-.11.44)
• Living with both parents (OR=2.13; 95% CI: 
1.37-3.31)
• Speaking only English with parents (OR=0.34; 
95% CI: .16-.74)
• Sexually active (OR=0.43; 95% CI: .28-.68)
• Gang member (OR=0.26; 95% CI: .07-.87)
• Incarceration (OR=0.50; 95% CI: .26-.94)
• Medication taking behavior (OR=1.25; 95% CI: 
1.14-1.37)
  
Independent Predictors of 
Completion of Care 
• Medication taking behavior (OR=1.28; 
95% CI:1.16-1.41)
• Living with both parents (OR=1.87; 95% 
CI:1.08-3.25)
• Sexual intercourse (OR=0.54; 95% CI-
.31-.94)
• Speaking mostly or only English with 
parents (OR=.34; 95% CI .12-.91)
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Recommendations
• Need to collect more specific information
• Encourage clinic procedures that 
increase compliance 
• Recruit supportive family members 
/friends to facilitate treatment
• Future research should focus on foreign-
born adolescent populations in various 
regions of the US
  
Individual Determinants of 
Compliance
• Understanding the medical regimen
• Belief in the benefits of treatment
• Positive attitudes regarding treatment
• High levels of self esteem and self efficacy
 
 
 
 
 
 
Environmental Determinants of 
Compliance
• Family member reinforcement in the home
• Good patient/provider communication
• Systematic approaches for patient 
monitoring, follow up and reinforcement
• Convenience of picking up medication from 
the clinic
• Use of pill containers and cueing behaviors 
  
Individual/Environmental 
Determinants of Completion of 
Care
• Regular appointment-keeping behavior
• High levels of adherence 
• Community health workers
• Reinforcement of positive behaviors by 
health care staff
• Peer counselors to clarify health concerns
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PARTICIPATORY RESEARCH APPROACHES 
Shawna Mercer, M.Sc., Ph.D. 
Health Scientist,  
Public Health Practice Program Office, Office of the Director 
Centers for Disease Control and Prevention 
 
 
 
  
Sharpening the Focus on Turning 
Research into Practice: The 
Promise of Participatory 
Research Approaches
Shawna L. Mercer, PhD, MSc
Office of Science and Extramural Research
Public Health Practice Program Office
Centers for Disease Control & Prevention
 
 
 
 
 
 
Bottleneck in Translating Public 
Health Research into Practice
• There is insufficient recognition of the 
complexities inherent in putting public 
health research findings into practice 
across diverse communities, settings, 
and situations 
4 To be relevant for practice, research must 
meet diverse practice needs
  
Challenges for Taking 
Research Results to Practice
1. Internal vs. external validity 
(generalizability):
4 Internal: 
 Are we measuring what we purport to measure?
4 External:
 How applicable is this to real-world rural 
settings and situations?
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Challenges for Taking 
Research Results to Practice
2. Best practices vs. locally appropriate 
and affordable practices
4 For special populations
 e.g., minority populations in rural areas
4 In underserved areas
4 For those of lower socioeconomic status, lower 
education
4 Behavioral vs. medical interventions
  
Best Practice Application Gaps
• Accessibility gap 
4Do I have the same resources as the 
experimenters?
• Credibility gap 
4How different is their situation of practice 
from mine?
• Expectations gap 
4Is it really necessary for me to strive for 
such lofty goals in my practice?
» Lancaster B. Closing the gap between research 
and practice. Health Educ Q 1992;19:408-411
 
 
 
 
 
 
A Solution for Taking 
Research Results to Practice  
)An upstream approach 
4By actively engaging practitioners, policy 
makers, community members in the 
research process, it is more likely the results 
will be relevant to their needs
  
Participatory Research is…
• “Systematic inquiry
• With the collaboration of those affected by 
the issue being studied
• For the purposes of education and taking 
action or effecting social change”
Green, et al., 1995 
Study of Participatory Research in Health Promotion. 
 
 
 
 
 
 
What is Participatory Research?
• It is not a method
• It is an approach
4Involves engaging potential users and 
beneficiaries of the research in the research 
process
4A wide range of study designs and research 
methods can be used
 Selection depends on the research questions and 
feasibility issues
  
Whose Participation 
Should be Sought?
• Who is to be affected by the research 
results? 
4Geographic communities
4Other groups sharing common characteristics 
 Ethnic groups, practitioners, policy makers, health 
departments
 Minority or special populations living in rural 
settings
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“Mom, Dad’s been doing participatory research again.”   
How Much Participation is 
Needed?
• At a minimum:
4helping to formulate research questions 
4 interpreting and applying the research 
findings
• Possibly also:
4Selecting and using methods 
4Analyzing data
• Rule of thumb:
4Dependent on complexity and labor-
intensiveness of methods and analyses
 
 
 
 
 
 
Considerations in Developing   
OSER’s Extramural Prevention 
Research Grant Program (EPRP)
• Tenets of participatory research:
4Grass-roots initiative
4Local control and autonomy 
• What are the implications for funding, 
supporting, judging (not threatening or 
undermining) participatory research?
  
Needs and Preferences of 
Researchers and Practitioners
• A vision for participatory research
• Adequate time for true participation
• Investigator-initiated research
• External peer-review 
• Infrastructure capacity, methodology, 
and other cross-cutting issues
• Multiple levels of intervention 
• Take research results to scale and 
sustain effects
 
 
 
 
 
OSER Grant Funding FY2003-
2005: Community-Based 
Participatory Prevention Research
• To stimulate investigator-initiated 
participatory research on community-
based approaches to prevention
4Multi-disciplinary
4Multi-level research
4Community
4Cross-cutting
 Caveat: guided by community needs
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Community-Based Participatory Prevention 
Research Grants:  LOIs Submitted from Each 
State (N = 435)
MA: 28
RI:   1
CT: 5
NJ:  6
DE:  2
MD: 13
DC:  14
Alaska, Hawaii and Puerto Rico are not to scale.
AK :  2 HI:  2 PR:  5
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EPRP’s Second Round of Grants:  
Response and Funding
• Response:
4570 letters of intent (LOI)
4311 full applications
• Funding:
440+ projects approved for funding
4~$11.4 million
4~25 projects funded
4Each project: ~$450,000 per year for 3 years
  
Range of Projects Funded
• Cross-cutting research such as:
4Diabetes, asthma, obesity 
4physical activity, nutrition, tobacco 
prevention, drug prevention, violence/injury 
prevention
4youth and school-based health 
4workforce development 
4reduction of health disparities 
4Increasing access to care 
 
 
 
 
 
 
Diabetes in Hispanic Appalachians
• Issue:
4Growing numbers of Hispanics moving into rural Appalachia 
(migrant and permanent)
4High levels of diabetes; low access to care
• Research team:
4East Tennessee State University Researchers
4Hispanic community and provider partners
• Site:
4Southern Appalachia
• Intervention:
4Development of tailored interventions to enhance detection, 
management, and prevention of diabetes
4Education to increase the capacity of Hispanic community to 
identify and solve its other health problems
  
References
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Community-Based Participatory Research for 
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Replicating Effective Programs:
Turning Research Into Practice
Agatha N. Eke, PhD
Centers for Disease Control and Prevention (CDC)
Atlanta, Georgia, USA
  
Institute of Medic ine Report
The IOM Report on HIV prevention 
recommended: 
Key DHHS agencies that fund HIV 
prevention research and interventions 
should invest in strengthening local-
level capacity to develop, evaluate, 
implement, and support effective 
programs in the community.
 
 
 
 
 
 
HIV Prevention Strategic Plan
By 2005, strengthen the capacity 
nationwide to monitor the epidemic, 
develop and implement effective HIV 
prevention interventions and evaluate 
prevention programs.
Goal Four
  
Goals
• HIV prevention agencies should conduct 
interventions that are science-based.
• Research-based HIV prevention behavioral 
interventions should be made available for 
use by prevention agencies.
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Experience
Our experience in the Centers for Disease 
Control and Prevention’s (CDC) Replicating 
Effective Programs (REP) project has 
taught us valuable lessons on what 
researchers & prevention agencies need to 
do to achieve these goals.
  
A New Model of Behavioral Research
• Old Model = Research project ends with publication 
of articles that present research findings
• The research community has a responsibility to 
translate and transfer the fruits of research in ways 
that are useful to society [A shift in paradigm].
• New Model = Active partnership among researchers, 
prevention agencies, & communities at all stages of 
research & transfer into practice
 
 
 
 
 
 
The REP Project: Part of the New Model
• Started in 1996 as a 2-year project
• US$400,000 for each effective, research-based 
intervention
• Converts interventions into packages (kits) for use 
by local HIV prevention agencies
• Funds researchers to collaborate with community 
advisors to prepare the intervention packages
• Other prevention agency collaborators conduct 
trials/case studies of implementing the intervention 
using the packages, training, & TA
  
The REP Project: Continued
• So far, REP has:
– converted 7 interventions into packages
– 3 packages in formal preparation
– 1 package in informal preparation (CITY)
 
 
 
 
 
 
REP Criteria to Determine An 
Intervention’s Effectiveness
• Completed research study
• Measured behavioral or biologic outcomes
• Collected pre- and post-test data
• Used treatment & control/comparison groups
• Retained ≥ 70% of participants
• Evaluated using quantitative statistics
• Found to have statistically significant positive 
effects
  
Translation and Transfer Steps for 
Researchers
Year 1 of REP
• Form advisory committee of HIV prevention 
providers and community members
• Translate science into lay language
• Develop package contents & format with 
advisory committee
• Find other HIV prevention agencies to field test 
package
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Translation and Transfer Steps for 
Researchers (cont’)
Year 2 of REP
• Orient agency to intervention and collaboratively 
tailor & adapt it
• Train agency staff in technical skills & 
intervention delivery
• Provide technical assistance on implementation 
and problem-solving
• Evaluate the process & debrief the agency staff
• Refine package based on agency input & 
produce final version
  
Transfer and Implementation Phases for 
HIV Prevention Agencies
Pre-Implementation Phase
• Obtain administrative, agency staff, & 
community buy-in
• Line up resources & designate responsibilities
• Orient gatekeepers
• Get training for staff who will conduct the 
intervention
 
 
 
 
 
 
Transfer and Implementation Phases for 
HIV Prevention Agencies (cont’)
Implementation Phase
• Tailor delivery to agency & local circumstances
• Adapt intervention for population & setting
• Schedule start-up steps
• Assure quality of delivery & fidelity to Core 
Elements
• Obtain technical assistance
  
Transfer and Implementation Phases for 
HIV Prevention Agencies (cont’)
Maintenance Phase
• Dedicate sufficient resources
• Institutionalize as part of agency’s mission
• Re-adapt to changing circumstances
• Obtain gatekeepers’ acceptance of intervention 
modifications
 
 
 
 
 
 
Lessons for Converting Research into 
Prevention Practice
• Keep detailed, accessible records of interventions
• Identify “core elements” of interventions to 
simplify implementation by prevention agencies
• Researchers should work with prevention 
agencies in converting research into practice
• Develop simple, clear packages of “How to” 
materials designed for prevention agencies
• Shorter & simpler interventions are easier to 
implement
  
Records of intervention
• Intervention’s design & protocol
• Copies of original posters, brochures, videos, 
& other materials
• Details of procedures & logistics
• Costs of intervention separate from costs of 
research
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Identify “core elements” of 
intervention
• Critical features of an intervention’s intent & 
design
• Thought to be responsible for an intervention’s 
effectiveness
• Identified by operationalization of the underlying 
theory & experience in using the intervention
  
Researcher and prevention agency 
collaboration
• Have researchers, agencies, and communities 
design & test packages together
• Adapt interventions to agency resources, 
community needs, & local priorities
• Provide training & technical assistance along 
with packaged intervention protocols
• Collaborate until agency is comfortable with 
the intervention
 
 
 
 
 
 
Packages of “How to” materials
Protocol manual
»Sufficient detail but concise
»Non-technical language
»Clearly written
»Practical
»Appealing & easy to use
Sample posters, brochures, videos, and 
other materials
  
Short and simple interventions
• Few components
• Brief
• Easy delivery skills
• Simple technology
• No monetary incentives
 
 
 
 
 
 
New Model = Active partnership among researchers, 
prevention agencies, and communities at all stages 
of research and transfer into practice
If this perspective is accepted as the model for 
putting science-based interventions into 
practice,
• Researchers should design interventions that 
can be conducted by prevention agencies
• Researchers need to plan ahead for the 
transfer process during their research studies
• Funders need to pay for all stages of the 
research, transfer, and implementation 
process
  
Conclusions
• REP is a part of a new model for researchers & 
funders.
• Transfer is complex and expensive but possible.
• Transfer requires alliance between researchers & 
prevention agencies.
• Infrastructure & support for conversion, 
dissemination, & implementation are needed.
• Challenges will be compounded when transfer 
becomes nationwide.
• Challenges of wide-scale transfer of effective 
behavioral interventions must be met to impact 
the AIDS epidemic.
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For more information
Visit the Replicating Effective Programs plus 
(REP+) website at:
www.cdc.gov/hiv/projects/rep/default.htm
Consult CDC’s special journal supplement on 
technology transfer:
Turning HIV Prevention Research Into Practice, 
AIDS Education and Prevention, 12, 
Supplement A, 2000
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Diffusion of Effective 
Behavioral Interventions 
(DEBI)
Capacity Building Branch
Division of HIV/AIDS Prevention
CDC
  
 Handoff Between Research (PRB) 
and Practice (CBB) 
SYNTHESIS REP DEBI 
FAST TRACK
 
 
 
 
 
 
Goal of Diffusion of Effective Behavioral 
Interventions (DEBI) Project
To develop and coordinate a national-
level strategy to provide high quality 
training, technical assistance, and 
other capacity building activities to 
diffuse science-based HIV 
interventions to state- and 
community-level HIV programs.
  
Diffusion of Effective Behavioral Interventions:
A Nine-Step Process
1 Planning: system level; individual intervention level
2 Needs assessments and Customer Profiling
3 Marketing and Satellite Broadcast
4 Intervention program package design
5 Training curricula/TA guide development
6 Training trainers, coaches, providers
7 TA to CBOs and HDs implementing programs
8 Evaluate process and outcomes
9 Refine diffusion strategy based on lessons learned
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DEBI Three Phases
Planning Phase (12-months): design/pilot/ 
conduct interest/needs assessment; produce 
pkg. copies; design/pilot evaluation tools; 
build partnerships; plan marketing & diffusion 
strategy; develop/pilot TOT/TOC, TOF guide, 
& TA Guide 
Implementation Phase (3-months): train 
master trainers & coaches (“Training Institute”)
Roll-Out Phase (24-months): train 700 
agency facilitators, provide TA, evaluate 
process, monitor outcomes
  
Training Components
Curricula design to teach prevention providers 
the methods to implement the intervention.
Intervention institutes to teach trainers how to 
train direct prevention service providers.
Regional, state-wide, and local intervention 
trainings to widely diffuse the intervention 
technology to direct prevention service 
providers.
 
 
 
 
 
 
Intervention Training Curricula
Approved by original researchers 
Highly explicit, detailed guidance
Based on Adult Learning Principles
Appropriate for as a TOT or direct 
provider curriculum
Piloted/revised prior to major roll-out.
  
Intervention Institutes
Train the Trainer/Coach
Researcher involvement
Intensive skill-building around the 
intervention
Develops trainer/coach partnerships
Develops training/coaching 
implementation plans
 
 
 
 
 
 
Regional, state-wide, and local 
intervention trainings
Coordinated by AED
Provided by training teams
Intervention manuals and 
other intervention materials will 
be distributed
  
Training Partners
CBB Training Team
Prevention Training Centers 
Education Training Network
CBA Trainers
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Family of Coaches
CBA Priority Area 2 Providers
BSSV
CBB Science Application Team
Health Department capacity 
building providers
  
Coaching
Coaching is on-site, phone, or e-mail 
technical consultation by a mentor or role-
model technical assistance or capacity 
building provider
 
 
 
 
 
 
Other supports for diffusing 
effective interventions
Satellite Broadcasts
Chat rooms or list serve
Newsletters
Follow-up conference calls
Distribution of package updates
Conference affinity session for current 
users of an intervention package
  
2002: Started Blending REP & 
DEBI
In REP’s Year 1, DEBI:
– Helps REP PIs with their TOF curriculum
– Provides TA Guide template
– Develops a TOT/TOC curriculum
– Starts planning diffusion strategy with REP PI
In REP’s Year 2, DEBI:
– Observes facilitator training
– Trains trainers & coaches
– Has coaches observe REP implementation
– Makes plans for package production
 
 
 
 
 
 
Lessons Learned
In order to move research to practice, 
an active partnership is needed at all 
stages among communities, 
researchers, prevention agencies and 
diffusion agents.
Need to strengthen communication 
between communities, applied 
scientists, researchers, and all 
partners. 
  
Lessons Learned
Diffusion is a multidisciplinary effort 
that includes people with shared 
vision: peers, frontline staff, 
community/agency change agents, 
curriculum writers, trainers, TA 
providers, researchers, and agency 
administrators. 
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Lessons Learned
Understanding more about the 
relationship between agency capacity 
and implementing with fidelity will 
improve diffusion efforts. 
What researchers identify as an 
“effective intervention” be not be 
perceived as “effective” by the 
community. 
  
Lessons Learned
Everybody wants to “adapt” 
interventions to make them their own.  
Adaptation and tailoring are 
absolutely critical to maintaining the 
efficacy of the intervention.
“Playing” with or implementing part of 
an intervention may build conceptual 
utility and lead to adoption.
 
 
 
 
 
 
Lessons Learned
Successful diffusion involves overcoming 
many myths such as:
– CBOs don’t want or can not handle 
science based interventions. 
– Researchers and communities do not 
work well together
– Interventions can not be changed or 
updated
– Interventions are meant to replace the 
current work of communities
  
For more information
Visit the Disseminating Effective Behavioral 
Interventions (DEBI) website at:
http://www.effectiveinterventions.org
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Effective Interventions 
for Asthma
Leslie P. Boss, MPH, PhD
Air Pollution and Respiratory Health Branch
National Center for Environmental Health
CDC
lboss@cdc.gov
  
Objective
• Share our approach to:
• Increasing availability of effective community 
interventions for asthma
• Know what interventions existed 
• Know the result of asthma intervention 
research activities from the past
• Know what intervention research is currently 
ongoing
• Identify intervention gaps
 
 
 
 
 
 
Asthma
• Roughly one in 17 Americans have asthma
• Traditionally addressed clinically
• Complex disease, challenging to diagnosis 
and treat
• Under diagnosed and under treated
• Behavior change needed
– People with asthma
– Parents of children with asthma
– Medical care providers
• Complex interventions
  
Implementing Effective 
Interventions
• Such interventions have to exist
• Need to know about them
• Must be appropriate for the population in 
need of intervention
• Need to have access to the documented 
procedures and materials
• Need to have staff with necessary 
competencies for implementation or provide 
training needed to meet the competencies
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Intervention 
research
Identification of 
effective interventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
  
Widespread Implementation
• Rooted in the 
community
• Science-based
• Implemented as part of 
a comprehensive and 
integrated program
Intervention 
research
Identification of 
effectiveinterventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
Stakeholder
input
 
 
 
 
 
 
Intervention gaps?
Are there populations in 
need of intervention for 
whom there appear to be 
no effective interventions?
If yes, is there already an 
effort underway to fill that 
gap?
Intervention 
research
Identification of 
effectiveinterventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
Stakeholder
input
  
Is Additional Intervention 
Research Needed?
• What interventions 
already exist?
• What intervention 
research is currently 
underway?  
• Does that research have 
the potential to provide 
interventions for 
populations in need?
Intervention 
research
Identification of 
effective interventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
Stakeholder
input
 
 
 
 
 
 
Intervention Research
• Often funded by outside 
organization, usually 
NIH
• Positive health outcome
• Dissemination of results
• Research designed with 
translation in mind?
Intervention 
research
Identification of 
effectiveinterventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
Stakeholder
input
  
Identification of Effective 
Interventions
• Identified criteria for 
labeling interventions 
as effective
• 193 publications 
reviewed
• Initially 16 interventions 
identified as effective; 
now 43.
• Initially 2 of 16 ready to 
implement; now 5.
Intervention 
research
Identification of 
effectiveinterventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
Stakeholder
input
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Translation
• Removes research 
elements;
• Modifies the protocol 
based on research 
findings;
• Updates materials;
• Develops components as 
needed;
• Assures that revised 
procedures and materials 
are widely available.
Intervention 
research
Identification of 
effectiveinterventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
Stakeholder
input
  
Translated Interventions
Wee 
Wheezers
at Home
Home
Power 
Breathing
Open Airways
(RAP)
School
Medical 
Home
ALA 
project
ACT for Kids
(NCICAS)
Wee 
Wheezers
Clinic/ED/
hospital
ProvidersAdultsTeensYoung 
school
Pre-
school
Intervention 
site
 
 
 
 
 
 
Sharing the Information
• Internet
– Summary of publications of 
effective intervention 
research
– Accessing intervention 
packages
– Case studies
– Bibliography
• Searchable database
– Ongoing intervention 
research
• E-mail, conferences, 
publications, etc.
Intervention 
research
Identification of 
effectiveinterventions
Translation
Widespread 
community
implementation
Identification of 
Intervention gaps
Defining needed
research
Stakeholder
input
  
www.cdc.gov/nceh/airpollution/asthma/
interventions/interventions.htm
(or go to www.cdc.gov/asthma, 
And follow the trail to ‘Interventions”)
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DTBE Appropriation and Funding
Kate O’Toole, MBA
Associate Director for Management 
and Operations
  
FY2003 Congressional Appropriation 
to CDC for Tuberculosis
• FY2003 Appropriation = $136,514,000 
(includes S&E)
• Earmark = $125,000 in PHPPO’s budget
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USAID Funding to DTBE
• USAID total funding = $2,551,246
• Overhead tap (15%) = $  382,687
• Balance = $2,168,559
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Discretionary Funding to DTBE
TB
USAID
HIV
 
Project Concept Solicitation: April 
1, 2003
• DTBE solicited research concepts from CDC, 
TBESC, and TBTC investigators. 
• A standardized “project concept form” was used.  
• For CDC staff, all funding proposals (research and 
other) were submitted, but only research proposals 
were forwarded to the CDC/TBESC research 
concept reviewers.
 
 
 
 
 
 
Determination of Appropriateness 
for TBESC: Early April 2003
• TBESC Research Chair and the DTBE 
Associate Director for Science (ADS) 
determined if a appropriate for TBESC.  
  
TBESC RC Review of Project 
Concepts: April 10, 2003
• Before and at the TBESC semi-annual meeting, the 
RC reviewed the research concepts that were 
considered appropriate for TBESC.  
• Prioritized each project concept by giving it a score 
of high, medium, or low.  
• TBESC and CDC investigators whose concepts 
were ranked high or medium were allowed to revise 
and resubmit their project concepts incorporating 
the RC’s comments/recommendations.
 
 
 
 
 
 
TB Leads review of project 
concepts: Early May
• The DTBE Senior Staff independently reviewed the 
project concepts using the same ranking system as 
the RC:  low, medium and high with 
comments/recommendations. 
• They ranked concepts based on the merit of the 
concept to the Division and its mission, and the 
comprehensiveness of collaboration.
  
Joint TBESC RC/DTBE TB Leads 
meeting:  May 12, 2003
• The joint TBESC RC/DTBE TB Leads group met in Atlanta 
to discuss the TBESC RC/TB Leads report.
• The final report to the TBESC and CDC investigators 
included the summary ranking of the TBESC RC and TB 
Leads group (including discrepant results) and 
recommendations to the PIs from each group.  
• Investigators whose concepts were ranked high by both 
groups were encouraged to develop their concepts into full 
TB Leads proposals.  
• A number of investigators whose proposals were ranked 
high and medium were also encouraged to develop their 
concepts into full proposals.
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Submission of TB Leads 
proposals:  October 1, 2003
• TBESC and CDC investigators and their 
collaborators developed and submitted 
proposals.  
• Only investigators who submitted project 
concepts were allowed to submit TB Leads 
proposals.
  
TB Leads Evaluation: October 14, 
2003
• The proposals were reviewed by the DTBE TB 
Leads group and ranked.  This included both 
research proposals and non-research related 
proposals that did not go through the TBESC review 
process.  Final funding decisions will be made when 
the congressional budget for TB is available but no 
projects are expected to be funded in FY2004.
 
 
 
 
 
 
FY2005
• Similar process
• Later initial deadlines
• Earlier decisions
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MAINTAINING THE MOMENTUM:  RECAP AND NEXT STEPS 
Nick DeLuca, M.A. 
Lead Health Education Specialist, 
Division of TB Elimination,  
Centers for Disease Control and Prevention 
 
 
Next Steps Proceedings
• Entertain additional input on further research 
needs (e.g. via list-serv, email, etc.)
• CDC Team will synthesize ideas 
• Share and solicit input on initial draft
• Finalize
  
Next Steps for Agenda
• Forum results
• Literature review
• Workgroups
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Appendix C: TB Behavioral and Social Science Research Gaps and 
Needs:  Major Research Topics, Subtopics, and Research Questions 
 
Overview 
 
The following section provides a listing of the major TB behavioral and social science research 
topics, subtopics, and specific research questions generated by the Forum participants.  For each 
topic and subtopic, a brief description is given, followed by an italicized paragraph(s) 
summarizing the general research concepts that were elicited by Forum participants; (a 
condensed list describing only the major research topics and subtopics can be found on p. 31-43).  
Under each topic and subtopic, the specific questions generated by Forum participants have been 
roughly organized in order from simplest research design (such as questions that would lead to 
descriptive or exploratory research) to most complex and most detailed (such as those which 
might lead to experimental or intervention research).  Because issues can be multi-dimensional 
focusing on different levels and behaviors, some research questions were placed under more than 
one major research topic and subtopic.   
 
In addition to research questions, participants also suggested methodologies that could be used to 
address the research gaps and needs.  Suggestions included greater utilization of behavior change 
models and theories as a basis for conducting behavioral and social science research; conducting 
needs assessments with a focus on patient-centered approaches; and moving from descriptive, 
exploratory research to developing and implementing interventions and utilizing evaluation 
methods to assess intervention effectiveness and efficiency.  Research questions that pose 
methodological points of inquiry are generally grouped together towards the end of each section. 
 
All questions were recorded verbatim from the flip chart notes and overhead slides collected at 
the Forum.  Every attempt was made to preserve the original intended meaning and context of 
the research gaps identified by Forum participants during the discussions.  Several questions that 
were either difficult to understand, did not fit under a specific category, or did not focus on 
behavioral or social science research were extracted from the list.   
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Major Research Topics, Subtopics, and Research Questions 
I. Background 
A. Health disparities 
Vast disparities exist in TB case rates, treatment outcomes, and TB mortality among 
many different population strata.  Historically, these disparities have often been based 
on socioeconomic status and within racial and ethnic minorities, the incarcerated, 
substance abusers, and homeless populations--populations especially vulnerable to 
poorer TB outcomes.  In 2002, TB case rates among non-Hispanic blacks continued to 
be eight times greater than non-Hispanic whites.1  In addition, the past decade has seen 
disparities emerge between U.S-born and foreign-born populations in the United 
States.  Identifying and eliminating disparities in TB case rates, as well as determining 
effective measures to reduce existing disparities, are important steps toward 
controlling and eventually eliminating TB. 
During the breakout sessions, Forum participants identified the need to better understand 
and address disparities in TB case rates and treatment outcomes.  
 What types of research on disparities in TB should be conducted at the community 
level?  Why do the disparities exist, and what can be done to reduce them?   
II. Intrapersonal 
Intrapersonal influences on behavior such as knowledge, attitudes, and perceptions, 
patient satisfaction, and social stigma affect the individual behavior of patients 
including health seeking behaviors and adherence to treatment.  This level also 
addresses individual-level issues that may affect providers’ behaviors, such as 
adherence to guidelines and recommendations. 
A. Patients’ knowledge, attitudes, and perceptions (KAP) 
An individual’s knowledge, attitudes, and perceptions with respect to health in general 
and with a specific illness, such as TB, influence his/her behavior.  Specifically, these 
factors can influence health seeking, understanding of the diagnosis, understanding of 
treatment, treatment initiation, treatment adherence, and general interactions with 
health care providers. 
Forum participants identified the importance of further understanding patients’ 
knowledge, attitudes, and perceptions with respect to TB, with a particular focus on latent 
tuberculosis infection (LTBI).  The need to identify any differences in these factors 
among different ethnic and cultural groups, specifically Latinos and other foreign-born 
populations, was emphasized.  Finally, participants called for the further use of health 
behavior models and theories to be used as frameworks to better understand the factors 
that influence knowledge, attitudes, beliefs and practices of TB patients.  
 How well do patients understand LTBI and TB disease?  Is knowledge associated with 
adherence?   
 What are the KAP of TB in Latino immigrants? 
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 What is the explanatory model of TB in Latino immigrants? (Including beliefs about 
health and sources of illness from Kleinman) 
 What are the health education needs of people with TB?  What are patients’ knowledge 
on TB facts, treatment, adherence, etc.? 
 What are the health education needs (and KAP) of newly arrived immigrants and/or 
“transient” foreign-born persons with respect to TB transmission, treatment, and 
adherence? 
 What emotions do patients feel when hearing their diagnosis?  How can we best assess 
these emotions and help address them? 
 What are the effects of knowledge and attitudes among different ethnicities and 
nationalities on LTBI treatment initiation, adherence, and completion? 
 What is the relationship of patient fears about TB diagnosis and/or treatment and 
completion of treatment? 
 How can behavior change theories and models be used to better understand and 
intervene (interventions) for LTBI?  
 Can we adapt the Prochaska and DiClemente’s Transtheoretical Model utilizing the 
stages of change constructs to TB patient education (particularly LTBI)? 
 What intervention(s) and activities effectively remove or minimize patient engagement 
barriers?  How do other barriers, including patient fear, affect TB treatment 
completion? 
 What qualitative (ethnographic) research (e.g., case studies) can we conduct with 
patients in each group to provide descriptive content on 1) changes in experience over 
time, and 2) communication to family, peers, and others in a patient’s household? 
 What literature exists on the accuracy of self-reporting, including issues that relate to 
interviewer and respondent relationships (e.g., gender, class), patient sensitivity, social 
desirability bias, and demand characteristics? 
B. Patients’ behaviors 
1. Health care-seeking behaviors 
Health care-seeking behavior for TB includes the recognition of TB-related symptoms, 
presentation to health facilities and/or alternative medical resources (e.g., family and 
community healers), and adherence to effective treatment regimens and treatment 
monitoring. Individual factors, such as knowledge, attitudes, gender, sex, ethnicity, 
income, and education, in addition to health service barriers, including accessibility 
and acceptability of care, cost of services, and quality of care, can often delay or 
prevent a person from seeking TB care and treatment.  
Forum participants identified the need to further understand and influence the barriers 
and facilitating factors to seeking health care for LTBI and TB diagnosis, treatment 
monitoring, and completion of treatment for different populations.  Specific questions 
were raised regarding the availability, accessibility, acceptability, and affordability of 
care. In addition, the group discussed the role of further understanding how an 
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individual’s perceptions of the health care system and health care providers influence 
their health seeking behavior.  
 For different groups, what are the barriers to care seeking?  Do they include the 
availability, accessibility, acceptability, and affordability of care?  Is stigmatization a 
reason for delay in seeking care for TB?  
 Why do persons who have symptoms and known past exposure not present earlier for 
diagnosis?  Do barriers include denial or fear? 
 What factors predict initiation of LTBI treatment? 
 What is the effect of using QuantiFERON testing vs. Purified Protein Derivative (PPD) 
on patient acceptance, especially regarding LTBI? 
 From the case worker perspective, what are some patient models of disease regarding 
treatment-seeking behavior? 
 What is the image of “public health centers” among foreign-born persons?  How does 
this image affect health-seeking behavior? 
 What are the systematic (operational) issues regarding delays in TB diagnosis? Are 
foreign-born TB patients (compared with U.S.-born) more likely to have longer delays 
in seeking care?  Are they likely to utilize more health care providers than U.S.-born 
persons before diagnosis? 
 How is a foreign-born patient’s TB treatment-seeking behavior in this country 
influenced by the policies and practices of his/her home country?  (Suggested 
methodology was to conduct a linked study with the foreign-born TB patient’s country 
of origin focusing also on the communities, providers/programs, policy makers, etc.) 
 What social and economic disparities hinder people from seeking care?  Does perceived 
racism hinder health-seeking behavior? 
 What are the effects of medical pluralism on treatment-seeking behavior?  What are the 
delays and sources of care? 
 How can we reduce aversion to venipuncture?  How do we increase the value of one 
visit for LTBI testing? 
 Will educational materials which address common misconceptions towards TB increase 
treatment-seeking behaviors among foreign-born persons? 
2. Adherence to treatment 
Treatment regimens for LTBI and TB include providing the safest, most effective 
therapy in the shortest amount of time and ensuring adherence to prescribed regimens.  
The major determinant of a successful treatment outcome is patient adherence to the 
prescribed drug regimen.   Nonadherence can lead to inadequate treatment which can 
result in relapse, continued transmission, and the development of drug resistance.   
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Directly observed therapy (DOT) and self-administered therapy are two strategies 
commonly used in TB control.  DOT, a major component of case management, is 
currently recommended for all patients with TB disease.  In addition to DOT, research 
has shown the use of incentives and enablers can also enhance patient adherence.  
Directly observed treatment for LTBI is less common due to limited resources.  
Ensuring treatment completion of LTBI poses unique challenges as it is often self-
administered.   
Forum participants identified the importance of further understanding the barriers and 
facilitators that affect the initiation, duration, and completion of treatment of LTBI and 
TB disease, specifically for different populations, such as foreign-born persons and 
incarcerated/newly-released prisoners.  Discussion focused on ways to better understand 
and enhance DOT.  In addition, a focus of the discussion centered on how to improve 
patient acceptance of LTBI treatment.  The discussion also posed questions on how 
behavior change theories and models could be utilized to better understand and overcome 
barriers to treatment for LTBI and TB disease.   
 Who is at high risk for non-adherence?  
 What indicators predict patient adherence to treatment for TB/LTBI, particularly in 
groups such as Latino immigrants? 
 What factors influence positive adherence, and how are these to be used to predict 
treatment regimens (daily/bi-weekly) necessitated in different DOT groups?  
(Suggested methodology is the use of retrospective studies) 
 What are the barriers to completing LTBI treatment? 
 What are the true “costs” of adherence (e.g., job loss, day care, and loss of social 
status)? 
 What are some ways to address issues that relate to adherence and completion of LTBI 
and TB treatment among “hard to reach populations” (e.g., persons released from jail)? 
 What is the relationship of patients’ capacity to engage in the TB treatment plan and 
completion of treatment? 
 What types of framing (i.e., positive vs. negative) best promote adherence?  
 Which conceptual models best explains TB adherence behavior? 
 What is the relationship of the patient’s participation in health care decisions and 
effective TB treatment completion? 
 How can we best understand and then manipulate patient risk/benefit calculations 
regarding LTBI initiation and completion?  
 What interventions can address basic needs (e.g., housing) and treatment adherence 
versus those that focus only on treatment adherence through methods such as education 
and/or incentives? 
 What cultural and educational interventions address adherence with TB and LTBI 
treatment? 
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 What interventions and activities effectively remove role model barriers to TB 
treatment completion? 
 Can peer support (e.g., the pairing of a patient with someone who is also experiencing 
the disease) aid in adherence?  What is the usefulness of a patient-to-peer educator 
match? 
 Does a core team approach, which includes former TB patients who have successfully 
completed treatment, improve adherence and treatment completion among persons 
from high-risk groups?  
 What is the effect and cost-effectiveness of a cultural intervention (e.g., educational 
intervention) on LTBI therapy adherence in Latino immigrants? 
 Will the use of a standardized educational intervention guided by constructs from 
health behavior theories increase the number of skin test positive contacts initiating / 
completing treatment?   
C. Patient satisfaction  
Patient satisfaction is how individuals regard the health care services or the manner in 
which they are delivered by health care providers as useful, effective, or beneficial.  It 
is often based on patient expectations of care and the self-assessment of their 
experiences.  Patient satisfaction may play a major role in a patient’s behaviors.  If a 
patient is dissatisfied with the relationship with their provider or with the clinical 
setting, he or she is much less likely to be adherent to medications, keeping 
appointments, identifying contacts, and so forth.  Research has shown that patient 
satisfaction can be increased with effective patient-provider communication and 
development of a trusting relationship. 
Forum participants identified the importance of the relationship between a patient, 
provider, and health care system that serves them and the need to better understand this 
relationship and the role it plays, especially from the perspective of different ethnic and 
cultural groups. Forum participants also expressed the importance of determining how 
patient satisfaction may be influenced by TB care and services. They also highlighted the 
need to explore the influence of patient satisfaction on behavior such as adherence. 
 What patient, clinic, or service factors influence patient satisfaction with TB services?  
What factors correlate with patient default? 
 What is the relationship between patient satisfaction with the TB treatment process, 
structure, and system and TB treatment completion? 
 What are some ways to elicit feedback from patients about how to improve TB care? 
What types of exit surveys after treatment completion should be used? 
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D. Social stigma 
Evidenced both in research and in practice, stigma associated with TB appears to be 
universal.  The consequences of stigma can be seen affecting care-seeking behaviors, as 
persons have been known to hesitate or choose not to disclose their TB status to family, 
friends, and co-workers out of fear of being socially ostracized, in addition to losing 
their employment or temporary housing.  Research has demonstrated that in some 
cases, personal rejection occurs as a result of the stigma surrounding TB.  Stigma has 
also been shown to hinder adherence to treatment.  By identifying the consequences of 
stigma, social science research has illustrated the need for effective intervention 
strategies to mitigate it.  
During breakout discussions, the research questions surrounding stigma highlighted the 
continuing need to identify the effects or consequences of stigma on care seeking, 
adherence to treatment, and cooperation with health care providers, especially during 
contact investigations, to determine whether certain populations or sub-populations (e.g., 
foreign-born communities) are adversely affected by stigma and in which settings (e.g., 
residential or workplace).  Forum participants also raised the issue of better 
understanding different perspectives and sources of stigma.  Additionally, discussions 
revolved around the need for identifying and testing effective ways to mitigate the 
influences that stigma has on individuals and communities.   
 What current research exists on stigma associated with TB as well as other issues (e.g., 
HIV/AIDS)? 
 How does stigma differ by income levels? Are low-income patients as concerned with 
stigma as middle or upper class TB clients?   
 What effects, positive and negative, does stigma have on decisions to seek help, initiate 
treatment, and complete treatment? 
 What are some reasons, such as stigmatization, for delays in seeking care for TB?  
 What is the effect of stigma on foreign-born women with regard to TB? 
 How can worksite and residential site-based outreach, such as in nursing homes and 
homeless shelters, be done in non-stigmatizing and non-penalizing way, so that people 
do not have to fear losing their jobs or the ability to stay at a site? 
 How can we use what we have learned about stigma to motivate patients? 
 What are some ways to reduce perceived TB stigma among patients and their families?  
What tests can we conduct to determine the best approaches to improving TB program 
efficiency and treatment completion rates? 
 Would frequent media production on TB prevention and stigma increase TB awareness 
for government officials? African-American communities? 
 Can stigma be reduced through ad campaigns? (Suggested methods include using 
various experimental designs) 
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 What survey research can we conduct in patient and provider populations to assess 
discrimination, stigma, and treatment issues among people with HIV/TB as well as 
people with TB in the home environment, community, and worksite? 
 Are current conceptual frameworks (for understanding stigma) adequate? 
o If “yes” to above, what frameworks (e.g., focus groups, interviews, and surveys) 
can be used to collect research on providers and patients? 
o If “no” to above, what formative research can be conducted on the origins of TB 
stigma and its specific components?  
 How do we define “stigma” from the perspectives of the patient, provider, and 
community? Who is the stigmatizer and why?  (Suggested methods include the use of 
focus groups and the Delphi technique) 
E. Providers’ knowledge, attitudes, and perceptions  
A health care provider’s knowledge, attitudes, and perceptions (KAP) about LTBI and 
TB play an important role in their ability to diagnose and treat individuals with TB.  A 
variety of factors, such as medical and health-related training (e.g., U.S.-training vs. 
foreign training, generalist, or specialist), cultural and ethnic background, practice 
settings, preferred sources of information and learning styles can influence providers’ 
knowledge, attitudes and beliefs about LTBI and TB.   
Forum participants identified the need to better understand the TB-related knowledge, 
attitudes, and perceptions of different providers in a variety of practice settings,  including 
private physicians, primary care physicians, civil surgeons, international medical 
graduates (IMG), and providers who serve foreign-born populations.  Forum participants 
called for the further use of health behavior models and theories to be used as 
frameworks to better understand the factors that influence knowledge, attitudes, beliefs 
and practices of TB providers and how these factors influence their ability to diagnose 
and treat TB patients.  
 What are the current levels of TB KAP of health care providers, particularly among 
non-health department providers, primary care physicians, civil surgeons? 
 Are provider characteristics (e.g., attitudes and knowledge) and other factors (e.g., time 
and workload) important in predicting adherence and successful treatment? 
 What are effective methods for raising TB awareness (e.g., the index of suspicion) as a 
differential diagnosis among private health care providers? 
 In seeking to change foreign-trained physicians’ views of Bacille Calmette-Guerin 
(BCG) vaccine and LTBI, is the message or the process more important? 
 In what ways do gender and ethnicity preconceptions of patients affect program 
performance, including timeliness of diagnosis, nature of relationship with patient, and 
case management?  (Suggested methods include using a mix of qualitative and 
quantitative methods, such as conducting interviews/surveys with providers* and 
patients; having providers and patients keep diaries; and observations.) 
*Providers can include a broad spectrum, (e.g., outreach workers and anyone who has contact with patients). 
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 What specific methods or approaches are most effective in educating private health care 
providers about LTBI and TB? 
 What are some ways to develop and test alternative modes of educating IMGs and 
private providers regarding disease and treatment of LTBI and TB? 
 What are some ways to conduct a quasi-experimental group design with practitioners 
using a “standardized” approach versus a tailored messaging approach (e.g., counseling 
and encouragement vs. education)?  Some behaviors on which to focus include 
adherence behavior, appointment keeping, and completion of treatment. 
F. Provider training and practices  
Providers serving individuals at risk for TB in the United States come from a wide 
range of backgrounds and perspectives.  They may have differing knowledge, 
attitudes, and practices related to TB prevention and control based on factors such as, 
where they completed their medical training, residency, board certification 
requirements, and continuing education experiences.  Personal and cultural factors 
may also affect their practices.  All of these factors may influence the providers’ level 
of professional competence, cultural competency, and clinical behaviors, including 
their adherence to professional practice guidelines.  
1. Diverse training 
Providers have different levels of knowledge, attitudes and practices related to TB 
prevention and control, based on factors such as where they completed their medical 
training, residency, board certification requirements, and continuing education 
experiences.  Moreover, many foreign-trained providers and international medical 
graduates (IMG) have an increasingly important role in TB prevention and control 
efforts, as they may be the first point of contact for foreign-born individuals with TB.   
Forum participants identified the need to assess the impact of working with providers of 
different cultural and professional backgrounds, who have undergone different types of 
training in the area of TB control. Participants also identified the need to improve 
collaborations between health department and non-health department providers.   
 How can health care workers best assess patient levels of knowledge and be trained to 
match educational messages and interventions to patient needs? 
 How do we best train TB case workers based on lessons learned?   
 What successful practices have been used to entice non-health department providers to 
cooperate with the health department?   
 How can we get private providers and international medical graduates to do a better job 
of diagnosing, prescribing, and treating LTBI?   
 How can we better improve foreign-trained providers’ contributions to TB control in 
non-health department settings? 
 Can an educational / awareness campaign encouraging providers to consider TB in the 
differential diagnosis of respiratory symptomatic patients increase detection of disease 
in care settings (e.g., emergency rooms, walk-in clinics)? 
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2. Cultural competency 
The role of cultural competency in U.S. TB programs has become increasingly 
important, especially over the past two decades as the proportion of persons with TB 
who are foreign born has rapidly increased and now surpasses U.S.-born cases.  In 
addition, widening disparities have emerged among other U.S.-born groups, such as 
African Americans in the Southeast.  Efforts to promote health and prevent and treat 
disease within culturally diverse groups will involve building the capacity of programs 
to become culturally competent.  This is extremely important in health care, as it has 
generally been shown that minority groups use fewer services and are less satisfied in 
general with their care.  Furthermore, patients may avoid care out of fear of being 
misunderstood or discriminated against.  Providers need to be aware of and 
understand the impact that culture can have on a patient’s TB knowledge, attitudes, 
beliefs, and practices.  By increasing the cultural competency of providers, they will be 
better equipped to provide the most appropriate TB care and treatment.  
Forum participants identified the need to further understand the role of cultural 
competency on the delivery of services to TB patients and ways to increase cultural 
competency among health care providers, including public health nurses and outreach 
workers. In particular, participants focused on how culturally competent health care 
workers can influence patient’s adherence to treatment for LTBI and TB.  
 Does being cultural competent make a difference? How can health departments become 
sensitive to patients’ needs without stereotyping? (Suggested methodology is to 
conduct evaluation research) 
 Does cultural competency have any effect on relationships with patients?  Does it lead 
to better adherence and completion rates? 
 Is further research needed on the effect of cultural competency training (evaluation and 
efficacy) for outreach and public health staff?   
 What is the effect of cultural competency training of staff on LTBI adherence in 
immigrants? 
 What core components would constitute a training program to enhance cultural 
competency among front line health care providers?  Which components generate the 
most significant awareness of change? 
 What are the cultural competency training needs of public health nurses and TB 
outreach workers?  What are the evaluation outcomes of such training? 
 From a research, treatment, and control perspective, how should the issue of “pigeon 
holing” stereotypes be addressed among TB control staff, providers, and patients? 
 How do providers best acknowledge and incorporate traditional cultural beliefs and 
behaviors of foreign-born patients into patient-centered needs assessments, TB 
screening, diagnosis, and patient treatment plans? 
 How do we, as researchers and program persons, acknowledge, utilize and/or 
incorporate the use of traditional methods among ethnic groups (especially among 
foreign-born persons from Southeast Asia) regarding TB treatment? 
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 Are clients more likely to complete treatment if their provider(s) is of the same 
ethnicity, gender, class, or language? (Suggested methodology is to conduct 
intervention studies research, especially on topics, such as LTBI adherence) 
 Regarding message acceptability, is there a difference in knowledge and adherence 
behavior when the caregiver is matched with the patient on race, gender, or both, 
particularly in generally segregated communities? 
 What specific methods should be developed for assessing cultural beliefs and behaviors 
that are related to TB? 
3. Clinical Practices 
Clinical practices of providers can include TB screening and treatment, patient 
management, collaborating with the health department for contact investigations, and 
adherence to guidelines and recommendations.  Just as patients are faced with 
individual or structural barriers to adhering to LTBI and TB treatment, health care 
providers also face numerous challenges and barriers to adherence to TB screening 
and treatment guidelines and recommendations.  Providers must be aware of CDC and 
American Thoracic Society guidelines in order to implement them.  In addition, other 
barriers such as provider background and practice setting may influence their 
adherence to guidelines.  Identification of barriers to the awareness of and adherence 
to guidelines and ways to address these barriers can improve provider practice and 
lead to the provision of more effective health care.   
Forum participants identified the need to determine ways to increase providers’ 
awareness and adherence to TB treatment guidelines for providers in different health 
care settings.  In these discussions, “providers” include private providers, community 
health workers, case workers, non-health department physicians, and foreign-trained 
providers.  
 What provider behaviors best prevent TB outbreaks? How can they reduce diagnostic 
delay in patients with TB?  
 What are the effects of medical pluralism on provider response to patients’ treatment 
models?  (Special relevance should be given to foreign-born persons for delayed 
diagnosis and adequate treatment of LTBI and TB) 
 How do opinion leaders change behavior of others?  How can opinion leaders improve 
translation of recommended treatment standards to provider practice? 
 What type of practitioner’s guideline is needed to proactively identify “high-risk of 
drop-out” patients in order to address issues which would prevent dropping out of care?  
What information should be provided to reinforce and support positive health behaviors 
and their determinants? 
 What methods should be explored for improving provider adherence to TB guidelines 
and recommendations? 
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III. Interpersonal 
Interpersonal influences on behavior focus on the relationship between two individuals 
or units regarded as a pair.  Examples include the patient-provider relationship and its 
impact on both the patient and provider as well as influences of a family member, 
significant other, or peer on a patient. 
A. Communication between patients and providers 
Communication between patients and providers is critical for effective health care.  It 
is a fundamental element that helps to shape the patient-provider relationship and 
foster trust.  Communication includes appropriate linguistic concordance, optimal use 
of interpreters when necessary, verbal and nonverbal expressions and cues, and good 
listening skills by providers.  Communication also ultimately reflects the dynamics of 
the relationship between a provider and the patient.  Provider-patient communication 
can impact trust, patient satisfaction, and treatment adherence.  
Forum participants identified the need for additional research to understand the role of 
provider-patient communication in effective TB case management. Participants discussed 
the need to foster positive interactions and to build trusting and caring relationships 
between patients and providers.  
 How do we create and improve positive interactions and build trusting and caring 
relationships between patients and providers? 
 What are the key components to building trust in the patient/provider relationship? 
B. Family and peer influences 
A TB patient’s family, peers, and social networks can be very influential on the 
patient’s behavior.  Family and peer influences can affect an individual’s decision to 
seek treatment and to adhere to provider treatment recommendations.  In addition, 
peer and social influences can impact a TB patient’s willingness to identify contacts 
during a contact investigation.  
Forum participants identified the need for research to further understand the family and 
peer in terms of whether and when a patient enters (and remains in) care.  
 How can we reach supporting populations to reduce fear of TB transmission in 
household/worksite? 
 How does TB affect families as a whole? 
 How do we better educate the coworkers, friends and relatives of the TB patient? What 
messages do family members and others need in order to accept and support the 
patient’s diagnosis? 
 How can TB program staff integrate the families (including extended family members) 
and the communities of TB patients into the TB process of education, case 
identification, treatment, follow-up, prevention, and re-integration into the job and 
community to prevent stigma and discrimination? 
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 What are some ways to develop culturally sensitive and appropriate strategies to 
educate families and coworkers and communities about TB? 
 What is the effect of family member influences, especially women, on their family 
member’s health seeking behavior? 
 How can TB programs assist and support female patients in fulfilling their familial 
roles given their illness?  
 How can social networks be involved in positive and facilitating ways regarding a 
patient’s TB experiences? 
 What are the community influences on health behaviors? What is the impact of 
community health workers (peers) on treatment initiation and completion? 
 What is the role of social support in LTBI adherence in Latino immigrants? 
 What is the application of a social network framework to at-risk TB populations? 
 What is the relationship of the patient’s role models to effectively completing TB 
treatment?   
 Who are the best, most effective role models or opinion leaders of high-risk patients? 
IV. Health Systems and Organizations 
Influences of health systems and organizations on behavior focuses on how structural, 
economic, and other organizational forces can affect the views of individuals, small 
groups, and communities.  Examples include the availability, accessibility, and use of 
health care services by individuals, and collaboration between and among provider 
communities and other systems. 
A. Organizational structure  
The way in which the health care system is organized may play a role in affecting both 
patient and provider behaviors.  Whether the system has a vertical or horizontal 
structure, whether services are integrated with other health and social services or are 
part of a collaborative network, and how the health care system is impacted by other 
systems within a society may impact availability, delivery, and acceptability of services. 
1. Collaborations between provider communities and systems  
There are many different social and behavioral determinants involved in TB 
transmission, identification, and treatment success.  Certain factors that place 
individuals at high risk for TB, such as poverty, substance abuse, and homelessness 
can be greatly impacted by the availability and quality of social services.  Both private 
and public collaborations between and among existing social service agencies and TB 
control efforts, as well as timely and appropriate social service referrals for individuals 
with TB, may play an important role in the efforts to successfully eliminate TB. 
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There are also a number of relevant collaborations between TB services and other 
health-related entities that may need to be better understood and cultivated.  Given the 
high rate of TB/HIV co-infection among certain populations, collaboration between or 
integration of TB and HIV services may lead to better treatment outcomes and 
improved satisfaction among persons receiving these services.  Collaborations with 
mental health and substance abuse services, homeless shelters, and correctional 
facilities hold equal promise.   
Forum participants identified the need to determine ways to increase collaboration 
between TB programs and other health and social service agencies for related conditions 
(e.g., HIV/AIDS, mental health, and substance abuse) to improve TB diagnosis, case 
management, and integration of services.  Specific areas for increased research include 
focusing on patients with multiple/varied needs, U.S.-Mexico border issues, and 
collaboration with correctional systems, Immigration and Customs Enforcement, and 
other agencies. 
 What mix of TB and other services are most effective in different communities, and 
what are the difficulties encountered in providing such a mix? What mix is best for the 
patient and provider? 
 What are some ways to develop collaborations with the justice system (e.g., county 
jails)? 
 What are some ways to increase U.S. (south of border) and Mexico/Central America 
collaboration through the use of the government, health care providers, academic 
institutions, and community agencies?  How should the community of origin be 
factored into this? 
 What are the country specific TB prevention and control strategies of Mexican, Central, 
and South American health departments and communities? 
 How can TB control and prevention partnerships be developed between U.S. and 
Mexican local health departments, specifically in Mexican communities? 
 What are the barriers that health providers and health departments face when doing TB 
control and education with labor and services providers? 
 What are some ways to identify and compare better methods on increasing 
collaboration between TB control programs and other health and social service 
agencies? 
○ How can coordination of care (i.e., systems of care) be increased for patients with 
multiple health issues, such as co-morbid conditions?   
○ How can coordination of mental health care with TB treatment and adherence 
interventions be increased?  How can patients with mental health problems best 
receive care?  
○ What can be applied from HIV practices to TB with regard to incorporating 
screening and care into jail settings? 
○ How can TB be integrated into HIV provider and community planning group 
activities?  What about substance abuse provider activities? 
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○ How can constraints, such as environmental ones, be overcome in the 
implementation and provision of HIV counseling and testing in TB programs and 
clinics? 
 What specific interventions would positively impact the fact that clients in correctional 
facilities are referred to the community [health center] for follow-up of LTBI therapy? 
 What strategies or models for collaboration lead to better patient outcomes, not only for 
TB, but for a patient’s holistic health?  (Suggested methodology is to conduct 
operational research using case studies.)  
 Using an HIV case model, what type of comparison can be made on the following:  1) 
an increase in the number of those who know their TB status; and 2) the number who 
receive appropriate treatment?  
2. Impact of sharing patient information 
Patients who have other health and/or social issues such as TB/HIV co-infection, 
diabetes, substance abuse, and mental health issues, in addition to TB or LTBI, may 
have multiple providers. The sharing of patient information becomes a crucial 
component in the provision of proper and effective health care, especially as it relates 
to a patient’s TB treatment regimen and follow-up care.  Providers who take a holistic 
approach to their patient’s health and who thus have a complete picture of their 
patient’s health and well-being are better equipped to make well-informed decisions 
that ensure the most appropriate TB care and treatment. 
Forum participants identified the need to focus upon the impact of sharing (or not 
sharing) patient information on case management, service coordination, and health 
outcomes among managing providers in varying settings, such as health departments and 
correctional, mental health, and substance abuse facilities. 
 What is the impact of sharing and not sharing of patient information on provider 
behavior and treatment outcome? 
 Does the sharing of client records among managing providers (e.g., county health 
departments, jail system, mental health facilities, and substance abuse facilities) 
increase the quality of case management for clients with TB? 
 What are the key elements of a medical record that health providers need to start and 
continue care? 
 What type of retrospective analyses of clinical medical records can be conducted to 
develop a patient profile?  How can factors and determinants be identified for patients 
who completed care and for those who dropped out, based on their medical charts? 
 What types of evaluation can be conducted on health data transfer systems currently in 
place for TB? 
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B. Service delivery 
The delivery of health services plays a major role in how patients receive TB care and 
treatment.  From an organizational perspective, accessibility and acceptability of 
services, cost of services, and quality of care can often delay or prevent a person from 
seeking TB care and treatment.  Through the use of patient-centered approaches and 
effective case management, these systematic barriers can be reduced or alleviated, 
resulting in improved provision of care and better treatment outcomes. 
1. Patient-centered approaches 
Patient-centered approaches focus on bringing together compassion, empathy, 
responsiveness, and resources to the needs, values, and expressed preferences of 
individual patients.  Effective patient-centered care is essentially a partnership 
between the provider and the patient.  It involves determining individual patient needs 
and expectations while ensuring that efforts are made to address those needs and 
expectations by the health care provider(s). 
Forum participants recognized the potential benefits of delivering TB control services 
which embody a patient-centered approach, and suggested that additional research is 
needed to identify, compare, and standardize different methods and models for patient-
centered care. 
 What are some patient-centered approaches that can be tested, standardized, and 
replicated? 
 What are some ways to develop and compare different methods for conducting patient 
needs assessments? 
 How are client-centered needs assessments best utilized in developing client-centered 
interventions?  Do we need to restructure needs assessment tools to be holistic? 
  How do we demonstrate the added value of patient-centered TB treatment? How can 
this be applied to other services?  What are the synergistic influences of TB control 
programs on those other services? 
2. Case management  
Quality case management is an important component of effective TB care.  It holds the 
potential to increase treatment adherence and treatment outcomes by tailoring case 
management to the patient, by making appropriate referrals to needed health and 
social services, and helping to remove barriers to treatment success.  However, little 
empirical evidence exists that systematically confirms the effect of the various types of 
case management practices.  Part of the reason for this may be that many case 
management practices are not standardized and vary based on case management 
models and institutions.   
Forum participants identified the need to determine the influences of case management 
on multiple outcomes (e.g., treatment outcomes, reduced homelessness, care for substance 
abuse, receipt of other appropriate social and other health resources) as well as 
approaches to strengthen case management practices. 
 107 
 How can negative outcome expectations be overcome in order to provide HIV 
counseling and testing in TB clinics? 
 What is the impact of using case management strategies in homeless shelters (and also 
jails) on multiple outcomes, including LTBI adherence, reduced homelessness, and 
increased access to mental health care and substance abuse treatment? 
 Would the quality of case management improve if addressing social needs was a 
standard part of the model? 
 What types of demonstration projects can be used to apply case management strategies 
that are effective with patients with active TB to LTBI patients? 
 What are some ways to conduct theory based experimental or quasi-experimental 
studies that test specific methods to improve efficiency and effectiveness of TB control 
programs?  
3. Advantages and disadvantages of directly observed therapy  
Directly observed therapy (DOT), in which a health care worker or other qualified 
individual watches the patient swallow every dose of the prescribed drugs, is an 
extremely effective strategy for making sure patients take their medicines.  DOT is 
strongly recommended as part of a patient-centered case management plan because it 
is difficult to reliably predict which patients will be adherent.  Successful treatment 
programs are dependent upon public health programs and providers accepting 
responsibility for a patient’s care by ensuring that DOT is appropriately administered.  
As TB incidence declines and programs are turning their attention to the treatment of 
LTBI, more TB programs are trying to use DOT for LTBI patients.  Data indicating 
low completion rates among patients on treatment suggests the importance of 
determining the appropriate use for DOT with LTBI patients. 
Forum participants identified the need to conduct further research on the effectiveness of 
varying DOT modalities for LTBI and TB, such as clinic, home, or field-based DOT.  
Forum participants also raised the need to identify patient-centered DOT strategies that 
are most appropriate to the particular needs of patients, questioning the one-size fits all 
mentality.  Participants also focused on the need to further delineate the usefulness of 
DOT in treating TB and other co-morbid conditions, such as HIV. 
 What are the most effective DOT strategies based on existing research? 
 How can DOT services be most cost effectively delivered?  
 Given that directly observed preventive therapy (DOPT) is an expensive modality, what 
are cost-effective models for achieving treatment of LTBI? 
 Does the initial education of the infected patient regarding the use of DOPT affect the 
completion of treatment?  Are factors, such as advising not to use alcohol, initially 
emphasized? Is the lack of a health department’s legal power to enforce LTBI 
important to why clients drop out? 
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 What case control studies can be conducted to identify predictors of persons who 
succeed and persons who fail in self-administered programs for LTBI, and who may 
benefit from DOPT? 
 What additional research is needed on DOT with regard to TB treatment adherence? 
Are there parts of the DOT process that interfere with adherence? 
 What method, clinic-based versus home-based DOT for TB treatment, works best and 
for which patients? 
 Can changes be made to the DOT process that will aid in adherence (e.g., increase in 
patient participation, feelings of control)?  
 Is selective DOT a viable option? What components of DOT can be delivered 
separately? 
 What are some ways to test and evaluate different directly observed therapy-short 
course (DOTS) “flavors” for appropriateness? 
 How can patients be screened in terms of determining 1) what basic needs will enable 
them to complete therapy, and 2) what flavor of “DOTS” (e.g., observation, control, or 
medicine pick up) works best for them? 
 Is DOT for HIV and TB helpful in treating both diseases?  
 How should a randomized clinical trial (RCT) of full vs. selective DOT with a detailed 
protocol for patient management be conducted?  What specific components (e.g., home 
visits, clinic visits, or self-management) are effective? What specific outcomes, such as 
completion rate, failure and relapse rate, multi-drug resistance, and cost-effectiveness, 
are important to measure? 
4. Role of incentives and enablers 
Research has shown that the use of incentives and enablers can enhance patient 
acceptance as well as adherence to treatment for both TB disease and LTBI.  
Incentives and enablers help patients continue and complete treatment and are widely 
used in facilities providing TB services.  Incentives and enablers are most beneficial 
when they are tailored to the patient’s special needs and interests.  Learning as much 
as possible about individual patients through the use of patient-centered approaches 
will help to identify their needs and better assist them in completing treatment. 
Forum participants identified the importance of further understanding the barriers and 
facilitators that affect the initiation, duration, and completion of treatment of LTBI and 
TB disease, and the role that incentives and enablers can have in achieving TB treatment 
goals, specifically for diverse populations such as foreign-born persons and incarcerated 
or newly released prisoners.   
 What are some ways to identify and distinguish basic needs from incentives and their 
impact on treatment completion? 
 What is the role and effectiveness of incentives in completion of treatment, particularly 
with DOT and without DOT?  What about the use of DOPT? 
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 What incentives are effective with different foreign-born populations?  With African-
Americans in the southeast?  With the homeless? 
5. Contact investigations 
The contact investigation is an important component of TB prevention and control 
efforts, as it is a process for identifying persons exposed to someone with infectious TB, 
evaluating them for LTBI and TB disease, and providing appropriate treatment for 
LTBI or TB disease.  In TB programs in the U.S., there is wide variability in the way in 
which contact investigations are conducted.  Furthermore, the contact investigation 
can be sensitive for TB patients as they are required to elicit personal information, 
such as who they interact with, how often, and where. Little is known about the social 
and emotional impact of these investigations on the individuals involved and on the 
identification and follow-up of contacts.   
Forum participants identified the need to determine ways to improve contact 
investigations by, for example, gaining a better understanding of patient and contact 
perceptions and being more sensitive to involved parties to enhance contact investigation 
outcomes.  Finally, more research is needed with providers to examine their perspectives 
on contact investigations. 
 What are the perspectives of patients, contacts, and providers of contact investigations? 
What are the problems associated with contact investigations? How can the yield and 
patient satisfaction with contact investigations be increased? 
 How can contact investigations be improved?  How can the process be better explained 
and made less intrusive to patients?  What is the distinction between TB control and TB 
care?  How can these be differentiated, and what would it look like?  How can the 
process be made less punitive without jeopardizing public health? 
 Why do some contacts not want to be examined?  For patients with TB disease who 
were unidentified but knew they were contacts, what barriers did they encounter that 
prevented them from getting tested? 
 What are some ways to systematically collect data on TB control and other programs in 
various settings, (e.g., prisons and homeless shelters) during investigations of TB 
outbreaks in order to identify “missed opportunities?” 
6. Health communications 
Health communications can be used to share information on TB with the general 
public, local communities, patients and contacts, as well as providers. Research has 
demonstrated that misconceptions about TB and the stigma associated with the disease 
still abound, suggesting the continuing need to increase knowledge and awareness of 
TB through effective channels of communication.  Further research to better 
understand informational needs, identify appropriate and effective media for 
channeling information, and testing health messages related to many aspects of TB for 
a variety of audiences will enhance the effectiveness of TB control efforts and hopefully 
mitigate the stigma associated with TB. 
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Forum participants identified the need to identify specific and tailored messages and 
messengers for improving communication about LTBI and TB diagnosis and treatment 
among patients and providers, as well as among family members and within the 
community. 
 What messages do family members need to accept and support the patient’s diagnosis? 
 What type of message will increase the completion of LTBI treatment?   
 How do we integrate messages with traditional health beliefs of foreign-born patients 
and of the community? 
 What are current media messages in TV news and programs, newspapers, and 
magazines about TB and people with TB? Do these messages in daytime/primetime 
programs, newspapers, and magazines need to be improved or changed to be more 
effective? 
 Regarding message acceptability, is there a difference in knowledge and adherence 
behavior when the caregiver is matched with the patient on race, gender, or both, 
particularly in generally segregated communities? 
 What is the role of peers and other messengers in the delivery of health messages for 
patients, contacts, and providers? 
 Does a core team approach, which includes former TB patients who have successfully 
completed treatment, improve adherence and treatment completion among persons 
from high-risk groups? 
 How do opinion leaders change behavior of others?  How can opinion leaders improve 
translation of recommended treatment standards to provider practice? 
 What are the best places to advertise to high-risk groups? 
 What specific educational interventions are most effective in reaching clients in terms 
of type of delivery, type of message, time entailed, messenger, and cost-effectiveness? 
7. Special challenges of high risk settings and populations 
a. HIV/TB 
Co-infection of TB and HIV presents challenges for both patients and the 
providers serving them.  One challenge is related to the potential lack of 
collaboration among TB and HIV programs.  It is important that TB providers 
offer HIV voluntary testing and counseling to both TB patients and high risk 
contacts, and that HIV providers offer TB screening and follow-up.  Patients who 
have both TB and HIV may also face challenges associated with the burden of 
taking medicine for both diseases, as well as with the stigma associated with both 
illnesses. 
Forum participants identified the need to conduct research on patient, provider, and 
agency barriers to the integration of voluntary HIV testing and counseling in TB 
programs as well as the incorporation of TB services in HIV/AIDS programs. 
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 How do the views of disease and patient agencies differ between TB as a single 
disease and HIV/TB co-infection? 
 Regarding HIV testing of persons with TB and LTBI, how can we better 
understand why TB and LTBI clients resist testing for HIV?  What motivators can 
be used to get TB and LTBI clients to get tested? 
 How can the provision of HIV counseling and testing in TB programs be 
improved? 
 How can we help TB program managers and front line staff integrate HIV 
volunteer counseling and testing (VCT) into their TB program activities?  What 
are the barriers and how can we reduce them? 
 Is there a way that TB can be better integrated into HIV community planning 
group activities? 
 How can we overcome the environmental constraints to implementing HIV 
counseling and testing in TB clinics?  How can we overcome the negative 
outcome expectations to providing HIV counseling and testing in TB clinics? 
 What survey research can we conduct in patient and provider populations to 
assess discrimination, stigma, and treatment issues among people with HIV/TB as 
well as people with TB in the home environment, community and worksite? 
 What are some effective models that can be used to increase HIV testing of TB 
patients? 
b. Homelessness, unstable housing, and mental health issues 
TB control also faces significant challenges when dealing with homeless 
populations or with individuals who may also be experiencing mental health or 
substance abuse issues.  These issues, combined with a lack of stable housing, 
make TB screening and follow-up, diagnosis, contact investigations, treatment 
initiation, adherence, and completion of treatment extremely challenging. 
Forum participants identified as important the need to assess the TB knowledge, 
attitudes, and perceptions (KAP) as well as other influences on behavior of homeless 
populations. Participants also identified the need to consider using patient-centered 
case management strategies to identify and address competing health and social 
issues for this population. 
 What are the TB KAP and influences of homeless people? 
 What is the impact of using case management strategies in homeless shelters (and 
also jails) on multiple outcomes, including LTBI adherence, reduced 
homelessness, and increased access to mental health care and substance abuse 
treatment? 
 How do we address the impact mental illness and addictions have on TB?  
(Suggested methodology is to conduct intervention research.) 
 What research is needed on mental health issues in regard to client behavior?  
What are some effective interventions that address mental health issues (co-
morbidities) of people with TB? 
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c. High mobility jobs and migrant labor 
Given their mobility, migrant farm workers and other migrant populations 
present unique challenges to TB prevention and control programs with respect to 
diagnosis, treatment, continuity of care, and contact investigations.  U.S.-Mexico 
border issues, such as immigration and frequency of border crossings, create 
additional challenges. 
Forum participants suggested conducting descriptive and ethnographic research 
using case studies as a possible method, among this special population.  This type of 
research might help to determine ways to access migrant networks, mechanisms for 
tracking patients in a non-stigmatizing way, and ways to increase completion of 
care. 
 In what ways does TB affect migrant groups vs. the general population? 
 How can we “track” migrant TB patients so that we follow-up on their treatment 
but don’t stigmatize them? 
 What data sources can be utilized to identify sites with high rates of migrant 
populations including Mexicans? 
 What survey tools can be used to access migrant populations within networks, 
such as employment settings, clinics, etc.? 
 What descriptive research can be conducted that tracks a small sample of mobile, 
high-risk populations? 
 How can migrant “pockets” (i.e., locations with significant populations) be 
identified? 
o What types of ethnographic research studies using quantitative and qualitative 
methods need to be conducted? 
o How should patients be screened for disease?  How can persons with 
TB/LTBI be placed into care? 
o How should patients in care be followed to completion? (Suggested method: 
Interview patients at 18 months) 
 How should the following be conducted with mobile or migrant populations: 
o Targeted testing for significant percentages of TB?  
o Placing patients on TB treatment? 
o Enrolling patients in Migrant Clinician Network’s TBNet program? 
o Following patients through to treatment completion? 
o Following up with patients upon treatment completion, including reviewing 
for ease of contact, ease of tracking, percentage complete, and percentage 
lost? 
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d. Incarceration 
Jails and prisons pose a unique challenge for TB prevention and control.  Efforts 
have been made to improve the relationships between health department TB 
programs with jails and prisons to enhance TB screening and follow-up among 
inmates and correctional personnel.  In addition, continuity of care can be a 
particular challenge for TB patients who are incarcerated during treatment and 
who are later released from prison or jail while on treatment.   
Forum participants discussed the need to conduct further research to identify ways 
to improve TB screening activities, as well as adherence to and completion of 
treatment for incarcerated persons and newly released prisoners.  In addition, 
participants called for further research to examine how screening and treatment for 
TB can be incorporated into the diagnosis and treatment for other diseases such as 
HIV.   
 How can we provide demonstrations and conduct evaluations of programs 
intended to improve TB testing and follow-up in jails? 
 What ways can we improve adherence and completion of TB/LTBI treatment 
among “hard to reach populations” (e.g., persons released from jail)? 
 How do we address TB for incarcerated populations returning to the community? 
 What specific interventions would increase referral of clients in correctional 
facilities to community facilities such as health centers for follow-up of LTBI 
therapy? 
 How can we evaluate the use of incentives and educational based interventions 
aimed at increasing adherence to LTBI and TB treatment for persons being 
released from jail? 
 What can we learn and apply from HIV to TB with regard to incorporating 
screening and care into jail settings? 
e. Substance use 
Substance abusers are at increased risk for TB. Substance abusers may have 
competing priorities that may prevent them from being diagnosed with TB, 
accepting and adhering to treatment regimens, and identifying contacts. 
Forum participants identified the need to better understand the TB knowledge, 
attitudes, and perceptions (KAP) of substance abusers as well as determine the best 
ways to address these issues, so that this population will receive the most effective 
TB care and services. 
 What are the TB KAP/influences of substance abusers?  
 How can patients with substance abuse problems best receive TB care? 
(Suggested methodology is a call for basic research) 
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f. Foreign born 
Although TB case rates have steadily declined since 1992, TB in foreign-born 
persons represents a significant challenge for TB control efforts in the United 
States.  In 2002, TB case rates among the foreign born comprised 51% of 
reported TB cases in the United States.2  Foreign-born populations may have 
unique cultural characteristics, practices, and circumstances related to their re-
settlement and adjustment to the U.S. that may influence their TB treatment and 
care.    
Forum participants identified the need to acknowledge, understand, and incorporate 
different health-related cultural beliefs and practices of foreign-born patients.  
Other issues that warrant exploration included foreign-born persons’ perceptions of 
the U.S. health care system and/or the providers who deliver care, determining the 
role of gender and ethnic differences between patients and providers, and 
identifying and addressing the wide range of barriers foreign-born persons 
encounter when accessing services related to LTBI/TB diagnosis, treatment 
initiation, adherence, completion, and follow-up. 
 What are the effects of knowledge and attitudes among different ethnicities and 
nationalities on LTBI treatment initiation, adherence, and completion? 
 What are the health education needs (and KAP) of newly arrived immigrants 
and/or “transient” foreign-born persons (e.g., Latino immigrants) with respect to 
TB transmission, treatment and adherence? 
 Are immigrant males at higher risk of contracting TB due to labor and 
environmental issues? 
 What is the image of “public health centers” among foreign-born persons?  How 
does this image affect health-seeking behavior? 
 What is the effect of stigma on foreign-born women with regard to TB?  
 What are the systematic (operational) issues regarding delays in TB diagnosis? 
Are foreign-born TB patients (compared with U.S.-born) more likely to have 
longer delays in seeking care?  Are they likely to have more or less access to 
health care providers than U.S.-born persons? 
 What are the effects of migration patterns on foreign-born persons with regard to 
stigma, beliefs, social support, access to care, and ensuring continuation and 
completion of treatment? What happens at other end?  How does a patient’s social 
support structure change with his or her relocation? 
 What are the barriers that immigrants face when accessing TB prevention, case 
identification, education, treatment, and follow up? 
 Will educational materials, which address common misconceptions towards TB, 
seen regionally throughout the world, increase treatment-seeking behaviors 
among foreign-born persons? 
 What factors predict adherence to treatment in Latino immigrants?  
 What is the role of social support in LTBI adherence in Latino immigrants? 
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 How do we best incorporate cultural beliefs and behaviors into patient treatment 
plans, especially for Mexican and other foreign-born populations? 
 What incentives work with various foreign-born populations?   
 How do we integrate messages with traditional health beliefs of foreign-born 
patients and their community? 
 What is the effect of new immigration policies on TB case identification, follow 
up, treatment, and adherence, especially for Latino immigrants? 
 What type of research is needed to maximize screening of new and recent 
arrivals?  How is access to these populations gained?  How can collaboration with 
Immigration and Customs Enforcement (ICE) and other similar agencies that 
focus on foreign-born persons be increased? 
 What are some ways to help undocumented persons overcome their fear of 
government agencies and institutions? 
 What is the explanatory model of TB in Latino immigrants? (Beliefs about health 
and sources of illness from Kleinman) 
 What type of bottom-up education package can be used for educating patients of 
different cultural groups about TB questions they may have, such as on TB 
medication, while also being sensitive to influences, such as the patient’s gender 
and age (e.g., family generation)? 
 What is the effect and cost-effectiveness of a cultural intervention (e.g., 
educational intervention) on LTBI therapy adherence in Latino immigrants? 
 How is a foreign-born patient’s TB treatment-seeking behavior in this country 
influenced by the policies and practices of his/her home country? (Suggested 
methodology was to conduct a linked study with the foreign-born TB patient’s 
country of origin focusing also on the communities, providers/programs, policy 
makers, etc.) 
g. Pediatrics 
Children with LTBI and TB represent another population with unique 
characteristics and needs.  The diagnosis and treatment of children is often 
dependent upon the role of the parent, primary care giver, and other adults.   
Forum participants felt it was important to conduct research to test alternative 
models to increase LTBI and TB screening and treatment among children. 
 What provider behaviors can lead to more efficient LTBI diagnoses in children? 
Can the tuberculin skin test (TST) be avoided for low risk children? What tests 
should be conducted for the use of new testing tools for children?  How do we get 
providers to use these screening tools, if effective? 
 What alternative models can be used for delivery of LTBI treatment among 
children? An example of an alternative model is the use of school-based parent 
administers with and without prompts (e.g., phone call reminders). 
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V. Community  
Influences that are community-related affect behavior on both small and large-group 
levels, such as those in community settings.  Examples include influences of family and 
social networks on individuals, the relationship between local health services and 
individuals and communities, and the impact of social stigma of TB on groups. 
A. Impact of TB services on communities and patients 
Whether defined by a geographic region, a common interest or shared ethnic or 
cultural background, communities play an important role in people’s lives.  Because a 
community typically shares a set of common interests and values and gains strength 
from this collective entity, it is important for health care providers to understand the 
communities they serve to effectively meet the community’s needs.  Developing a 
respectful, collaborative relationship with communities may strengthen the delivery of 
health services and improve the general health and well-being of communities as a 
whole.   
Forum participants identified the need to determine the perceptions of TB within 
communities and to understand the origins of those perceptions and the influence of 
forces that affect people’s perceptions, such as the media.  Participants also expressed the 
need to develop tailored, culturally-specific interventions to increase understanding of TB 
and reduce the stigma associated with TB. 
Participants across all groups discussed the need to determine the optimal relationship 
between health departments and the local communities they serve, as well as the role of 
community groups like community-based physicians in increasing TB awareness and 
delivering TB services.  Suggestions were made to conduct more participatory action 
research and to define and determine how local communities can become involved in 
locally driven research. 
1. Influences of family and social networks 
Family groups and social networks have been shown to be extremely influential on 
many different health outcomes.  In terms of TB outcomes, this influence can manifest 
itself positively by facilitating or supporting, for example, care-seeking, treatment 
adherence, and other patient behaviors.  Conversely in other cases, misconceptions 
held by those close to individuals with TB can have negative effects such as increasing 
the level of stigma attached to the disease resulting in social ostracism or isolation.  
Furthermore, family units and social networks are often adversely affected by the 
introduction of TB and the consequent stressors into their networks.  Successful TB 
control efforts based on a strong understanding of these issues may maximize the 
positive influences of social networks and minimize disruptions to family and social 
networks.  
Forum participants identified the need to better understand the role of social networks on 
health behaviors and determine strategies for strengthening the positive influences of 
social networks.  Specific focus was given to identifying ways in which TB programs can 
work with families to better understand and mitigate the impact of TB services on social 
networks. 
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 How can we reach supporting populations to reduce fear of TB transmission in 
households and worksites? 
 How does TB affect families as a whole? 
 How do we better educate the coworkers, friends, and relatives of the TB patient? What 
messages do family members and others need to accept and support the patient’s 
diagnosis? 
 How can TB program staff integrate the families (including extended family members) 
and the communities of TB patients into the TB process of education, case 
identification, treatment, follow-up, prevention, and re-integration into the job and 
community to prevent stigma and discrimination? 
 What are some ways to develop culturally sensitive and appropriate strategies to 
educate families and coworkers and communities about TB? 
 What is the effect of family member influences, especially women, on their family 
member’s health seeking behavior? 
 How can TB programs assist and support female patients in fulfilling their familial 
roles given their illness?  
 How can social networks be involved in positive and facilitating ways in a patient’s TB 
experiences? 
 What are the community influences on health behaviors? What is the impact of 
community health workers (peers) on treatment initiation and completion? 
 What is the role of social support in LTBI adherence in Latino immigrants? 
 What is the application of a social network framework to at-risk TB populations? 
 What is the relationship of the patient’s role models to effectively completing TB 
treatment?   
 Who are the best, most effective role models or opinion leaders of high-risk patients? 
2. Social stigma 
Evidenced both in research and in practice, stigma associated with TB appears to be 
universal.  The consequences of stigma can be seen affecting care-seeking behaviors, as 
persons have been known to hesitate or choose not to disclose their TB status to family 
or friends out of fear of being socially ostracized.  Research has demonstrated that in 
some cases, personal rejection occurs as a result of the strong stigma surrounding TB.  
Stigma has also been shown to hinder adherence to treatment.  By identifying both the 
sources and consequences of stigma, social science research has illustrated the need for 
effective intervention strategies. 
Social stigma was an issue raised in all of the breakout groups, highlighting the shared 
perception of the need to better understand its sources and identify effective ways to 
address it.  During breakout discussions, forum participants specifically noted the need to 
define stigma from various perspectives, identify existing research to understand the 
impact of stigma, and propose specific measures to address and reduce stigma.  Among 
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these measures, it was suggested to identify ways in which the public health community 
can alter its presentation of epidemiologic data to avoid the perpetuation of existing 
stigmatizations and to reinforce that TB is a curable disease. 
Proposed research questions focused on identifying the effects or consequences of stigma 
on care seeking and adherence to treatment, and determining whether certain populations 
or sub-populations are adversely affected by stigma.   
 How does stigma differ among different ethnic groups?  How does it vary with 
demographics?  (Suggested methodologies include conducting formative and 
quantitative research). 
 How can stigma be reduced among certain groups?  (Suggested methodology is to 
provide massive education to those groups.) 
 What are some ways to enhance the presentation of epidemiological data in order to 
avoid stigmatization and to increase community empowerment? 
 What are some ways to avoid stigmatizing a community and to avoid essentialism of 
TB stigma and discrimination?  
 How can the families and the communities of TB patients be integrated into the 
patient’s treatment, follow-up, and re-integration into the job and community to prevent 
stigma and discrimination? 
 How do we define “stigma” from the patient’s perspective?  …The provider’s 
perspective?  …And the community’s perspective?  Who is the stigmatizer and why? 
(Suggested methods include the use of focus groups and the Delphi technique) 
 What are general community perceptions about TB and people living with TB?  Where 
do they derive their understandings?  What, if any, media influences exist that affect the 
community’s perceptions?  (Suggested methodologies include conducting surveys [e.g., 
mail surveys] among university and high school students; and conducting focus group 
discussions with church groups and other existing community groups.) 
 Are current conceptual frameworks (for understanding stigma) adequate? 
o If “yes” to above, what frameworks (e.g., focus groups, interviews, and surveys) can 
be used to collect research on providers and patients? 
o If “no” to above, what formative research can be conducted on the origins of TB 
stigma and its specific components?  
 What survey research can we conduct in patient and provider populations to assess 
discrimination, stigma, and treatment issues among people with HIV/TB, as well as 
people with TB in the home environment, community, and worksite? 
 What are some ways to conduct an intervention study on the impact of locally 
developed education and messaging within communities on decreasing stigma? 
 What are some ways to develop and test community based culturally specific 
interventions to increase awareness and knowledge of TB and to reduce stigma 
associated with treatment? 
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VI. Public Policy 
Public policy influences focus on the implications that public policies have on the 
behaviors of individuals, groups, communities, and organizations, with special 
emphasis on issues relating to government commitment, funding, health insurance, and 
immigration policies. 
A. Government commitment and funding  
Governmental entities, from federal to local, play a critical role in TB-related services.  
From federal-level research funding to service delivery at local health departments, TB 
control is affected greatly by policy decisions.  Given these arrangements, the 
development of a better understanding of the policy process and greater engagement of 
decision-makers by those working in TB control may lead to improvement in TB 
services. 
Forum participants identified as important the need to focus on identifying appropriate 
decision makers, potential advocates, and strategies to influence TB-related policies. They 
also specifically addressed funding issues such as the identification of effective ways to 
advocate for TB funding as well as possible models for allocation of funds within the TB 
framework. 
 Who are the TB local, state, and national policy-makers?  What are their interests? How 
can TB be made a policy agenda item? 
 How can state programs be influenced to advocate for TB? Where are the decisions 
being made? 
 Who are the best advocates for TB control? (i.e., What is the role of state programs in 
advocacy?) 
 What are the best ways to advocate for TB funding? 
 What are some ways to conduct a demonstration in which TB funding is allocated 
similarly to Ryan White Care Act dollars?  What are some ways to test an HIV model 
(e.g., Ryan White Care Act) within the TB framework? 
 Which cultural interventions can be practically integrated into TB programs with 
limited resources? 
B. Health insurance  
As of 2002, data from the U.S. Census Bureau indicated that 43.6 million people were 
uninsured in the United States.3  The lack of health insurance among people in the U.S. 
creates a serious impediment for those who seek or wish to seek health care for LTBI 
or TB disease, especially as it relates to TB testing and treatment.  It is unknown to 
what extent a lack of appropriate insurance coverage or fear of treatment costs hinder 
care-seeking, but it is suspected that this economic deterrent has clear negative 
implications. 
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Forum participants identified the need to determine the effect of health insurance or lack 
of appropriate coverage for TB services on health behaviors and health outcomes, 
including access to TB diagnosis and treatment.  Further research is needed to determine 
the impact this has on TB patients and their families, in addition to finding alternative 
funding solutions to increasing health care costs and expenses. 
 What is the effect of health insurance (or lack thereof) in regards to early interventions 
for the treatment of TB? 
 How can the poor get health access (e.g., insurance)? 
C. Immigration policies 
With over half of TB cases in the United States occurring among individuals born 
outside of the country, the link between immigration and TB services has become 
increasingly important in recent years.  Efforts to coordinate public health efforts with 
immigration activities pose an evolving challenge as changes occur to immigration 
policy and enforcement agencies.  Understanding the impact of these specific changes 
as well as developing a broader body of knowledge of immigrant issues in general, will 
likely lead to improved TB services and better health outcomes. 
Forum participants identified as important the need to focus on the effect of immigration 
policies, specifically regarding recent changes to policies, on TB services.  Additional 
discussion focused on the need to develop strategies for collaboration with immigration 
authorities to increase access to immigrant communities. 
 What is the effect of new immigration policies on TB case identification, follow-up, 
treatment, and adherence?  What about their effect on TB control among Latino 
immigrants? 
 What types of research are needed to maximize the screening of new and recent 
arrivals?  Issues to address include access to the population and collaboration with 
Immigration and Customs Enforcement. 
 How can undocumented persons be helped to overcome their fear of government 
agencies and institutions? 
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